Genetic Programming for Biomarker Detection in Classification of Mass Spectrometry Data by Ahmed, Soha
Genetic Programming for
Biomarker Detection in
Classification of Mass
Spectrometry Data
by
Soha Ahmed
A thesis
submitted to the Victoria University of Wellington
in fulfilment of the
requirements for the degree of
Doctor of Philosophy
in Computer Science.
Victoria University of Wellington
2015

Abstract
Mass spectrometry (MS) is currently the most commonly used technology
in biochemical research for proteomic analysis. The primary goal of pro-
teomic profiling using mass spectrometry is the classification of samples
from different experimental states. To classify the MS samples, the iden-
tification of protein or peptides (biomarker detection) that are expressed
differently between the classes, is required.
However, due to the high dimensionality of the data and the small
number of samples, classification of MS data is extremely challenging.
Another important aspect of biomarker detection is the verification of the
detected biomarker that acts as an intermediate step before passing these
biomarkers to the experimental validation stage.
Biomarker detection aims at altering the input space of the learning
algorithm for improving classification of proteomic or metabolomic data.
This task is performed through feature manipulation.
Feature manipulation consists of three aspects: feature ranking, fea-
ture selection, and feature construction. Genetic programming (GP) is an
evolutionary computation algorithm that has the intrinsic capability for
the three aspects of feature manipulation. The ability of GP for feature
manipulation in proteomic biomarker discovery has not been fully inves-
tigated. This thesis, therefore, proposes an embedded methodology for
these three aspects of feature manipulation in high dimensional MS data
using GP. The thesis also presents a method for biomarker verification, us-
ing GP. The thesis investigates the use of GP for both single-objective and
multi-objective feature selection and construction.
In feature ranking, the thesis proposes a GP-based method for ranking
subsets of features by using GP as an ensemble approach. The proposed
algorithm uses GP capability to combine the advantages of different fea-
ture ranking metrics and evolve a new ranking scheme for the subset of
the features selected from the top ranked features. The capability of GP as
a classifier is also investigated by this method. The results show that GP
can select a smaller number of features and provide a better ranking of the
selected features, which can improve the classification performance of five
classifiers.
In feature construction, this thesis proposes a novel multiple feature
construction method, which uses a single GP tree to generate a new set of
high-level features from the original set of selected features. The results
show that the proposed new algorithm outperforms two feature selection
algorithms.
In feature selection, the thesis introduces the first GP multi-objective
method for biomarker detection, which simultaneously increase the clas-
sification accuracy and reduce the number of detected features. The pro-
posed multi-objective method can obtain better subsets of features than
the single-objective algorithm and two traditional multi-objective approaches
for feature selection. This thesis also develops the first multi-objective
multiple feature construction algorithm for MS data. The proposed method
aims at both maximising the classification performance and minimizing
the cardinality of the constructed new high-level features. The results
show that GP can dis- cover the complex relationships between the fea-
tures and can significantly improve classification performance and reduce
the cardinality.
For biomarker verification, the thesis proposes the first GP biomarker
verification method through measuring the peptide detectability. The method
solves the imbalance problem in the data and shows improvement over
the benchmark algorithms. Also, the algorithm outperforms a well-known
peptide detection method. The thesis also introduces a new GP method for
alignment of MS data as a preprocessing stage, which will further help in
improving the biomarker detection process.
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Chapter 1
Introduction
This chapter introduces the thesis and includes the problem statement, the
motivations, the research goals, the major contributions, and, finally, the
organisation of the thesis.
1.1 Problem Statement
Nowadays, mass spectrometry (MS) has become the most dominant tech-
nique for high-throughput analysis of proteomes and metabolomes [169].
The main task of MS data analysis is the classification of samples from
different classes.
Classification of MS data from control and treated biological samples
can lead to the identification of features (biomarkers), which can predict a
specific experimental status. The set of detected features provide informa-
tion about the effect of therapy or lead to describe new molecular targets
for therapeutics [47]. To detect the biomarkers, the obtained MS profile
must be analysed through several computational methods.
The mass spectrometer produces spectra datasets, where each spec-
trum consists of tens of thousands of features, which create a large feature
space for classification [173]. Another issue is the small number of sam-
ples generated by the mass spectrometer due to cost and time constraints.
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These factors make biomarker detection in MS data (identification of fea-
tures for classification) extremely challenging [182].
The spectrum is also interrupted by different kinds of noises during
the stages of analysis in the mass spectrometer, which results in reduc-
ing the quality of the data. Due to the noise introduced to the MS data
spectra, a preprocessing framework must take place. The selection of the
preprocessing steps and parameters can also affect the biomarker detec-
tion process [142]. In addition to the previously mentioned challenges in
MS data, the biomarkers sometimes appear at a low abundance that intro-
duces another difficulty in the selection of the correct proteins that can be
defined as the biomarkers.
After the biomarker detection, the biomarkers pass through two other
stages which are shown in Figure 1.1. The detection stage produces the
possible list of biomarkers, which then pass to verification through mea-
suring their detection probability in the mass spectrometer. Finally, the
verified biomarkers pass to the experimental validation that involves test-
ing these biomarkers laboratory. The first two stages of biomarker iden-
tification (feature manipulation and biomarker verification) are tackled in
this thesis. However, the experimental validation is beyond of the scope
of this research.
Underlying computational problems: The compuational problems here
are firstly the large number of features. This introduces the problem of
curse of dimensionality which represents a major obstacle for classifica-
tion. Generally, in feature manipulation, the search space increases expo-
nentially according to the number of features(2n subsets of features if the
number of features is n) [110]. In case of thousands of features, it is im-
possible to exhaustively search all subsets of features which form the can-
didate solutions. Secondly, the small number of training examples which
makes the search for the relevant features more difficult [178]. Thirdly,
for verification, the class imbalance problem of the data which makes the
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Figure 1.1: Stages of the biomarker identification process
performance more the bias to the majority class, and hence, the features
selected or constructed will also be biased to the majority class [70].
Meanwhile, most of biomarker detection methods produce a long list
of biomarkers, and it is impractical to send all of them for experimental
validation. Intermediate verification of biomarkers can reduce the num-
ber of biomarkers for experimental validation, and thus reduce the cost.
Biomarker verification of proteomics MS data can be performed through
the prediction of their detectability in the mass spectrometer, which can
be done through linking the peptide detectability to their physiochemical
properties. However, peptide detection is not an easy task either because
of the imbalance problem of the data (i.e. the number of detected peptides
in the observed class is very small compared to the number of peptides in
the non-observed class). The imbalance problem makes building a predic-
tive model for peptide detection a challenging problem.
Feature manipulation can help to solve the biomarker detection prob-
lem [8]. It provides a means to transform the representation of the in-
put to a classification algorithm to improve its performance [106]. Feature
manipulation consists of feature selection and feature construction. Feature
manipulation is particularly useful in solving the problem of the curse of di-
mensionality, which causes the degradation of the performance of the clas-
sification algorithm. Feature ranking, which is a branch of feature selection,
involves weighing individual features according to their relevance to the
classification task [18]. Feature selection directly eliminates non-relevant
and redundant features of the problem [117]. Neither feature ranking nor
selection creates new features, while feature construction creates new high-
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level features as functions of the original features to enhance the quality of
representation [63].
Feature manipulation can be performed as filter, wrapper or embedded
approaches [117]. In filter approaches, information based evaluation is
typically used to measure the goodness of the features [106]. In wrapper
approaches, a classification algorithm is wrapped to the system to evaluate
the features. In the embedded approaches, the classification algorithm is
itself the feature selection method, i.e. the feature manipulation and the
classifier training process are combined into a single process [123].
Feature manipulation of the high dimensional MS data is a hard task
due to the large search space and the small number of samples. Many ma-
chine learning approaches have been proposed to solve feature selection
and ranking in MS data [148, 156]. However, most of these approaches
depend on the univariant feature selection measure, such as formal statis-
tical tests (t-test) or independent feature ranking. The individual ranking
or selection of features obviously neglects the relationships between the
features [31, 104, 162, 188].
Also, very few works on biomarker detection consider feature con-
struction to improve the performance of classification. Furthermore, ver-
ification of the detected biomarkers, using their peptide detectability, has
not been considered to date.
Genetic programming (GP) is an evolutionary algorithm [92] which
can build programs and functions dynamically. The programs built by
GP range from mathematical expressions to classification models, and, GP
can therefore be flexible in searching the complex solution space. GP has
the potential to deal effectively with the challenges in MS data. However,
there has been little work using GP for MS biomarker detection.
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1.2 Motivations
The MS technology effectively performs the analysis and characterization
of alterations in proteins and metabolites. It offers the possibility of discov-
ering novel biomarkers through the use of machine learning approaches
to analyse the data [120].
Biomarker detection is a difficult problem, especially when the num-
ber of features is large, thus increasing the search space exponentially [25].
Most of the benchmark biomarker detection paradigms depend on the in-
dividual feature evaluation (single feature ranking). The individual evalu-
ation introduces a set of redundant features which, when they are working
together, often degrade the classification performance.
The filter approach for feature selection might introduce redundancy to
the features. Despite the better performance of the wrapper approaches,
they require high computational cost and can lack generalisability to clas-
sifiers other than the wrapped classifier used for evaluation. The embed-
ded approach has the potential to avoid the disadvantages of a filter and
wrapper approaches as it is not computationally intensive like the wrap-
per approach, and also can provide better performance than the filter ap-
proach [106].
1.2.1 Why GP
GP is an effective evolutionary global search algorithm [85]. The most
common form of GP is a tree-based representation that offers great po-
tential for biomarker detection through feature manipulation. The major
reasons are presented as follows.
• GP has an automatic and intrinsic feature manipulation capability as
a part of the evolutionary process for building a classification model.
Therefore, it acts as an embedded approach [178].
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– For feature selection, the individuals of GP consist of functions,
variable terminals and constant terminals. The variable termi-
nals correspond to the features of the dataset. These individuals
vary in size and not all the features appear in the individuals,
which make the selection of features intrinsically in GP [92].
– For feature ranking, in the variable-length individuals, some
features appear more than once, which gives a weighing factor
to the more frequent features.
– For feature construction, the features can be combined through
the mathematical operators by means of individual codification,
which constructs a high-level feature automatically [124].
• GP as an evolutionary technique has the potential to search huge
spaces for optimal or near optimal solutions, unlike some existing
techniques that are often trapped in local optima (e.g. Hill climbing)
[92].
1.2.2 Limitations of Existing Approaches
The limitations of the existing approaches for MS biomarker detection are
summarised in Table 1.1.
1.3 Goals
The overall goal of this thesis is to develop a new embedded GP approach
to biomarker detection and verification in the classification of MS data. To
achieve this goal, we investigate the following research objectives.
1. Develop a new GP ensemble approach to feature ranking. The exist-
ing approaches depend mostly on an invariant measure to evaluate
each feature independently which can result in redundant or irrel-
evant features. The proposed algorithm is expected to combine ad-
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Table 1.1: limitations of the Existing Approaches
using individual feature ranking,
which ignores relationships be-
tween features [188],
The potential of GP for feature selection or
ranking has seldom been investigated for
biomarker detection in MS data.
using wrapper approaches which
are computationally expen-
sive, especially with the high-
dimensionality of MS data [133],
Using GP in classification problems, as either a
filter or wrapper approach for feature ranking,
selection and construction, has shown promis-
ing performance. However, the use of the em-
bedded capability of GP, which can combine
both filter and wrapper approaches’ advan-
tages, has not been seriously investigated.
using principle component analy-
sis or wavelet transformation to
transform the data for classifica-
tion, which require certain assump-
tions and constraints and are lim-
ited to specific kinds of tasks [144].
The potential of GP in biomarker detection,
particularly in feature construction has not
been investigated before.
There is gap between biomarker
detection and biomarker verifica-
tion
the use of GP for biomarker verification has
not been explored before, especially to solve the
problem of imbalance in the datasets.
Most previously approaches are
single objective
Biomarker detection is a multi-objective prob-
lem. The objectives are maximising classifica-
tion performance and minimising the number
of features used for classification, considering
that the detected features must pass an experi-
mental validation stage. Experimental valida-
tion is costly and, careful selection is needed
to decide which biomarker will pass through
it. However, GP based multi-objective optimi-
sation has never been used for MS biomarker
detection.
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vantages of several feature ranking metrics, select a smaller number
of top ranked features, and evolve a better ranking of the features.
This objective will be discussed in Chapter 3.
2. Develop a new GP approach to multiple feature construction. Most
of the previous GP feature construction approaches are taking a wrap-
per approach to constructing a single feature which is insufficient to
improve the classification or take a filter approach and use multiple
GP trees to develop multiple features equal to the number of classes
and this will increase the computational cost. Our approach will con-
struct new high-level features by taking an embedded approach, and
will use a single GP tree to construct multiple features automatically
through the use of the output of different branches of the tree. The
proposed approach is expected to discover complex relationships be-
tween original features, reduce the number of selected features, and
enhance the classification performance. This objective will be dis-
cussed in Chapter 4.
3. Develop a new GP embedded approach to feature selection in MS
data using multi-objective optimisation. The existing approaches
did not consider multiobjective optimisation for MS biomarker de-
tection and hence, it is worth investigation. The proposed approach
is expected to select subsets of the original features that enhance the
classification performance using the intrinsic capability of GP to se-
lect features automatically while building the classification model.
Meanwhile, the multi-objective method is expected to keep the trade-
off between the classification accuracy and the number of features
without the prior assumption of the importance of each objective.
The set of non-dominated feature subsets is expected to be better
than or similar to the SPEA2 [192] and NSGAII [27] approaches for
feature selection and the single objective approach. This objective
will be discussed in Chapter 5.
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The single objective method feature construction approach proposed
in Chapter 4 will be extended to a multi-objective method in that
Chapter. The new GP multi-objective algorithm is expected to keep
the trade-off between the classification performance and the num-
ber of new features. The proposed GP method is evolving a set of
Pareto-front non-dominated constructed features which can improve
the performance of the classification algorithm.
4. Develop a GP biomarker verification method that will be trained on
both yeasts and human serum datasets using the peptides physico-
chemical properties as features. This method is intended to bridge
the gap between the biomarker detection and the experimental val-
idation stages which has not been considered before. The capability
of GP to perform unbalanced classification will be used to build the
prediction model of the peptide detection problem. The detected
biomarkers can be provided as examples in the test set to the system
to verify their detectability in the mass spectrometer. This objective
will be discussed in Chapter 6.
5. Further investigation on the MS data preprocessing will be performed
by developing a new GP approach for multiple alignment of the LC-
MS data. The proposed method will help in correcting the distortion
in the data and thereby, improve the biomarker detection process.
This method is presented in Chapter 7.
1.4 Major Contributions of the Thesis
The thesis makes the following contributions that are summarised in Fig-
ure 1.2.
1. The thesis proposes a new embedded-based ensemble feature rank-
ing approach by combining two feature ranking metrics. The new
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approach considers both the classification performance and the num-
ber of features. The proposed method successfully improves the per-
formance over using each metric independently by eliminating the
redundant features and selecting the most relevant ones. The system
also acts as a classifier and proves the capability of GP to outper-
form state-of-the-art classifiers. Testing the proposed approach on
MS datasets with predefined biomarkers shows that the top ranked
features contain most of the predefined biomarkers.
Parts of this contribution have been published in:
Soha Ahmed, Mengjie Zhang, Lifeng Peng: Improving feature rank-
ing for biomarker discovery in proteomics mass spectrometry data
using genetic programming. Connect. Sci. 26(3): 215-243, 2014.
Soha Ahmed, Mengjie Zhang, Lifeng Peng: Feature Selection and
Classification of High Dimensional Mass Spectrometry Data: A Ge-
netic Programming Approach. Proceedings of the 11th European
Conference on Evolutionary Computation, Machine Learning and
Data Mining in Computational Biology (EvoBIO2013), Vienna, Aus-
tria, Lecture Notes in Computer Science: 43-55, 2013.
Soha Ahmed, Mengjie Zhang, Lifeng Peng: Enhanced feature selec-
tion for biomarker discovery in LC-MS data using GP. Proceedings
of the IEEE Congress on Evolutionary Computation (CEC2013), Can-
cun, Mexico, 584-591 2013.
Soha Ahmed, Mengjie Zhang, Lifeng Peng: Genetic Programming
for Biomarker Detection in Mass Spectrometry Data. Proceedings of
the 25th Australasian Conference on Artificial Intelligence (AAI2012),
Sydney, Australia 2012: 266-278.
2. The thesis proposes a novel multiple feature construction GP sys-
tem. The existing feature construction methods can construct ei-
ther a single feature or multiple features from multiple independent
runs/programs depending on the number of classes. However, the
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proposed algorithm automatically combines original features using
the mathematical operations and constructs new multiple high-level
features from a single evolved program. The results on several bench-
mark datasets show that the proposed algorithm has the potential
to create new features, which improve the performance of common
classifiers. More investigation of the features selected from the con-
struction stage shows that most of the selected features in the GP
individuals are the biomarkers predefined by the domain experts.
Parts of this contribution are published in:
Soha Ahmed, Mengjie Zhang, Lifeng Peng, Bing Xue: Multiple fea-
ture construction for effective biomarker identification and classi-
fication using genetic programming. Proceedings of the 23rd Ge-
netic and Evolutionary Computation Conference (GECCO), Vancou-
ver, BC, Canada, 2014: 249-256.
Soha Ahmed, Mengjie Zhang, Lifeng Peng: A New GP-based Wrap-
per Feature Construction Approach to Classification and Biomarker
Identification. Proceedings of IEEE Congress on Evolutionary Com-
putation 2014, Beijing, China, 2756-2763, 2014.
3. The thesis proposes a new GP-based multi-objective embedded fea-
ture selection method for biomarker detection. The system uses GP
to find complex relationships between features and classes, and then
selects subsets of features based on their discrimination power be-
tween different classes. The results show that GP finds more and
better relationships between the features more than the conventional
methods. The GP multi-objective algorithm uses the ideas of Non-
dominated Sorting Genetic Algorithm (NSGA II) [27] and Strength
Pareto Evolutionary Algorithm (SPEA2) [192] to maximise the clas-
sification accuracy and minimise the cardinality of features. The re-
sults show that the embedded approach outperforms the traditional
multi-objective methods and the single objective GP approach. This
12 CHAPTER 1. INTRODUCTION
thesis also proposes the first multi-objective GP feature construction
approach for biomarker detection. The system aims at maximising
the classification performance and minimising the number of the
constructed features simultaneously. The proposed algorithms pro-
duce lower number of high-level features that improve the classifi-
cation performance on the used benchmark MS problems.
4. This thesis uses GP as a peptide detection method to verify the de-
tected biomarkers. The proposed method solves the class imbalance
problem in the data and avoids the bias to the majority class by giv-
ing equal weights to both classes when building the classification
model. The GP method is trained on three different datasets using
the peptides physicochemical properties as feature vectors. The pro-
posed algorithm improves the classification accuracy of the minority
class which contains the biomarkers peptides thus helping to verify
of these biomarkers.
Parts of this contribution have been published in:
Soha Ahmed, Mengjie Zhang, Lifeng Peng: Genetic Programming
for Measuring Peptide Detectability. Proceedings of the 10th Simu-
lated Evolution And Learning (SEAL2014), Dunedin, New Zealand,
2014, 593-604.
Soha Ahmed, Mengjie Zhang, Lifeng Peng: Prediction of detectable
peptides in MS data using genetic programming. Proceedings of the
23rd Genetic and Evolutionary Computation Conference (GECCO
Companion2014), Vancouver, BC, Canada, 2014: 37-38.
5. The thesis presents preliminary results of a new GP method for mul-
tiple alignment of LC-MC. The proposed method aims at correct-
ing the distortion that will assist in improving the detecting of the
biomarker candidates.
Parts of this contribution has been published in:
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Soha Ahmed, Mengjie Zhang, Lifeng Peng: A Genetic Programming
Based Approach to Multiple Alignment of Liquid Chromatography-
Mass Spectrometry. Proceedings of the 12th European Conference
on Evolutionary Computation, Machine Learning and Data Mining
in Computational Biology, EvoApplications (EvoBIO), Lecture Notes
in Computer Science. Granada, Spain, 2014: 915-927.
1.5 Organisation of the Thesis
The rest of the thesis is organised as follows.
Chapter 2 presents a review of the literature on biomarker detection of
MS data, feature manipulation using GP, and other Evolution Computa-
tional(EC) algorithms. The major contributions of the thesis are presented
in Chapters 3-6. Each chapter addresses one of the research objectives of
the thesis required to fulfill the overall goal. The contributions chapters
are shown in Figure 1.2. Chapter 7 presents some investigations on the
use of GP for alignment of LC-MS data. Chapter 8 concludes the thesis.
Chapter 2 explains the background for MS data generation, details the
nature of the data and the preprocessing steps. The basic background for
machine learning, classification, feature manipulation, evolutionary com-
putation, particularly GP, and multi-objective optimisation are presented
in this chapter. It reviews related work on MS data biomarker detection,
feature manipulation using EC techniques, particularly using GP. It also
discusses the open questions and challenges that form the thesis motiva-
tions.
Chapter 3 proposes a novel GP-based method for ensemble feature
ranking in MS data. It includes two feature ranking metrics, selects the
best features from both metrics and measures the goodness of the selected
features, depending on their frequency of occurrence in the evolved pro-
grams. The scores are then used for further ranking of features. A variety
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Figure 1.2: Overview of the major contributions
of classification algorithms, including GP, are used to test the top ranked
features from several benchmark MS problems.
Chapter 4 develops a new multiple feature construction GP approach.
The proposed method automatically constructs multiple new high-level
features from a single evolved model. The single objective method uses a
new fitness function that maximises linear discriminant analysis and min-
imises the p-value of the constructed features. The proposed approach
with the constructed features is examined and compared with the meth-
ods using the original selected features.
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Chapter 5 proposes multi-objective GP-subset feature selection meth-
ods using embedded fitness evaluation. The multi-objective method aims
to maximise the classification accuracy and minimise the number of biomark-
ers. The method is tested and compared with the single objective method
and two benchmark multi-objective methods. The empirical results on
several benchmark problems are presented and discussed. The chapter
also discusses some advanced topics on feature construction by using multi-
objective GP for maximising the classification performance and minimis-
ing the number of high-level features. The method is mainly based on
GP with ideas from NSGAII and SPEA2 for measuring the Pareto fitness.
These algorithms are all embedded approaches that use the capability of
GP for feature manipulation during the process of evolving a classification
model.
Chapter 6 proposes the use of GP for measuring the peptide detectabil-
ity through building a classifier that uses the peptides’ physiochemical
properties to predict whether the peptides will be detected in the mass
spectrometer. The detection of peptides indicates whether they can be
verified as biomarkers or not. Since the detectable peptides are very small
compared to the non-detectable, the problem is tackled as an unbalanced
classification problem.
Chapter 7 discusses and examines a GP alignment method that is de-
veloped in our work.
Chapter 8 summarises the thesis work and highlights the research goals
and overall conclusions. It also indicates some possible future work and
research directions.
1.6 Benchmark Datasets for Evaluation
Some benchmark MS datasets with varying difficulty and properties are
used to test the performance of the proposed GP approaches. Evaluating
the methods also involved testing them on a range of classifiers to test
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their generalisability in regards to many classifiers and they are not biased
to a specific classier.
MS datasets are typically continuous data. The datasets are obtained
from several sources (available online or obtained from various MS labs,
including VUW school of Biological Sciences proteomics lab). The datasets
are carefully chosen to have a different number of features (365– 45200),
as well as different number of instances (10– 253). We also used some
datasets with predefined biomarkers to test the biomarker detection rate
of the proposed approaches.
Mostly, MS datasets are binary classification problems (case/ control).
In some cases, datasets involve three classes (case/ control/ treated) or
four classes (case stage 1/ case stage 2/ treated/ control).
Table 1.1 summarises the datasets that are used as representative sam-
ples of the MS classification problems that the proposed approaches can
solve with the explanation of the thesis chapters that used the dataset.
In the table, the number of samples is shown in the third column, and
the number of examples in each class is given between brackets. The
last eleven datasets contain some predefined biomarkers that are spiked
into the datasets during the preparation process. More details about the
datasets acquisition are explained in the following chapters.
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Table 1.2: Benchmark MS Datasets
Name of the Dataset # Features # Samples Chapter
Ovarian cancer high-
resolution (OVA1)
15000 216 (121+95) chapters 3,4
and 5
Ovarian cancer low-
resolution (OVA2)
15154 253 (162+91) chapters 3,4
and 5
Premalignant pancre-
atic cancer (PAN)
6771 181 (80+101) chapters 3,4
and 5
Arcene (ARC) 10,000 200 (100+100) chapters 3,4
and 5
Detection of drug-
induced toxicity (TOX)
45200 62(28+34) chapters 3,4
and 5
Hepatocellular carci-
noma (HCC)
36802 150 (78+72) chapters 3,4
and 5
Detection of glycan
biomarkers (DGB)
16075 128(78+25+25) chapters 3,4
and 5
Prostate cancer (Pros) 15,000 (63+190+26+43) 322 chapters 4,5
Apple-plus 773 40 (10+10+10+10) chapter 4
Apple-minus 365 40 (10+10+10+10) chapter 4
DSa porcine CSF 9889 10 (5+5) chapter 3
DSb human urine 29529 10 (5+5) chapter 3
DSc human urine 29529 12 (6+6) chapter 3
DSd human urine 29529 24 (12+12) chapter 3
DSe human urine 29529 30 (15+15) chapter 3
DSf human urine 29529 12 (6+6) chapter 3
DSg human urine 29529 24 (12+12) chapter 3
DSh human urine 29529 30 (15+15) chapter 3
DSi human urine 29529 30 (15+15) chapter 3
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Chapter 2
Literature Review
This chapter is divided into five main parts. The first part explains the
basic background of mass spectrometry technology, while the second part
describes the background of machine learning, feature manipulation and
classification algorithms used throughout the thesis. The third part gives
a description of evolutionary computation (EC) algorithms including ge-
netic programming and other common EC algorithms. The fourth part of
the chapter includes a description of multi-objective optimisation and its
most common algorithms. The fifth part of the chapter discusses the pre-
vious work on biomarker detection of mass spectrometry data and points
out the main limitations of previous approaches. The fifth part also ex-
plains the related work of feature selection and construction done using
different algorithms specifically genetic programming. The chapter ends
with a summary.
2.1 Mass Spectrometry
Mass spectrometry (MS) offers high throughput analysis of the biolog-
ical samples by determining the elemental compositions of these sam-
ples [169, 177]. The mass spectrometer measures the molecular masses of
proteins or peptides, and these masses can be used for identification of the
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compounds [103]. It is composed of three parts, which are the ionisation
source, the mass analyser and the detector. Firstly, the proteins or peptides
are ionised in the ionisation source. Secondly, these ionised molecules are
analysed by the mass analyser, which measures their mass to charge ratios
(m/z). The third part is the detector, which counts the ions for each m/z
value and produces the spectrum.
There are two working modes for the mass spectrometer. The first is the
full mode, which measures the m/z values of the parent ions. The product
spectrum is called MS spectrum. This spectrum is composed of the m/z
ratios of the ions and their corresponding relative intensities. An example
of the MS spectrum is shown in Figure 2.1. The second is the tandem
mode, which fragments the parent ions and measures the m/z ratios of the
fragment ions. The produced spectrum from the tandem mode is called
MS/MS spectrum [103].
Figure 2.1: Mass Spectrum example [95]
To make the spectrum less complex, a separation procedure is often
performed on the samples prior to the mass spectrometer. This separating
method can be a liquid or gas chromatography (LC or GC). The result-
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ing spectrum is called the LC-MS or GC-MS spectrum that contains the
retention times, the m/z ratios and their corresponding intensities [169].
The MS technique is the dominant technique used nowadays for the
identification and quantification of the molecules in biological samples,
leading to the elucidation of their chemical structures and the discovery
of biomarkers in biomedical research due to its high sensitivity, high accu-
racy and high-throughput capability [20].
MS can be applied to proteomic or metabolomic research areas. In pro-
teomics, the first objective is to quantify the proteomes that offers better
understanding of cellular and the structural [11, 167] mechanisms. The
second objective is to identify the quantified protein. The third objective is
the biomarker discovery, where biomarkers are the molecules that indicate
specific biological states linked to pathogenic processes, or pharmacologi-
cal responses to a therapeutic intervention. In the metabolic research area,
the role of MS can be extended to the biochemical reactions and biomarker
discovery characterizing physiologically important metabolites.
However, running MS is a time-consuming process, and it is not prac-
tical to produce a large number of samples. Also, each sample typically
has a huge number of features (as many millions of features) [20].
2.1.1 Proteins and Peptide
A protein is a molecular compound that consists of a chain of amino acids.
When two amino acids of the proteins are linked together through the
peptide bond, they form a dipeptide. More amino acids linked together
are called polypeptide. Very large polypeptide chains form the proteins
[125].
Proteins are the governors or the controllers of the cells which have a
variety of cellular functions. Some proteins (e.g. enzymes) are responsible
for determining which reactions take place. Others have their role in sig-
naling and transport. Structural proteins form some elements that make
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the cells maintain its shape and size [149]. Also, motor proteins gener-
ate mechanically forces. Furthermore, the presence or absence of proteins
are not only important to the state of a cell, but also changes in the abun-
dance of these proteins can make the discrimination between healthy and
diseased cells.
2.1.2 Metabolome and Metabolite
A metabolite is any substance involved in metabolism or the metabolic
process, i.e. the process including a set of chemical reactions that changes a
molecule into another either for storage or for use in another reaction or as
a by-product [179]. The metabolome encompasses a large variety of com-
ponents including lipids, amino acids, organic acids, nucleotides, steroids,
vitamins, sugars, etc. Metabolome is the complete set of Small-Molecule
metabolites. Figure 2.2 shows the relationships between genome, pro-
teome and metabolome.
2.1.3 Mass Spectrometry-Based Proteomics
Proteomics is the process of exploring the whole proteome that is the en-
tirety of the proteins and its modifications [167]. Unlike the genome of the
organism, the proteome constantly changes over time. For example, the
proteomes of healthy and patient people are different. Proteomics aims
at an analysis of the changes of the different states of the proteome. This
analysis will help biologists gain more knowledge about the functions of
the protein and will also help medical scientists develop agents and meth-
ods to cure diseases.
MS is a key technology for high-throughput protein analysis. MS has
achieved great progress toward the identification, quantification, and char-
acterization of the proteins that constitute a proteome [20].
2.1. MASS SPECTROMETRY 23
Figure 2.2: General schema showing the relationships starting from
Genome to Metabolome. Image published under free document license
in the Wikipedia (http://www.wikipedia.com).
2.1.4 Mass Spectrometry-Based Metabolomics
Metabolomics is the set of chemical reactions that occur in cells that are or-
ganised in the metabolic pathways where the chemical is transformed into
another chemical through a series of steps according to this pathway or
map [37]. Mass spectrometry provides a powerful tool for metabolomics
analysis which can guide researchers to the metabolic states and provide
vital information in the decision-making step for target identification and
validation in drug research.
2.1.5 MS Research Directions
MS research has four main directions:
• Proteins and peptide identification: the first method of identifica-
tion is the peptide mass fingerprinting which uses the masses of
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the peptides to search a database of predicted theoretical masses
that would have been produced from digestion of known proteins
[191]. The second method is the De-novo (peptide) sequencing that
is performed without prior knowledge of the amino acid sequence
[69,105,166]. This process works by assigning amino acids from pep-
tide fragment masses of a protein [163].
• Proteins and peptide quantification: determining the quantity of a
specific protein in the sample is another area arising for MS. Protein
quantification through MS can be done in two methods chemical la-
beling or label-free methods [185].
Using the labeling methods [19], a mixture of proteins are labeled
with an isotope that is used to compare the peaks directly from dif-
ferent samples. The labeling methods include SILAC (Stable Isotope
Labeling with Amino acids in Cell culture) [127] and ICAT (Isotope
Coded Affinity Tags) [65]. These methods provide accurate protein
quantification but are considered expensive as they require addi-
tional processing steps and high-cost labeling agents. The label-free
methods depend on the signal intensities (detected peaks for each
peptide) to measure the abundance of the peptide. Label-free quan-
tification has two possibilities, either extracting the ions from the
spectra or the spectral count, i.e. the number of MS spectra in which
peptides of an analysed protein can be found.
• Biomarker detection and classification algorithms: biomarker detec-
tion and classification algorithms are related to the process of find-
ing the peaks or the feature patterns (biomarkers) that can be used to
classify samples and discriminate different classes, e.g., from differ-
ent cell states or from healthy and control classes. Biomarker discov-
ery usually starts with feature selection to overcome the high dimen-
sionality problem. The selected features are passed to a classifier to
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assess the classification accuracy of the selected features. The set of
features that provide better classification are the biomarkers.
• Peptide detection for biomarker verification and protein quantifica-
tion: after biomarker detection, the detected biomarkers pass through
two other stages, verification and experimental validation. Peptide
detection, which is the probability that a the certain peptide can be
observed in a mass spectrometer, can be used as a verification method
of candidate biomarkers. The process of peptide detection can also
be used for absolute quantification of peptides and proteins. The
task of peptide detection can be performed using machine learning
techniques by training a model using a peptide sequence’s proper-
ties. The peptides of the observed class are classified as the verified
biomarkers. Peptide detection is the middle stage between biomarker
detection and experimental validation.
2.1.6 Biomarkers
The term ”biomarker” can be defined as a biological marker or a medical
sign that acts as an indicator of a specific medical state. Biomarker refers
to the indications of a specific illness or non-illness of a patient. In the
literature, there are more precise definition of biomarker for example, the
National Institutes of Health Biomarkers [59] Definitions Working Group
defined a biomarker as ”a characteristic that is objectively measured and
evaluated as an indicator of normal biological processes, pathogenic pro-
cesses, or pharmacologic responses to a therapeutic intervention.” The
World Health Organization (WHO), and in coordination with the United
Nations and the International Labour Organization, has defined a biomarker
as ”any substance, structure, or process that can be measured in the body
or its products and influence or predict the incidence of outcome or dis-
ease” [158].
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Biomarker can also indicate the effect of therapies and drugs that can
be extended to discoveries of new drugs and prognosis of diseases. A
biomarker is a protein, peptide or a metabolite which occur in a biological
sample.
From a machine learning point of view, a biomarker is an important
feature that has a higher capability to discriminate between the different
classes. Hence, the set of features that provide better classification are the
biomarkers. In MS spectrum, each instance is composed of a number of
features where each feature refers to a certain peptide or metabolite. The
feature is composed of the feature identity which is the m/z value, and a
feature value which is the intensity value. The intensity values are used
in the feature manipulation algorithm to determine the biomarker candi-
dates. This process is referred to as the biomarker detection process. The
m/z value of each biomarker is used afterwards to identify what protein
or matabolite this biomarker is.
2.1.7 Mass Spectrometer
The general setup of a simple mass spectrometer is composed of three
parts: The first part is ion source in which the mixture of molecules is
ionised to facilitate the separation process of these ions according to their
mass to charge (m/z) ratio measured using the second part which is mass
analyser. The third part is the detector which counts the resulting ions for
each mass [167]. The structure of the mass spectrometer in shown in Fig-
ure 2.2. There are different techniques of ionisation and mass analysis.
Figure 2.3: Mass spectrometer structure [167].
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ionisation techniques
ionisation techniques include matrix-assisted laser desorption ionisation
(MALDI), surface-enhanced laser desorption/ionisation (SELDI) and elec-
trospray ionisation (ESI) [165].
For MALDI, the analyte has to be mixed with a matrix substance. The
mixture is dried out and crystallized then it is hit with a laser in the vac-
uum. At a specific time, the matrix absorbs the energy and blows up pro-
ducing the ionised molecules in the process [12, 168]. Most of the MALDI
ions are only singly charged, which makes MALDI spectra easy to inter-
pret and analyse. SELDI is a variation of MALDI that uses a target modi-
fied to achieve biochemical affinity with the analyte compound [50].
The second method of ionisation is the electrospray ionisation (ESI)
[112], where the analyte is mixed with a liquid. ESI is usually coupled with
LC to separate the mixture and make the spectra even simpler before the
MS analysis. The analyte solution passes through an electrospray needle
to release the ions. Figure 2.4 shows ESI schematics.
Figure 2.4: Electrospray ionisation (ESI) schematics [58].
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Mass analysers
The mass analyser helps in determining the mass range, sensitivity and ac-
curacy of the instrument [167]. There are different types of mass analysers,
the most common including [186]:
• Sector field mass analyser: uses electric or magnetic fields for de-
flections, where the lighter, more charged, faster ions are more de-
flected [54].
• Time-of-flight (TOF): TOF accelerate the ion produced by the static
electric field and then measure the time they need to reach the detec-
tor [167]. Lighter ions reach the detector first.
• Linear quadrupole ion trap: This mass analyser uses electrical fields
to stabilise or destabilise ions passing through a radio frequency
quadrupole field. Using this approach, certain ions are trapped in
a two-dimensional electrical field and can be selectively discarded
from the trap by their m/z value [186].
• Fourier Transform Ion Cyclotron Resonance (FT-ICR) mass anal-
yser: This analyser makes ions move circularly with a homogeneous
magnetic field. The frequency of rotation depends on the m/z of the
ion. To measure ions with different masses the alternating field is
changed, and the signals for different masses retrieved via Fourier
transform (FT) [186].
• Orbitrap: This is perhaps the most recent mass analyser [186]. Or-
bitrap takes up a circular motion (orbit) through electrostatic attrac-
tion. At the same time, it oscillates along the axis of the central elec-
trode. This oscillation generates signals in the detectors that can be
mapped to mass-to-charge ratios by FT. In contrast to the FT-ICR, an
orbitrap uses an electrostatic rather than a magnetic field. Therefore,
no cooling is necessary. The resolution is nearly as good as that of an
FT-ICR [54].
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Detectors
The mass analyser destroys the ions during analysing, so the detector de-
tects a particle and then multiplies the effect of this particle as the number
of detected ions is often very small [36]. Possible detectors are a photo-
multiplier, secondary ion multiplier, ion-to-photon detector, Faraday cup,
channel electron multiplier, or Daly detector [36].
2.1.8 MS Data Analysis
The pipeline of the MS data analysis consists of the following steps [97]:
• peak signal filtering and baseline subtraction: remove noise and base-
line artifacts that have resulted from instrumental, chemical or bio-
logical errors.
• peak extraction: detects and extracts the accurate positions, heights
and total ion counts of all the peaks.
• identification of the compounds (qualitative MS): identify the com-
pounds in a sample given peak information. For protein identifi-
cation, the MS takes the peptide mix as an input and produces a
list of masses which are used as indexes of the corresponding pro-
teins in a database of known proteins. The list of the masses is called
the peptide mass fingerprint (PMF). During the search the match-
ing proteins, the modified or unmodified peptides and their masses
together with scores per peptide and protein, and the sequence cov-
erage are given as results. This approach can work with a certain
complexity, but if there are many proteins in a sample, this approach
is no longer appropriate. Therefore mechanisms for fragmentation
of peptide are applied (tandem MS/MS) that allow prediction [191]
and de-novo sequencing [69, 105, 166] from fragmentation spectra,
making the identification of proteins in very complex samples possi-
ble.
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• quantification (quantitative MS): determines the quantity of each com-
pound in the samples. It is insufficient to know which proteins in the
cell, it is also important to know how abundant these proteins are to
be able to differentiate between normal and abnormal cells. MS en-
ables high-throughput ability to identify and quantify proteins from
the same sample. However, it is not easy to make it work quanti-
tatively because the measuring sensitivity differs between different
types of molecules [97, 167].
• intensity normalisation: normalise the ion counts of the compounds.
• multiple map alignment: correct the distortion and the fluctuation
of the retention time and m/z dimension of multiple raw or feature
maps in case of tandem MS. In case of MS, correct the fluctuation in
m/z values.
• classification and biomarker discovery: find the feature patterns (dif-
ferentially expressed peaks) that can be used to classify samples [97,
167]. A biomarker is the indication of a change in expression or state
of a protein or a metabolite that correlates with a risk of disease pro-
gression. Biomarker discovery will lead to drug discovery and de-
velopment, indicate drug efficiency, reduce cost and duration of ex-
perimental trials and finally, can help in the cure of diseases.
The use of MS technique for the identification and quantification of
the molecules in biological samples will lead to the elucidation of
their chemical structures and the discovery of biomarkers in biomed-
ical research due to its high sensitivity, high accuracy and high-throughput
capability [97].
Depending on the underlying type of mass spectrometer, a raw MS
spectrum or LC-MS/MS map, can vary from several hundreds of
megabytes up to several gigabytes, whereas only a small fraction of
data contains the signal of interest. This accentuates the need for fast
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and effective machine learning algorithms for each of the analysis
steps mentioned above. This will allow for high throughput, fast
proteomics and metabolic approaches.
2.2 Machine Learning
Machine learning is the research field dealing with algorithms for automa-
tion of knowledge from data [8, 18].
Two main approaches to machine learning are supervised and unsu-
pervised learning [8].
In supervised learning, the learning algorithm learns to produce the
correct outputs from given inputs. A typical example application of su-
pervised learning is classification in which a classifier takes, as input, the
description and properties of several examples of an object and produces,
as an output, a class label for that object [119]. The classification process
consists of two phases, training and testing where, in the training phase,
the classifier has been trained by or learned from examples from the prob-
lem called instances accompanied by the class labels, where the whole set
of instances is called the training set [119]. In the testing phase, the in-
stances that are unseen by the classifier are used to test the performance
of the classifier. The collection of instances used during the testing phase
is called the test set [119]. Another example of the supervised learning
is regression, i.e. the estimation of a function or modelling the problem
solution with equations [8].
In unsupervised learning the examples are unlabelled, which means
that during the training process the learning algorithm cannot use class la-
bels. An example of unsupervised learning is clustering. A main challeng-
ing problem of clustering is the evaluation of the clustering algorithm [8].
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2.2.1 Classification algorithms
Tree-based Classification algorithms
The tree-based classifiers use a tree or a series of trees as a learning method
to differentiate between classes and to build the predictive model [8]. Ex-
amples of tree-based classifiers include decision trees (DT), Random For-
est (RF) and Naive Bayes Tree (NB-Tree). DT classifiers follow the decision
tree learning method (C4.5) [8]. DT’s leaves represent class labels and its
branches represent features that lead to these class labels [8].
RF constructs a multitude of decision trees for training [21] while NB-
tree uses Naive Bayes classifiers at the leave nodes of a decision tree [89].
Non-tree-based Classification algorithms
The Non-tree based classifiers include Bayes classifiers, function classi-
fiers, Nearest Neighbour classifiers and rule-based classifiers. Bayes clas-
sifiers make a probabilistic approach to classification, which assumes that
the input-output relationships can be represented as probability distribu-
tions [8, 71]. NB is a probabilistic classifier based on Bayes theorem. NB
makes an assumption that all the input features are conditionally indepen-
dent [71].
Function Classifiers are the classification algorithms which depend on
a certain function for building the predictive model. Examples are Sup-
port Vector Machines (SVM), Neural Networks (NN) and Voted Percep-
tron (VP).
SVMs construct hyperplanes in a high dimensional space and classify
examples based on the side of the hyperplanes they fall on [71]. SVMs tend
to maximize the distance between these hyperplanes where the points are
fixed support vectors. The machine that uses that the hyperplane is called
the support vector machine [71,172]. NN classifiers work by transforming
the information through layers of a network. The network acts as a func-
tion that maps the instances or observations to the target class labels [24].
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VP is based on the perceptron algorithm and uses kernel functions to build
hyperplanes as decision boundaries [43].
In Nearest Neighbour classifiers, the output class is the class of the
nearest training example. Finally, rule-based classification algorithms de-
pend on the IF-then rule for building the classification model. Examples
of rule-based classifiers are Decision table (DT), where a possible subset of
features are used to construct the decision tables. The test set samples are
mapped to cells in the decision table. The samples in the test set are then
classified according to the label of the majority of training samples of the
cell they are mapped to in the table [88]. Another example is Conjunctive
Rule (CR), which builds a single conjunctive rule to predict the class labels.
It uses the "AND" logical operator to determine a correlation between fea-
tures and classes [180]. The OneR classifier performs classification like a
1-level decision tree [75]. The CART classifier generates partial decision
trees several times to infer rules [41].
2.2.2 Feature Manipulation
Feature manipulation consists of mainly feature selection and feature con-
struction. Feature ranking goes under the umbrella of feature selection
while feature extraction goes under the umbrella of feature construction
[106].
Feature selection is the process of selecting a subset of the original, rel-
evant features and neglecting the redundant or irrelevant features [106].
However, feature construction constructs a new set of high-level features.
There are three approaches for feature manipulation: the wrapper ap-
proach, the filter approach and the embedded approach [8].
Wrapper Approach
The wrapper approach uses a learning algorithm in the search process of
feature selection or construction. It depends on the learning algorithm
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(classifier) to evaluate the selected or constructed features. Its evaluation
is done without the knowledge of the structure of the regression or the
classification function. It can therefore be wrapped to any learning ma-
chine [117]. The evaluation depends on the classification performance
of the candidate solutions to find the best subset of features, which per-
forms best for classification. Usually, the wrapper approach is computa-
tionally more expensive when the number of features is large as it involves
training a classifier for evaluation and accordingly requires a large search
space [106].
Filter Approach
The filter approach is based on performance evaluation calculated directly
from the data. It does not depend on any learning algorithm [117], which
is the main difference between the filter approach and the wrapper ap-
proach. The filter approach typically uses a relevance measure, which is
often the measure of correlation between the features and the class labels,
or generally between the features and target values (outputs) [117]. For
feature ranking, this relevance measure can be calculated for each individ-
ual feature, providing a rank for each feature. The features of the lowest
rank are removed [63]. However, the ranking of individual features is
only useful if the features are independent of each other. If the features are
correlated, some low-ranked but important features (when contaminating
with other features) might not be taken into consideration and, therefore
will not be selected [123]. This makes filter approaches less effective as it
does not consider the relationship between the features.
Embedded Approach
In an embedded approach, the learning and the feature selection or con-
struction mechanisms interact with each other, which is the main differ-
ence between embedded methods and other feature manipulation approaches.
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Meanwhile, unlike the wrapper approach, the embedded approach does
not separate the learning from the feature selection or construction pro-
cesses. Instead, it determines the features and the classifier simultaneously
during the training process [63]. Examples of the embedded methods in-
clude decision trees, where the tree is built by partitioning the data accord-
ing to the importance of the features to the classification accuracy. Genetic
programming is also classified as an embedded approach as it has an in-
trinsic capability of selecting or constructing features, which can improve
the classification accuracy [132].
2.3 Evolutionary Computation
Evolutionary Computation (EC) is a branch of artificial intelligence, which
consists of evolutionary algorithms, swarm intelligence and others. Evo-
lutionary algorithms (EAs) are heuristic optimisation algorithms that are
inspired by the natural evolution and Darwinian principles, e.g. reproduc-
tion, selection, crossover and mutation. EAs are characterised by having
a population of solutions where, each candidate solution is an individual.
The evaluation of the individuals is done by means of a fitness function.
In the evolution stage, selection of individuals is performed, and different
genetic operators are applied to the selected individuals. Examples of EAs
algorithms are genetic algorithms (GAs) [74] and genetic programming
(GP) [92].
Another important branch of EC is swarm intelligence including, par-
ticle swarm optimisation (PSO) [84] and ant colony optimisation (ACO)
[32]. A brief description of GAs, PSO and ACO is provided below. GP will
be described in detail in the next subsection since it is directly used in the
thesis.
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2.3.1 Genetic Algorithms
Genetic algorithms (GAs) [74] are one of the first evolutionary algorithms
which has adopted the process of natural genetic evolution [55]. The pop-
ulation in GAs is encoded as chromosomes, where each chromosome is
represented as a series of fixed length of bits (0s and 1s) [118]. Similar to
other EC techniques, GAs use the genetic operators to evolve the popu-
lations during the search for the solution. The main difference in the use
of genetic operators in GAs is that the mutation is applied to one chromo-
some, while the crossover is applied to two chromosomes. GAs have been
successfully applied to a variety of applications such as pattern recogni-
tion [159], image processing [131] and bioinformatics [128].
2.3.2 Particle Swarm Optimisation
Particle swarm optimisation (PSO) [84] resembles the evolutionary com-
putation algorithms in many features. It uses a population of individu-
als encoding the solutions of the problem. These individuals are manip-
ulated according to the survival of the fittest rule. However, PSO and
other swarm intelligence methods are inspired by social behaviours [83].
PSO resembles the social behaviour of flying birds. It does not use ge-
netic operators like in GAs. However, individuals evolve by cooperation
and competition between the individuals. Each individual in the swarm
is called a particle. The particles search for the optimal solution by flying
in the search space according to its flying experience and its neighbour
particles [151].
2.3.3 Ant Colony Optimisation
Ant colony optimisation (ACO) [32] is inspired by the social behaviour of
ants which aims to find the optimal and shortest path to the food and the
colony [33]. Individuals of the population are represented by ants. The
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ants of the population make a path for other members of the colony to
follow by depositing a pheromone on the ground. The path that has the
most pheromones is produced as the best-designed solution.
2.3.4 Genetic Programming (GP)
The GP algorithm is inspired by the natural biological evolution, where
the phenotype of GP is the genetic program. The genotype of a GP pro-
gram is the representation of this program, which can vary according to
the type of GP. In the tree-based GP (which has also been used in this chap-
ter), each individual is represented by a tree consisting of a set of nodes of
terminals and functions, and only the fittest individuals pass directly to
next generations. Groups of individuals form the population, where the
evolution of the population is driven by selection and mating [92, 123].
+ 
* C 
A B 
Functions 
Terminals 
Figure 2.5: A GP Example that represents the program (A*B)+C.
Program Representation
A tree-based GP program is represented by a tree where the tree nodes
are functions and terminals. A function node performs an operation and
its child represents the arguments of this function, while a terminal node
has no children. The terminal nodes are either variables, representing the
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input values to the programs, or constant values which are randomly gen-
erated [136]. Figure 2.5 shows an example of a tree based genetic program
representing the program (A*B)+C, where the + and * are the functions
and the A, B, C are the terminals.
The main framework of GP consists of the following steps [123, 136]:
• An initial population is generated by a ”random” generation of indi-
viduals using the predefined function and terminal sets.
• Each individual of the population is evaluated and assigned a fitness
value.
• Generate iteratively new populations according to the following steps
until the stopping condition is met:
1. Select some of the individuals using a specific selection proce-
dure;
2. Apply genetic operators to the selected individuals to produce
new individuals;
3. Put the new individuals in the next generation;
4. Evaluate the new individuals, using the fitness function;
• When the stopping criterion is met, the best program is used as the
solution to the problem.
Initialisation of the Population
Like all other evolutionary computational algorithms, GP starts the search
by a randomly generated initial population. The methods of generat-
ing the initial population are either "grow method", "full method." or the
"ramped half-and-half method" [92, 123].
In the "grow method," all the nodes can be selected randomly from
the function and the terminal sets as long as the maximum depth is not
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reached. When the maximum depth is reached, the node must be selected
from the terminal set. This not the case in the ”full method”, where the
nodes less than the maximum depth are all functions, not terminals. The
"ramped half-and-half method" combines these two approaches, where
half of initial the population is generated using the grow method, and
the other half is generated using the full method. The main purpose of the
ramped half-and-half method is to deliver a diverse population [92, 123].
Evaluation of Individuals
The evaluation determines how good an individual or a program can solve
the problem. It is measured through the fitness function. The fitness func-
tion can be designed according to the task or the problem. For example,
it can be the classification accuracy (the number of correctly classified ex-
amples/total number of examples) in the classification task or the error
rate or the amount of time it takes to solve the problem (if the problem is
related to time). The fitness of an individual determines the probability of
its selection for the genetic operators [92].
Selection of Individuals
Selection provides the method for selecting the individuals who will pass
to the mating pool. There are different types of selection methods that
can be used in the GP algorithm, e.g. the roulette wheel selection (” Fit-
ness Proportional Selection”) where the individuals are randomly selected
based on their fitness in which the fitter individual has more chance to be
selected. Another popular selection method is called tournament selection
in which a specific number of individuals are picked up randomly from
the population according to the size of the tournament, and the fittest in-
dividual is selected. A big tournament size gives less probability to select
bad individuals. If the size is equal to one, the process will have a higher
randomness percentage, as the fitness will not be considered [136].
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Figure 2.6: Subtree Crossover. (a) and (b) are the parents where the high-
lighted node is the randomly selected node and the subtree rooted from it
is switched with the other subtree to form the two offspring in (c) and (d).
Genetic Operators
Genetic operators are needed to perform changes to the populations’ indi-
viduals so that new children passed to the next generation are not the same
Figure 2.7: Subtree Mutation.
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as those in the current generation. The basic genetic operators include
reproduction, crossover and mutation. The application of each of these
operators is determined by the rate or the probability assigned to each of
these operators. The reproduction operator simply copies the selected in-
dividuals by the selection method of the next generation. The crossover is
performed on two parents that are selected by the selection method used.
A node is selected randomly from each parent as a crossover point and
then swapping a subtree in each of the parents at the crossover point takes
place [92]. This concept is represented in Figure 2.6 by an example where
(a) and (b) represents the two parents (individuals) selected by the selec-
tion mechanism. The crossover point is selected and the subtrees under
the crossover are exchanged to form the new children (offspring at Fig-
ure 2.6 (c) (d)). The mutation operator is performed on one individual at
a time where a random subtree is selected and it is exchanged by a ran-
domly generated subtree. Another type of mutation makes a condition
that only a terminal replaces a terminal and a function replaces a function.
An example of the mutation is shown in Figure 2.7. Besides these genetic
operators, the elitism operator is usually used in GP to select the top or the
elite individuals of the population and copies it to the next generation to
make sure that the best individuals are not lost during the random selec-
tion mechanisms [92, 123].
2.4 Multi-objective Optimisation
When two or more conflicting objectives occur, and an optimal decision
needs to be taken. This results in a multi-objective problem [126]. Multi-
objective optimisation solutions are evaluated in terms of the trade-off be-
tween the conflicting objectives which can minimised or maximised [56].
A single objective optimisation problem can be represented mathemat-
ically as (if the problem is minimisation) [56],
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minf(x), x ∈ C (2.4.0.1)
where C is a set of constraints.
Multi-objective optimisation is formulated as
min(f1(x), f2(x), ..., fn(x)), x ∈ C (2.4.0.2)
where x is a feasible solution, n is the number of objectives (n > 0) and
C is the set of constraints. There is no feasible solution that can minimise
all objectives simultaneously. This introduces the need for Pareto optimal
solutions [126].
If a solution is not worse in all objectives and it is better than the an-
other in at least one of the objectives, it will dominate this solution [192].
Pareto optimal contains the set of non-dominated solutions where, a
specific solution cannot improve any of the objectives without degrading
at least one of the other conflicting objectives [126].
The non-dominated solution forms the Pareto front in which no solu-
tion can be judged to be better than others. Figure 2.8 shows an example
of the Pareto front when two objectives conflicts with each other and the
first objective tends to be minimised while the second objective tends to
be maximised.
2.4.1 Common Multi-objective Optimisation Techniques
Evolutionary algorithms (EAs )have been widely used to produce the Pareto
set. This is because they can produce multiple Pareto-optimal solutions in
a single run. EAs may make use of similarities of solutions by recombina-
tion of these solutions.
The most common evolutionary multi-objective optimisation techniques
include the following:
Non-dominated Sorted Genetic Algorithm (NSGA) [27] is an extension
of genetic algorithms for multiple objectives optimisation algorithms. The
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Figure 2.8: Pareto dominance example
algorithms use the evolutionary process to improve the fit candidate solu-
tions in the Pareto front. The population is sorted according to the Pareto
dominance [27].
NSGAII [27] extends NSGA, which was proposed to overcome the high
computational cost that occurs due to the non-dominated sorting in each
generation. NSGAII also introduces elitism to the algorithm that helps
to speed up the technique and prevents the loss of good solutions. The
dominance rank of a solution Si is used for evaluating the fitness, i.e. the
number of other solutions in the population that dominate Si. NSGAII
tends to minimise the fitness, i.e. a solution in the Pareto front will have
the best fitness of zero [27].
Strength Pareto Evolutionary Algorithm (SPEA) uses the population
and an external archive to store the non-dominated solutions [193]. The
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archive has a specific size limit and a clustering algorithm is used to re-
move the further non-dominated members, and keeps the solutions which
preserve the characteristics of the front. The fitness value is assigned to the
archive afterwards and the population solutions and then comes the mat-
ing selection phase.
The problem that face SPEA is the fitness assignment, where all the
individuals that are dominated by the archive solutions have the same
fitness. As a result, if the archive has one solution then all the population
individuals will have the same rank. The selection of this individual in the
archive is therefore decreased, making SPEA, in this case, act as a random
search algorithm. Another limitation of SPEA is the density estimation
that is used only during the clustering algorithm. This means that it is
used in regards of the archive. Finally, the clustering algorithm can lose
the outer solutions which are necessary to keep a good spread of the non-
dominated solutions [193].
SPEA2 [192] has solved some limitations of SPEA. SPEA2 uses a fine-
grained fitness assignment, truncated density estimation, fixed archive
size and it does not use a clustering algorithm. In SPEA2, the individ-
uals of the archive are the only individuals used in the mating selection
phase [192].
To evaluate the Pareto dominance, SPEA2 uses both dominance rank
and dominance count. Dominance rank of a solution is the number of the
solutions that dominate this solution, while the dominance count is the
number of solutions that a given solution dominates. A solution with a
smaller number of solutions that dominate it (lower rank) and a higher
count is a better solution.
2.5 Related Work
The MS data analysis for the biomarker detection task can be divided into
the following goals [103]:
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• Low-level biomarker discovery: discovering the MS peaks that are
responsible for differences between classes of diseased and normal
persons. This process is typically performed through feature manip-
ulation.
• High-level biomarker discovery: identifying the proteins, peptides
or the metabolites which correspond to the peaks.
• Verification of the candidate biomarkers: measuring the detectability
of the peptides in the Mass spectrometer.
• Validation of the verified biomarkers: passing the set of verified biomark-
ers to the experimental validation.
2.5.1 Statistics and Machine Learning for Biomarker De-
tection on MS data
Statisticians take a different view of the low-level biomarker discovery
task or finding the discriminating features. Typically a t-test, Wilcoxon
rank test or any suitable statistical test is done on each feature indepen-
dently to determine the score by which each feature discriminates between
different classes [103]. After this, an assumption is made that the features
are not discriminative, and the distribution of these test scores is modelled.
This distribution is commonly simulated by using a permutation test. The
permutation test is usually performed on one feature at a time, which will
result in thousands of significance tests (measuring the p-value). This ap-
proach was used in [104, 162, 188] after preprocessing. The limitation of
selecting features depending on the p-value was analysed and explained
in [110] with details. Using only the statistical approaches can result in
redundant features, and hence these biomarkers might be a result of noise
and not real biomarkers.
Machine learning approaches for biomarker detection have been used
for data classification and frequently a feature selection step is used to
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improve the classification performance [91]. [133] performed a predictive
study on ovarian cancer data where they used genetic algorithms to find
a subset of features (m/z values), which could improve the classification
accuracy. The selected features were used to classify the new samples.
The evaluation was done according to the ability of the features to form
two clusters with the correct membership in the class [103]. A similar ap-
proach was used by [10]. The optimal final set of features in these two
studies was formed from the original input space (features) and the fi-
nal classifier was a linear one. The approaches were only tested on one
dataset which might not be generalised to other datasets. Several studies
have been done afterwards that obtained near perfect classification accu-
racy on some different MS datasets [148,156]. However, the main problem
was the reproducibility of the results which remains limited.This means
that the biomarkers of these studies on the same datasets are different, and
hence these biomarkers might be untrustable. [100] used T-test and genetic
algorithms for feature selection in conjunction with SVMs as a classifier on
three SELDI datasets. In [100], the features selected by genetic algorithm
(top 10 features) performed better than T-test, which suggests that a high-
order interaction between features can provide more powerful discrimi-
nation. The main limitation of this algorithm is the high computational
cost of using the wrapper approach. In [144], the author used principle
component analysis (PCA), unfolded-PCA and partial least squares for
the classification of the normal and the drug injected mice analysed using
LC-MS. This was done after preprocessing and alignment of the data. [144]
used an LC-MS dataset, which is composed of two samples in each class in
the training set and one sample in the test set to perform the classification
and biomarker detection through visualisation of the data. In addition to
the disadvantage PCA of using the assumption that the dimensionality of
data can be reduced by linear transformation, using visualisation of the
data to detect the biomarkers might not be accurate.
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2.5.2 GP for Biomarker Detection using Feature Selection
GP has been used for biomarker detection using feature selection in MS or
LC-MS data few times. Only a small number of studies [35,53,76,109,187]
have used GP to combine features for the production of good classifiers.
These features have been indicated as the biomarkers. These studies have
been only applied to gene expression data and it have not been investi-
gated on MS data. GP was used in [187] to classify a prostate cancer MS
dataset, which showed that GP used a smaller number of biomarkers than
other classifiers with comparable classification accuracy. This is benefi-
cial, as usually a smaller number of features to be detected is preferable
in order to reduce the experimental cost required for validation of the de-
tected biomarkers [181]. However, the approach has not been extented
to more datasets and it has not been tested on datasets with predefined
biomarkers. Hence, it is not proved that the biomarkers detected are the
true biomarkers. GP was used in an early study [51] for the analysis and
the quantification of the amount of sucrose in orange juice. In this study,
the detection and quantification has been done by performing a regres-
sion process and the values estimated by GP were compared with the ex-
pected values of sucrose. This approach has not considered the power
of GP for feature selection, as the algorithm was using GP for quantifica-
tion of the missing values of the data and not for automatically selecting
the biomarkers. In [3] the features selected by GP with different fitness
functions achieved a certain level of success on MS and LC-MS datasets.
Moreover, in [154] different feature selection metrics were used with GP
to further select a smaller number of features. The features selected by
GP were used and those features managed to improve the classification
accuracy.
One hundred and six breast cancer patient samples were analysed us-
ing MALDI MS by [29]. These samples were analysed using GP for biomarker
detection by selecting protein clusters that can correctly classify breast can-
cer best. GP was used by [52] to analyse the metabolic biomarkers aimed
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at detecting changes in the levels of biochemical compounds by search-
ing among thousands of biochemical compounds. In [82], GP was used to
explore the metabolites (biomarkers) in specific plants by measuring the
concentration of these compounds and finding the rules that discriminate
these plants. LC-MS data was used in [82]where GP was used to inves-
tigate the function, and relation of a specific compound (salicylic acid) to
the resistance of diseases in the plant immune system.
Although these studies has considered the use of GP for selecting the
biomarkers, it has not fully used the adavantages of GP for discovering
the relevant features.
2.5.3 GP for Feature Construction
GP has been used successfully for feature construction in two trends: 1)
feature construction using attribute values for classification problems and
2) feature construction using raster graphics for object and edge detection
problems. In the former trend, the constructed features are the results of
scalar functions of original features [39]. In the latter trend that acts on
images, the constructed features are the filters which operate on the raw
images’ raw pixel values [44, 45, 94, 153]. GP has also been widely used
for feature construction [62,93,107,122] with promising results in terms of
improving classification accuracy. There have been different scenarios for
the use of GP for feature construction, for example, in [39] GP was used as
an embedded approach to construct features, while in [61,62], the authors
used a wrapper approach to construct important features. In addition, a
filter approach was used in [107] to construct a single feature per class
depending on the entropy measure.
These feature construction approaches (used for other applications other
than biomarker detection) has either constructed a single feature, which
might not be able to improve the classification performance of MS data
due to the high percentage of noise and small training examples, or con-
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struct features from multiple GP individuals (a feature for each class) which
will increase the computational cost in case of MS data.
Feature construction has not been used before for biomarker detection
despite the success of feature construction for improving the classification.
2.5.4 Other Evolutionary Algorithms for Biomarker Detec-
tion
Other EC techniques, such as GAs [137], PSO and ACO have been applied
in biomarker detection using feature selection [115]. Typical EC methods
for biomarker detection are briefly reviewed in this section.
Feature selection in GAs is performed by representing all the features
in each individual. Each chromosome is represented by n binary bits if
the number of features is n, where a 1 indicates that the feature has been
selected. The best solution has the subset of features selected throughout
the search process [78].
GAs have been applied to biomarker detection mostly as a wrapper
approach. For example in [116], SVMs is wrapped to GAs to discover the
biomarkers in gene expression data with the accuracy of SVMs as the fit-
ness function. The algorithm is divided into two phases where the first
phase the algorithm runs for a specific number of generations to select
features and each feature is assigned a score. For the rest of the gener-
ations, each feature is assigned an average fitness score by dividing the
total fitness score by the number of times that the feature was chosen
in an individual. The algorithm is robust.However, the main issue here
is the computational time of the wrapper approach. Another example is
in [137] where the wrapped classifier is 1-NN, and the algorithm employs
a procedure similar to bootstrapping to enhance the robustness of selected
gene signatures (biomarkers). None of these algorithms were applied to
biomarker detection in MS data where the amount of noise in this data
significantly affects the feature selection process.
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PSO has been widely used for feature selection with a high success
rate [183, 184]. Only a limited number of studies, such as [115, 121, 141]
used PSO for biomarker detection. In [115], a hybrid ACO/PSO algorithm
is used to identify the set of biomarkers in SELDI MS data, while in [141] a
simple PSO method wrapped to SVM is used for MS biomarker detection.
A multi-objective PSO approach wrapped to artificial neural network clas-
sifier was applied to gene expression data to maximise both specificity and
sensitivity. PSO can be a good choice for biomarker detection. However, it
does not have the embedded capability of GP, which gives GP the power
of combining the advantages of wrappers and filters.
2.5.5 Multi-objective Optimisation for Biomarker Detec-
tion
Multi-objective optimisation offers solutions to the optimisation of differ-
ent conflicting objectives [126].
Biomarker detection must consider the trade-off between the classifi-
cation performance and the number of features without the prior specifi-
cation of the relative importance of each objective. The number of features
should be as small as possible to be able to pass them to experimental val-
idation. Therefore, for evaluation of biomarker selection, two objectives
should be considered, maximise the classification performance and at the
same time minimise the number of features.
There have been a limited number of studies that use multi-objective
optimisation for biomarker selection in microarray gene expression data
[42,56]. PSO was used in [121] for multi-objective optimisation in gene ex-
pression data as a wrapper approach, using an artificial neural network for
evaluation. In [56], a Pareto Optimal approach (PO) with Analytical Hier-
archy Process (AHP) was used to select subsets of features in microarray
data for biomarker detection. In [42], a multi-objective genetic algorithm
was used on metabolomics MS data to maximise the classification accu-
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racy and minimise the number of features. None of the existing methods
used a multi-objective embedded approach for biomarker detection.
2.5.6 Peptide Detection for Biomarker Verification
Computational approaches to prediction of peptides’ observability in mass
spectrometer were adopted to address the complexity of the laboratory
methods. Decision trees [48] and artificial neural networks (ANN) [164]
have been used to relate the physiochemical properties of proteins to their
MS detectability. Evolutionary algorithms were also used in a small num-
ber of studies to solve the peptide detection prediction problem in MS
data. For example, genetic algorithms (GA) [170] have been used to solve
this problem where the aim was to reach the optimum experimental condi-
tions for protein detection in MS. GP was used only in two studies [38,175].
The verification of biomarkers is a hard problem due to the high dy-
namic range of proteins [79], the complexity of the data and the lack of a
universal bridging method. Early studies [48, 164, 170] have reported suc-
cess for the use of machine learning techniques for measuring the peptide
detectability. However, a complete understanding of the important prop-
erties necessary for peptide detection is lacking and a powerful method
which provides a model that can be interpretable is needed. Further-
more, the peptide datasets are usually highly unbalanced, which means
the number of peptides in the non-observable (majority class) is usually
much higher than the number of observable peptides (minority class).
This makes the classifier more biased to the non-observable class and mostly
the high responding peptides are not going to be correctly classified.
Classification of unbalanced data can be characterized as either exter-
nal or internal approaches [15]. External approaches create a balanced
class distribution for training by transforming the original unbalanced
data while keeping the learning algorithm unchanged [14].
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The internal approaches utilise the unbalanced ratio in the training
process and adapts the learning algorithm to deal with the uneven dis-
tribution of the classes [160]. This is done through cost adjustment in
the learning algorithm. Other methods combine internal and external ap-
proaches [34, 129].
GP has been used effectively for classification of unbalanced data [14–
16]. GP can be classified as an internal approach in which the cost ad-
justment is performed through using a fitness function that balances the
fitness between the two classes [155, 178]. Despite the capability of GP to
solve the various of problems involved with peptide detection (feature se-
lection and classification of unbalanced data), the use of GP is very seldom
investigated to solve this problem.
2.6 Chapter Summary
The MS provides means for biomarker detection that will be beneficial in
many applications, including early detection of diseases and discovery of
new drugs. The analysis of MS data for a biomarker detection is challeng-
ing due to the high-feature-to-sample ratio and the presence of noise in the
data. Biomarker detection is performed through feature manipulation.
Due to the flexibility and capability of GP to automatically select and
construct features, GP can be a promising choice for biomarker detection.
There has been a rapid grow in the MS biomarker detection research.
However, there are still major open issues that remain to be investigated:
Feature Ranking in Biomarker Discovery: Most of the previous meth-
ods used a single ranking method to rank features and used the top ranked
features for classification. However, different feature ranking metrics pro-
vide different ranks for the same features according to their evaluation
criteria. None of these methods tested the use of more than one ranking
metrics together. The collection of these ranking metrics can provide sub-
sets of top ranked features and low-ranked features. This collection has
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the potential to provide a better collection of features, leading to better
classification results. In [147], GP was used to combine four metrics and it
was applied successfully on datasets with a small number of features, but
it was not tested on datasets with a large number of features as in the MS
datasets. Also, using the single ranking schemes ignores the interactions
and relationships between the features.
Feature Construction: Most of the GP based feature construction ap-
proaches were based on constructing a single feature, either using this sin-
gle feature for classification or using this feature along with the original set
of features. Using the single constructed feature alone might not achieve
acceptable classification accuracy and using the combination of a single
constructed feature along with the original set of features will increase the
dimensionality [60, 107]. The second approach is therefore inappropriate
for high dimensional data like MS data, where the number of features ex-
ceeds thousands. Moreover, none of these methods investigates the effect
of constructing multiple features from a single tree during the evolution-
ary process of GP. Also, feature construction in MS data has not been con-
sidered before.
Multi-objective GP for Biomarker Detection: Multi-objective GP op-
timisation for MS biomarker detection using both feature selection and
construction has not been considered before and, investigation of this di-
rection needs to be carried out.
Biomarker Verification using Peptide Detection: The computational
approaches for peptide detection are effective, but the limitation of not
considering the imbalance problem of the peptides datasets lowers their
sensitivity performance. Moreover, the previous approaches mostly con-
sidered selecting the features using ranking methods, which ignores the
dependence and interactions between the features. Hence, considering GP
for performing these multiple tasks is a worthing trial and can potentially
lead to improving the process of detectability. Furthermore, verifying the
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detected biomarkers using the peptide detection method needs more in-
vestigation.
The next four chapters propose new GP algorithms that can address
the above issues.
Chapter 3
Ensemble Feature Ranking
3.1 Introduction
Feature selection is an important technique for biomarker discovery in MS
data because many of the classification techniques cannot easily handle
such a huge number of features. Feature ranking is a type of feature selec-
tion, where each feature is given a rank according to its relevance to the
classification task [147]. Different feature ranking approaches usually give
different ranks to the same features. Clearly, some of the top features may
be highly relevant or powerful while other features may be weakly rele-
vant or redundant [147]. Further selection and ranking of features based
on sets of features produced by different feature ranking methods have
the potential to provide a new and smaller set of features with less redun-
dancy and more relevance to classification.
3.1.1 Chapter Goals
The overall goal of this chapter is to investigate the capability of GP for im-
proving feature ranking performance. To achieve this goal a new ensemble-
based feature ranking GP algorithm has been developed. The algorithm
combines two well-known feature ranking metrics, namely information
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gain (IG) and relief-f (RF), to select a new and smaller set of features. A
new rank that can effectively improve the classification performance of the
selected features is given to each of the selected features. Meanwhile, GP
is used as a classifier as well, and the proposed algorithm takes an embed-
ded approach. Specifically, we will investigate the following objectives:
• what ranking scheme is suitable for selecting good features;
• whether a small number top ranked features obtained by the pro-
posed GP method can achieve better classification performance than
using all the original features;
• whether the smaller top ranked features can outperform a relatively
large number of the top ranked features obtained by IG and RF, re-
spectively;
• whether different classifiers using the 20 top ranked features can
achieve better performance than the 100 top ranked features obtained
by IG and RF, respectively.
Chapter Organisation: The rest of the chapter is organised as follows.
The second section describes the new ensemble GP method for feature
ranking in MS data. Experimental design are presented in the third sec-
tion. The fourth section descries the datasets and preprocessing. The fifth
section presents the results of discussions. Some further discussions are
presented on the sixth section. The seventh section gives a summary of
the chapter.
3.2 Ensemble Feature Ranking GP Algorithm
Different criteria are used in different feature selection metrics [147] these
can result in different sets of features, which may contain highly rele-
vant features and also weakly relevant features. Thus, we hypothesise
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that combining the features selected by multiple feature selection meth-
ods may yield better features that can improve the classification perfor-
mance. Our objective is to use GP as an ensemble method to guide the
feature selection process by combining top ranked features obtained by
two well-known feature ranking metrics, IG and RF. GP is expected to
produce a new and smaller set of features that can effectively improve the
classification performance of the selected features. The two metrics are
chosen due to their wide applications in the literature, their effectiveness
in high dimensional data [150] and also their distinct characteristics. The
two metrics were previously used in several bio-data mining applications,
and achieved good results [57, 77].
Figure 3.1 shows an overview of the proposed GP method. The pro-
posed method has four steps: (1) we use the two feature ranking tech-
niques (IG and RF) to rank the original features; (2) the top 100 ranked
features by each of the two metrics are used as terminals of the GP method.
According to the experiments, increasing the number of features from
each metric more than 100 has resulted in increasing the search space,
and therefore in decreasing the performance. The intrinsic capability of
GP is used to search for good combinations of those features to form a
(hopefully) better set of features; (3) the features selected by the best GP
evolved program of each run are ranked according to their frequency of
occurrence, and a new score is given to the features if it appears in more
runs; (4)the 20 top ranked features are used for evaluation (classification
with GP classifier and other classifiers). This parameter is selected accord-
ing to the literature [10, 133].
3.2.1 Overall Process
Since the datasets do not have a separate test set and also to overcome
the limitation of the small number of training examples, ten-fold cross-
validation is used where the data is divided into ten folds.
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Figure 3.1: Overview of the GP-based approach.
At the beginning of each of the 10-folds cross-validation process, the
random seed of GP is initialised, and the following steps are performed.
Since the GP process is initialised at every fold, the bias of GP to the feature
selection process is avoided. The process of 10-folds cross validation is
explained as follows. For each fold, 30 independent GP runs are used, and
hence, the total number of independent runs are 300.
1. Shuffle the data randomly;
2. Divide the data into ten-folds;
3. For every fold, do the following:
(a) Use the current fold as a test and the rest of the folds as the
training set
(b) Run the GP Algorithm
(c) Use the selected features to transform training and test sets.
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(d) Calculate the accuracy of the test set
4. Calculate the average accuracy of 10 folds.
The rationale is as follows. Firstly, one set of the high-ranked features by
one method and another set of high-ranked features by another method
are used as input. Using these two sets of features can provide a mixture
of some high-ranked and low-ranked features together that can potentially
perform better than using all the individual features.
Secondly, the two metrics IG and RF use different criteria to rank indi-
vidual features, and, we thus expect the combinations of the two groups
of features using GP could potentially lead to better performance.
Thirdly, using GP to select features from the high-ranked features from
IG and RF instead of all features can reduce the search space and also
computational cost.
Fourthly, GP has an implicit feature selection capability, and we expect
GP to select some individual features automatically from those chosen by
the two metrics. The selected features combine together via the operators
in the function set to form a small feature set, which can result in better
classification performance.
Finally, we hypothesize that the more frequently occurring features
must have the better impact on the classification. We therefore ranked
each feature in the new feature set according to their frequency of occur-
rence in the GP programs, and used the top 20 features for evaluation
(classification).
The aim of ranking the selected features is to examine the effect of the
top ranked features selected by GP. This is done by comparing them with
the top-ranked features by the individual feature metrics (IG and RF). For
feature selection and ranking, the terminal set is composed of the top 100
features from each of the two metrics (IG and RF).
The terminal set has therefore 200 feature terminals, besides to ran-
domly generated constant terminals. For the classification phase, the ter-
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minal set is composed of the top 20 features selected by GP. In the rest
of this section, we will describe the feature selection metrics, the terminal
set, the function set, the fitness function, and parameter settings for the
proposed method.
3.2.2 Feature Selection Metrics
The two feature selection metrics, Information Gain (IG) [150] and Relief-F
(RF) [161] , are used to rank the importance of the individual features. We
briefly describe them as follows.
IG determines the amount of information gained about a class when a
certain feature exists or not [147]. It is defined as follows:
IG(x`, ci) =
∑
c∈{c1,c2}
∑
x`∈{f,x¯}
P (x`, c)
logP (x`, c)
P (x`)P (c)
(3.2.2.1)
where x and x¯ denotes the presence, and the absence of a feature. The two
classes (healthy and diseased) are denoted by c1 and c2. The probability of
the occurrence features x` in a specific class is represented by P (x`, C). P (x`)
and P (c) represent the probability of the selection of a feature and class,
respectively.
RF searches for two nearest neighbours for a given example, one of
the same class (hit) and the other of a different class (miss) [161] , and
calculates the importance of the feature, which is given by:
I(X) = P(f | nearest instance ∈ different class)
−P(f | nearest instance ∈ same class)
where P refers to probability, f denotes a value of a feature. A good fea-
ture should differentiate between instances belonging to different classes
and should have similar values for the examples from the same class.
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3.2.3 Fitness Measure
We aim at generating a subset of features that can improve the classifica-
tion accuracy of the proposed GP approach, and at the same time reduces
the number of features. We define the fitness function as the classifica-
tion accuracy by restricting the fitness to select the minimum number of
features. The classification accuracy is given by the following:
A =
TP + TN
TP + TN + FP + FN
× 100% (3.2.3.1)
where TP is the number of true positives or the correctly classified disease
examples. TN is the number of true negatives or the correctly classified
healthy examples. FP and FN are the false positives and false negatives,
respectively. The evaluation of the fitness measure is performed after fil-
tering the selected subset of features by the evolved GP program.
We use the following fitness function:
fitness = A× (1 + σe−m/M) (3.2.3.2)
In Equation 3.2.3.2, A is the measure of accuracy obtained in Equation
3.2.3.1 and m is the number of features used (selected) in the GP program.
M is the original number of features and σ is a parameter that is used to
determine the relative importance between the classification accuracy and
the number of features. σ is given by
σ = 2a(1− CurrGen
MaxGen
) (3.2.3.3)
σ, in the early generations is more biased to decrease the number of fea-
tures but with increasing generations, the classification accuracy is given
more importance. a is a constant value of 0.1, CurrGen is the current gen-
eration number and MaxGen is the total number of generations.
When the value of m increases, the exponential factor e−m/M decreases
and so does the fitness value. Therefore, if two programs (at same training
point) have the same accuracy value, a higher fitness will be given to the
program that has a smaller number of features.
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A threshold value of 0 is used to classify the instances. For a specific
instance of the training set, if the program output is ≤ 0, the instance is
classified as c1; otherwise as c2.
3.2.4 Description of the Algorithm
Details about the algorithm are shown in Algorithm 1. The dataset is di-
vided using 10-folds cross validation as explained earlier. For each train-
ing set, the algorithm starts by creating the initial population of individu-
als. The main loop of search in GP will end by either reaching the maxi-
mum number of generations (MaxGen) or when achieving the maximum
fitness (fmax), 100%, which indicates that the problem is solved. The best
program is determined by updating the best fitness variable (fmax). The
fitness function aims at maximising the classification accuracy and min-
imising the number of features. The fitness of each program is determined
by using the program output as a decision stump to determine the TP ,
TN , FP , FN at line 8. The constant factor a is given a value of 0.1 on line
10. At line 11, the parameter σ is calculated to control the importance of the
classification accuracy and the number of features across the generations.
At line 12, the fitness is obtained by measuring the classification accuracy
of the program and multiplying it by a factor, which decreases the number
of features. At lines 13-16, the BestProgram with the best fitness in this
generation is obtained, then at line 17, the selection and breeding of indi-
viduals are performed. The features used in the BestProgram are sorted
according to their frequency in the program, and the feature vector along
with their ranks are returned as the result of this algorithm.
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Algorithm 1 Selection and ranking of features through evolving classifiers
/* The algorithm return the best GP program with smaller number of features that can perform better in
terms of classification accuracy */
Input D, a dataset of the form D=(N,c) where N is a set of instances of size N with 100 top features from
IG and 100 top features from RF. c is the vector containing the class label of the instances.
Output (X,r, ACC), a vector with the features selected in the best GP individual BestProgram and their
rank according to their frequency of usage. The algorithm also returns the accuracy of GP as a classifier.
1. for k=1 to 10
2. Divide D in to 10 folds
Take the current fold as a test set and the rest folds as a training set
P ⇐ create the initial population of individuals;
fmax ⇐ 0; // Initialization of the maximum fit-
ness
while CurrGen < MaxGen or fmax < 1 do
7. foreach individual ∈ P do
8. TP, TN, FP, FN ⇐ 0;
9. Compute TN, TP, FP, FN of the training set; // According to the
threshold value (zero)
10. a⇐0.1
11. Calculate σ = 2a(1− CurrGen
MaxGen
)
12. Evaluate fitness f = TP+TN
TP+TN+FP+FN
× (1 + σe−m/M );
13. if f > fmax then
14. fmax⇐ f ;
15. BestProgram⇐ individual;
16. end if
17. Perform selection and breeding; // Perform selection and genetic op-
erators
18. CurrGen⇐ CurrGen+1;
end while
Use BestProgram to evaluate the test set
Calculate the accuracy of the test set
Compute the frequency of occurrence ∀ X ∈ BestProgram; // Calculate
the number of usage of each feature in BestProgram
r[i]⇐ indexed descending sorted;
end for
25. Compute the average of all the folds as a result of GP classification accuracy ACC
26. return (X,r,ACC);
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3.3 Experiments Design and Setup
3.3.1 GP Settings
The MS data is represented by (m/z, I) = (m/z, I1, ..., In), where m/z is
a vector of the measured m/z ratios and Ii is the corresponding inten-
sity of the ith sample. The LC-MS data is represented by (time,m/z, I) =
(time,m/z, I1, ..., In), where time is the retention time vector of the produc-
tion time of a protein or a peptide. Them/z and time values do not change
across all samples as they correspond to the identity of the samples, thus
we can consider the m/z and time values as the features’ identities. The
feature values are the intensity profile. The objective here is to predict the
class label based on this intensity profile [182]. The thirteen datasets used
have two classes and the class labels can be defined as class 1 or class 2,
respectively.
Terminal Set. The goal of GP, as stated earlier, is to further select a smaller
number of features from the feature pool selected by IG and RF, and to
rank these features to improve the overall classification performance.
Function Set. The four common mathematical operators +,−,× and %
were used in addition to the square root √ and max functions. The di-
vision operator (%) is protected where it returns 0 for the division by 0.
The√ is also a protected operator, in which, if the argument is a negative
value, the absolute of this value is taken. The goal of using √ and max
functions is to evolve non-linear and complex functions that can perform
well for classification and feature selection.
GP Parameters. For the GP system, the tree-based GP [96] is used where
each program produces a single floating-point number at its root as a re-
sult of its evaluation (output). The standard subtree crossover and muta-
tion [145] are used with a probability of 80% and 15%, respectively. The
initial population is generated using the ramped half-and-half method
[145]. The individual program tree depth is minimum 5 and can be in-
creased to 8 during the evolution. The population size is 1024. The selec-
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Table 3.1: GP settings
Function set +,−,×, % √ and max
Variable terminals 200 features (top ranked 100 features from IG and RF metrics)
Constant terminals Randomly generated constants
Initialization method Ramped Half-and-Half
Initial tree Depth 5
Maximum tree depth 8
Generations 30
Mutation probability 15%
Crossover Rate 80%
Elitism 5%
Population Size 1024
Selection type Tournament
Tournament Size 10
tion method used is the tournament selection with a tournament size of
10. Elitism is taken here with 5% probability to make sure that the best
individual in the next generation is not worse than that in the current gen-
eration. The process of evolution will be terminated when the maximum
number of generations (30 generations) is reached. Table 3.1 summarises
the GP settings of our method. These parameters are estimated according
to the literature [92].
3.4 Datasets and Preprocessing
3.4.1 Datasets
Four MS datasets and nine LC-MS datasets were used in our experiments.
In the MS datasets, the samples include patients with cancer and healthy
individuals. The MS datasets include the following:
• OVA1 dataset [133]: this dataset is composed of 121 cancerous and 95
healthy samples. This dataset was generated from a hybrid quadrupole
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time-of-flight (TOF) mass spectrometer (ABI Qstar) fitted with a Pro-
teinChip1 array interface. The samples were analysed by surface-
enhanced laser deisotopic SELDI, and the m/z values range from
500 to 2000 Da.
• OVA2 dataset [133]: consists of spectra from 162 patients with ovar-
ian cancer and 91 healthy individuals. To produce this dataset serum
samples were analysed on two SELDI-TOF mass spectrometers and
the molecular masses range from 0 to 20,000 Da. Mass resolution is
routinely achieved below 400 Da.
• PAN dataset [49]: consists of a diseased group of 80 individuals and
a healthy group of 101 individuals. The samples were subjected to
SELDI-TOF MS on a Protein Biology System 2c. The m/z values
range from 800.00 to 11,992.91 Da.
• ARC dataset [64]: is composed of 100 cancerous samples (ovarian or
prostate cancer) and 100 healthy samples. The dataset results from
merging datasets from three different sources (ovarian cancer sam-
ples of two different types and prostate cancer samples). The data
was obtained with the SELDI technique and the m/z values range
from 200 to 10,000 Da.
The LC-MS datasets are generated from the serum samples with known
concentration of spike-in peptides which are the human defined biomark-
ers (class 1) or without spike-in peptides (class 2). The characteristics of
the LC-MS datasets are described as follows.
• Spike-in serum dataset: This dataset is obtained from Georgetown
University1. It contains thirteen peptide biomarkers spiked in the
first class samples while the second class includes only serum sam-
ples. Each class contains five samples.
1Available at: http://omics.georgetown.edu/massprep.html
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These two groups of data were generated from five serum samples
obtained from five healthy individuals, and the two groups were ac-
quired by the same LC-MS method. The spiked-in MassPrep peptide
mixture is a selection of nine peptides with a wide range of polarities,
and isoelectric points. Chromatographic separation was performed
on Waters NanoACQUITY system using BEH C18 column (Tuli et
al., 2012). The MS scan cycles of seven seconds included m/z values
ranging from 350 to 2000 Da and five MS/MS scans, where the m/z
values that range from 50 to 2000 Da. More details about the sam-
ple collection, preparation, and storage can be found in [169]. This
dataset is denoted as DSa.
• Spiked porcine CSF dataset: The number of samples in this dataset is
ten, five samples in each class, where class 1 samples are non-spiked,
and class 2 samples are high spiked. This dataset is characterised by
high between-class variability and low within-class variability. The
number of features in each sample is 9889 with 38 added spiked fea-
tures defined as the biomarkers. More details regarding the prepara-
tion and acquisition of this dataset are described in [73]. The samples
with spiked peptides were prepared by mixing 20 µ L CSF digest
with 20 µ L of a tryptic digest of horse heart cytochrome C. Spiked
and non-spiked samples were injected five times in a random order
into an Agilent QTOF 6. This dataset is denoted as DSb.
• Spiked human urine datasets: Seven datasets were obtained from 40
chromatograms, each with two classes that have high or low levels of
spiking levels of peptides. The number of biomarkers is 151, and the
total number of features in each sample is 29529. The datasets have
different between-class and within-class variabilities and different
samples sizes. Fifty urine samples were obtained and 200 µ L were
taken from each sample and spiked with a tryptic digest (Promega,
Madison, WI, V5111) of bovine carbonic anhydrase (Sigma, Stein-
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Figure 3.2: Properties of the LC-MS datasets used in the experiments.
heim, Germany, C3934, Uniprot entry: P00921) as well as with seven
synthetic peptides. The sample was analysed five times using an Ag-
ilent G2445A LC/MSD-Trap-SL ion trap mass spectrometer. We use
the following notation for each of the seven datasets: DSc, DSd, DSe,
DSf , DSg, DSh, DSi throughout the chapter to denote the seven hu-
man urine datasets. Figure 3.2 depicts the properties of the LC-MS
datasets used in the experiments. The datasets DSb, DSc, DSd, DSe,
DSf , DSg, DSh, DSi were all obtained from Netherlands Bioinfor-
matics Center2.
3.4.2 Data Preprocessing
Preprocessing of the MS data involves a sequence of operations. These op-
erations represent essential steps for analysing the data successfully. These
steps include:
2Available at: https://trac.nbic.nl/BiomarkerFeatureSelection
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Figure 3.3: Preprocessing steps of the low-resolution ovarian cancer
dataset. (a) the original spectrum. (b) the baseline adjustment of the first
signal. (c) resampling of this signal. (d) normalisation of the samples using
AUC.
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Figure 3.4: An example of the alignment of 10 spectra of the low-resolution
ovarian cancer dataset.
1. Baseline correction and signal filtering: remove noise and baseline
artifacts.
2. Peak picking and extraction: find and extract the real peaks corre-
sponding to molecules and remove the peaks that result from instru-
mental errors.
3. Multiple map alignment: correct the distortion of the retention time
and m/z dimension of multiple raw or feature maps.
4. Intensity normalisation: normalise the spectral counts to remove the
fluctuation in the intensity values across the different spectra.
The LC-MS data is a time series of the MS spectra. The preprocess-
ing of the non-chromatographic MS data can share some common steps of
preprocessing with the LC-MS datasets although the preprocessing frame-
work of the non-chromatographic MS is not exactly the same as the LC-MS
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data. For example, the steps of the baseline adjustment, filtering and nor-
malisation are the same for both MS and LC-MS datasets. However, the
alignments of MS and LC-MS data are different. The alignment of MS
data is performed on the m/z values while the alignment of LC-MS data
is done on both the retention time and m/z values.
OVA1 and OVA2 datasets: During the MS analysis, the number of fea-
tures produced in all the samples may not be the same. Therefore, the
first step is to make the number of features equal for all samples to obtain
the same m/z point at all MS spectra [133]. This is done by using the re-
sampling algorithm in the toolbox. The background and chemical noise
are removed by the baseline adjustment step. The noise is usually higher
at the low-intensity peaks. To estimate the baseline, a window of size 50
m/z for the high-resolution data is passed across the spectra and the min-
imum values of the m/z ratios are calculated. For the low-resolution data,
the window size is set to 500 m/z points. Afterwards, the baseline is re-
gressed and subtracted [133]. The third step is to remove the fluctuation
in the m/z values, which occurs due to the miscalibration of the machine.
The alignment of the m/z values is done by shifting and scaling the m/z
axis until the maximum alignment of intensity values is reached. The final
step is to remove the variation among the intensity values, which occurs
due to the changing of the levels of compounds or sometimes the sensitiv-
ity of the detector part in the machine. This is performed by normalising
each spectrum using the area under the curve (AUC). As an example, Fig-
ure 3.3 shows the original spectrum and the spectrum after three steps of
preprocessing of the low-resolution ovarian cancer dataset. An example
of the result of the alignment of 10 spectra is shown in Figure 3.4.
PAN dataset: The first step done for this dataset is baseline correction. The
baseline is estimated by segmenting the whole spectra into windows with
a size of 200 m/z ratio intensities. Afterwards, the means of the intensity
values under the windows are used as the baseline, and a regression of the
baseline is performed using a piecewise cubic interpolation method [49].
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The next step is to filter the noise. This is done using a Gaussian ker-
nel filter. The last step is the normalisation of the spectra using the AUC
method.
ARC dataset: The dataset is preprocessed by the providers by removing
the fluctuation or the technical repeats by averaging them, then removing
the baseline. Afterwards, smoothing the signals and alignment take place.
DSa dataset: This dataset is an LC-MS dataset, where each sample con-
Figure 3.5: Preprocessing of the raw data spectrum of DSa dataset. (a) The
original raw spectrum. (b) Peak extraction step. (c) Alignment step (d)
Filtering step.
sists of retention time, m/z ratios and their corresponding intensity [103].
Ideally, the same compounds detected by the same LC-MS should have
the same abundances, m/z ratios and retention times, but this is not usu-
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ally the case due to the experimental variation. Thus, the preprocessing of
this dataset is different from that of the non-chromatographic MS datasets.
The first step is the peak extraction, which selects the m/z features with
reasonable intensities and signal to noise ratio. This step is done by clus-
tering significant peaks and noisy peaks and removing the noisy peaks
using the toolkit. Figure 3.5 shows the raw data form and the data after
peak extraction, alignment and smoothing.
The alignment of the peaks is used to remove fluctuation or the small
variation of the data. Finally, smoothing of peaks is done in order to re-
move noise with each scan. This smoothing is performed using a per-
centile of the base peak intensity, where the base peak is the most intense
peaks found in each scan. The peak preserving resampling method is
adopted to produce the centroid data. To perform a two-dimensional anal-
ysis, the total time ion count (TTIC) for each m/z value is calculated. TTIC
is the sum of all intensity values of each m/z value at a specific retention
time value. After preprocessing, the number of features becomes 800 for
this dataset. The rest of the LC-MS datasets are available after prepro-
cessing.can be analysed using the same computational framework. This is
because the feature vector for both of them is the intensity vector and both
the m/z and the retention values are the feature identities.
3.5 Results and Discussions
To evaluate the performance of our proposed method for feature selection
and classification, we conducted a number of experiments on the four MS
datasets and the nine LC-MS datasets. The classification performance of
all the available features is used as a baseline, which is compared with
that of the 20 top ranked features resulting from the proposed GP (feature
selection and ranking) system, the 100 top ranked features from the IG
method and the 100 top ranked features from the RF method.
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The GP classifier was first used to evaluate the classification perfor-
mance of the top ranked features. The detailed results are shown in Table
3.2. To test the classification performance of the top ranked features on
other classifiers, NB, J48 decision tree, random forest and SVMs classifiers
were also used in the experiments, where the results are shown in Table
3.3.
3.5.1 GP Feature Selection and Classification Performance
Table 3.2 shows the classification performance of the GP classifier using
top ranked features resulting from the proposed GP system, the IG method
and the RF method. In Table 3.2,
• “ORG-GP” means the GP classifier using all the original features for
classification.
• “IG-GP” means the GP classifier using the 100 top ranked features
obtained by the IG method.
• “RF-GP” means the GP classifier using the 100 top ranked features
obtained by the RF method.
• “IGRF-GP” means the GP classifier using the 20 top ranked features
obtained by the proposed GP feature selection and ranking approach.
Table 3.2 shows the classification accuracy over 30 independent 10-fold
cross-validations runs (30×10=300 runs) for each dataset. The total num-
ber of runs performed are 15600 runs (300×13×4) for all thirteen datasets
and all four methods. As shown in Table 3.2, the proposed GP approach
with only the 20 top ranked features outperforms ORG-GP, IG-GP and RF-
GP on almost all of the datasets.
This confirms our previous hypothesis that GP can produce a smaller
set of features that can decrease the dimensionality and at the same time
improve the classification performance. This is mainly because the GP
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Table 3.2: Experimental Results
Ten folds cross validation (%)
Dataset Method #Features Best Acc Average Acc ±St.dev
OVA2
ORG-GP 15000 92.80 86.23±3.8
IG-GP 100 96.80 94.64±1.21
RF-GP 100 96.80 93.71±1.73
IGRF-GP 20 98.40 96.07±1.49 § ∗ ‡
OVA1
ORG-GP 15154 87.14 81.44±3.58
IG-GP 100 93.34 88.14±2.13
RF-GP 100 75.24 68.47±2.97
IGRF-GP 20 93.34 89.62±1.89 § ∗ ‡
PAN
ORG-GP 6771 56.11 44.96 ±5.28
IG-GP 100 61.11 51.82±4.83
RF-GP 100 69.45 60.17±4.53
IGRF-GP 20 70.00 62.35±4.16 § ∗ ‡
ARC
ORG-GP 10000 73.00 67.87±2.81
IG-GP 100 77.00 72.25±2.27
RF-GP 100 79.5 75.48±2.31
IGRF-GP 20 82.00 76.38±2.7 § ∗
DSa
ORG-GP 800 80.00 44.00±15.89
IG-GP 100 80.00 55.67±13.57
RF-GP 100 80.00 55.67±13.57
IGRF-GP 20 100.00 71.33±14.56 § ∗ ‡
DSb
ORG-GP 9889 100.00 88.00±13.49
IG-GP 100 100.00 91.33±9.37
RF-GP 100 100.00 98.33±3.79
IGRF-GP 20 100.00 99.33±2.54 § ∗ ‡
DSc
ORG-GP 29529 100.00 43.67±30.68
IG-GP 100 100.00 83.67±14.67
RF-GP 100 100.00 94.00±9.32
IGRF-GP 20 100.00 94.00±9.32 § ∗
DSd
ORG-GP 29529 100.00 48.67±20.63
IG-GP 100 100.00 92.33±9.35
RF-GP 100 100.00 86.3±14.26
IGRF-GP 20 100.00 93.60±8.77 § ‡
DSe
ORG-GP 29529 100.00 56.67±17.24
IG-GP 100 100.00 90.67±9.44
RF-GP 100 100.00 86.50±10.76
IGRF-GP 20 100.00 95.17±5.49 § ∗ ‡
DSf
ORG-GP 29529 100.00 54.78±16.53
IG-GP 100 100.00 92.89±7.67
RF-GP 100 100.00 92.33±7.54
IGRF-GP 20 100.00 94.11±6.35 §
DSg
ORG-GP 29529 80.00 43.67±17.32
IG-GP 100 100.00 93.00±12.64
RF-GP 100 100.00 72.33±19.42
IGRF-GP 20 100.00 87.67±11.67 § ‡
DSh
ORG-GP 29529 80.00 54.00±15.26
IG-GP 100 100.00 82.50±15.41
RF-GP 100 95.00 76.50±13.66
IGRF-GP 20 100.00 90.33±8.6 § ∗ ‡
DSi
ORG-GP 29529 80.00 49.11±14.62
IG-GP 100 100.00 82.11±10.26
RF-GP 100 100.00 84.67±9.91
IGRF-GP 20 100.00 89.11±6.19 § ∗ ‡
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classifier has the capability to form high-Level features from the low-level
features through its operators. The high-level features are the combina-
tions of the low-level features and the functions of the function set. There-
fore, these combinations help in discovering the hidden relationships be-
tween the low-level features and hence improve classification performance.
Another possible reason could be that the combination of some high ranked
features with some low ranked features can improve the classification per-
formance. Moreover, IG and RF can select relevant features and some
other less relevant features, thus GP as a search technique can select fea-
tures from both metrics and form a better set of features. Finally, the fre-
quency of a specific feature in the GP program indicates its importance
and usefulness in classification. Therefore, making a new ranking scheme
according to this hypothesis for the features can improve the classification
performance.
Making a new ranking scheme benefits in many ways. Firstly, using 20
features instead of 200 features in the terminal set substantially decreases
the dimensionality and search space. Secondly, using these 20 features
improves the classification accuracy. It was noticed that the variance be-
tween the different runs, i.e. smaller standard deviation, is considerably
lower in the case of the proposed approach in most of the datasets. This
suggests that the proposed solution can be considered stable. Finally, in
terms of biomarker detection, the proposed method can decrease the cost
of experimental validation by reducing the number of features to be tested.
In all the thirteen datasets, the baseline performance is worse than using
the feature ranking approaches. The 100 top ranked features obtained by
RF outperforms that of IG in five of the thirteen datasets.
To confirm the statistical significance of the results shown in Table 3.2,
a T-test with 90% confidence level is performed between IGRF-GP and
ORG-GP, IG-GP, or RF-GP. The results are presented as small symbols in
Table 3.2:
• “ § ” means “IGRF-GP” is significantly better than ORG-GP.
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• “ ∗ ” means “IGRF-GP” is significantly better than IG-GP with 100
features.
• “ ‡ ” means “IGRF-GP” is significantly better than RF-GP with 100
features.
The proposed method (IGRF-GP) is shown to be significantly better
than ORG-GP for all the datasets. In ten datasets, IGRF-GP is signifi-
cantly better than using IG-GP (100 features) and in eight datasets, IGRF-
GP shows significant better performance than RF-GP (100 features). In
DSg, the result of the T-test (p-value=0.0951) shows that the difference be-
tween “IGRF-GP” and IG-GP (100 features) is not really significant, which
means that IG-GP is similar to IGRF-GP. Overall, it is clear that IGRF-GP
achieved significantly better or similar performance compared to the other
three methods on these datasets but with a smaller number of features.
The results suggest that GP can be used successfully as a feature se-
lection method and also as a classifier, and that the early hypothesis of
using GP to mix the advantages of multiple feature selection metrics is
confirmed.
3.5.2 Using GP Features With Other Classifiers
For comparison, the original features, the 100 top ranked features of IG,
the 100 top ranked features of RF, and the 20 top ranked features of the
proposed GP system, were used in NB, J48, random forest and SVMs clas-
sifiers for classification. The results are shown in Table 3.3.
As shown in Table 3.3, the 20 top ranked features of the GP system
either outperform or have a similar performance to the original features
when used with the NB, J48 and random forest classifiers.
Using NB classifiers, the 20 GP features outperforms the 100 IG features
in five datasets and have similar performance in the rest datasets.
This suggests that GP can shrink the search space and decrease the
number of features by removing the redundant features and can increase
78 CHAPTER 3. ENSEMBLE FEATURE RANKING
Table 3.3: Classification performance for the tasks using NB, J48, Random
Forest and SVMs classifiers
Dataset Method #Features NB J48 Random Forest SVMs
OVA2
Org. 15154 76.28 95.65 93.28 100.00
IG 100 93.67 95.65 98.02 99.20
RF 100 91.69 97.23 97.62 97.62
GP 20 94.46 97.23 98.42 97.23
OVA1
Org. 15000 83.79 86.57 87.03 96.29
IG 100 88.42 87.96 88.88 93.52
RF 100 93.67 95.65 90.74 93.98
GP 20 90.27 88.88 91.67 93.06
PAN
Org. 6771 51.38 50.82 58.56 62.43
IG 100 57.45 63.53 64.64 66.29
RF 100 63.53 65.74 65.19 62.42
GP 20 65.74 64.08 74.03 71.27
ARC
Org. 10000 70.00 81.00 72.5 90.00
IG 100 67.50 75.00 81.00 78.00
RF 100 75.50 82.00 82.00 78.50
GP 20 73.5 80.00 80.00 73.00
DSa
Org. 800 70.00 90.00 40.00 70.00
IG 100 80.00 90.00 90.00 70.00
RF 100 80.00 90.00 90.00 70.00
GP 20 80.00 90.00 90.00 90.00
DSb
Org. 9889 80.00 90.00 70.00 50.00
IG 100 100.00 90.00 100.00 100.00
RF 100 100.00 90.00 100.00 100.00
GP 20 100.00 90.00 90.00 100.00
DSc
Org. 29529 90.00 90.00 90.00 100.00
IG 100 100.00 100.00 100.00 100.00
RF 100 90.00 70.00 100.00 100.00
GP 20 100.00 100.00 100.00 100.00
DSd
Org. 29529 66.67 58.33 41.67 58.33
IG 100 100.00 100.00 100.00 100.00
RF 100 100.00 100.00 100.00 100.00
GP 20 100.00 91.67 100.00 100.00
DSe
Org. 29529 75.00 91.67 86.67 83.33
IG 100 100.00 91.67 100.00 100.00
RF 100 95.83 91.67 100.00 100.00
GP 20 100.00 91.67 100.00 100.00
DSf
Org. 29529 73.33 90.00 86.67 83.33
IG 100 96.67 96.67 100.00 100.00
RF 100 100.00 93.33 100.00 100.00
GP 20 100.00 96.67 100.00 100.00
DSg
Org. 29529 50.00 41.67 41.67 58.33
IG 100 100.00 91.67 100.00 100.00
RF 100 100.00 100.00 100.00 100.00
GP 20 100.00 100.00 100.00 100.00
DSh
Org. 29529 83.33 79.16 77.27 86.36
IG 100 100.00 79.16 100.00 100.00
RF 100 95.83 87.5 100.00 100.00
GP 20 95.83 91.67 100.00 91.67
DSi
Org. 29529 70.00 90.00 83.33 76.67
IG 100 100.00 90.00 100.00 96.67
RF 100 96.67 90.00 100.00 96.67
GP 20 100.00 90.00 100.00 100.00
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or maintain the same performance. The only exception is DSh where IG
performs better than GP. The 20 GP features outperform the 100 RF fea-
tures in three datasets and their performance are similar in nine datasets.
The classification performance of SVMs using all the original features is
better than that of using the top ranked features of the GP system, IG and
RF in three datasets. However, SVMs using the 20 GP features achieve bet-
ter performance in the PAN datasets and DSa. In addition, SVMs with the
20 GP features achieve the ideal classification performance in eight LC-MS
datasets. Comparing Table 3.2 with Table 3.3, it can also be noticed that the
best classification performance of the IGRF-GP is better than NB, J48 and
random forest in most of the datasets. The performance of SVMs is very
competitive with GP classifier because both SVMs and GP are good for
binary classification. The good performance of GP in binary classification
is due to the splitting of the program output to positive and negative for
classifying the two classes. This is also due to the ability of GP to form
high-level features from the low-level features.
3.5.3 Biomarker Detection
The LC-MS datasets contain a number of artificially spiked peptides, which
should be detected as the biomarkers that differentiate one class from the
other class. The number of peptides defined as the real biomarkers is 13
in DSa (9 peptides with different charges). In DSb, there are 38 defined
biomarkers, while in rest of the datasets, the number of biomarkers de-
fined is 151. We tracked the features selected by the proposed GP method
to test the number of biomarkers detected. Figure 3.6 shows the number
of biomarkers detected and the biomarker detection rate obtained by the
proposed GP method, IG and RF.
As shown in Figure 3.6, the number of biomarkers detected by GP is
larger than that of IG and RF in all the datasets. In DSb, the biomarker de-
tection rate of GP is 100%. The performance of GP for biomarker detection
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Figure 3.6: Biomarker detection of the proposed method in comparison
with IG and RF.
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tends to be stable regardless of the sample size, the high within-class vari-
ability or the low between-class variability. This can be a reason for GP to
be advantageous for these types of tasks since only a very small number of
samples are available from the mass spectrometer. The performance of IG
is affected by the sample size to a larger extent. It can be observed that the
performance of IG increases in the datasetsDSe,DSf ,DSh andDSi, where
the number of samples is 24, 30, 24, and 30, respectively. In DSa, DSb and
DSc, where the between-class variability is high and the within-class vari-
ability is low, the performance of IG degrades although the biomarker de-
tection task here is simpler. The performance of RF is more stable than IG
across the datasets. In all cases, the proposed GP method merged the ad-
vantages of both metrics and detected more biomarkers than each metric
individually.
3.6 Further Discussions
3.6.1 The 20 top ranked features from the proposed GP
method, IG and RF using GP classifier
Another comparison with the top 20 features ranked by the proposed GP
method, and the top 20 features ranked by both IG and RF in terminal set
of a GP classifier is performed here. The results are shown in Table 3.4.
The significance test is also performed and the results are shown with the
following marks in Table 3.4.
• “ ?” means that IGRF-GP is significantly better than IG-GP with 20
features.
• “∧” means that IGRF-GP is significantly better than RF-GP with 20
features.
As can be seen in Table 3.4, the average classification accuracy of IG-GP
using only the 20 features is worse than using the 100 features (as shown
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in Table 3.2) in seven datasets. Compared with using the 100 top ranked
features, the average classification accuracy of RF-GP, using only the 20
features, decreases in four datasets. Although in some cases, using 20 fea-
tures from IG or RF improves the average accuracy over using the 100
features, IGRF-GP is still better than both IG-GP and RF-GP in almost all
cases. Specifically, the average classification accuracy of IGRF-GP is bet-
ter than IG-GP in all the cases and better than RF-GP in ten of the thirteen
datasets (nearly the same in two datasets). The significance tests show that
with 20 features, IGRF-GP is significantly better than IG-GP (20 features)
in six datasets and significantly better than RF-GP (20 features) in eight
datasets. According to the T-test results, IGRF is either significantly better
or similar to IG-GP (20 features) and RF-GP (20 features) and it is never
significantly worse than either of them.
3.6.2 The 20 top ranked features from the proposed GP method,
IG and RF, using other classifiers
The 20 top ranked features from the proposed GP method, IG and RF are
also used in NB, J48, random forest, and SVMs to test their classification
performance of these classifiers. The results are shown in Table 3.5.
Comparing the GP method with IG, when using NB as the classifier,
the classification performance of using the 20 features from GP is better
than using the 20 features from IG in six datasets. They are the same in
another six datasets, where both of them achieved the perfect performance
(100%) in five of these six cases. The performance of J48, random forest and
SVMs also show a similar pattern. In almost all cases, the classification
performance of the 20 features from GP is better or at least the same as
that of the 20 features from IG.
Comparing the GP method with RF, for all the four classifiers, the clas-
sification performance of the 20 features from GP is better or the same
as that of the 20 features from IG in almost all cases. In most of the DS
3.6. FURTHER DISCUSSIONS 83
Table 3.4: The performance of top 20 features selected by the GP method
compared to the top 20 features by IG and RF with GP classifier.
Ten folds cross validation (%)
Dataset Method #Features Best Acc Average Acc ±St.dev
OVA2
IG-GP 20 96.80 93.15±1.86
RF-GP 20 98.00 96.03±1.73
IGRF-GP 20 98.40 96.07±1.49 ?
OVA1
IG-GP 20 86.19 82.87±1.74
RF-GP 20 65.24 61.30±2.56
IGRF-GP 20 93.34 89.62±1.89 ? ∧
PAN
IG-GP 20 61.67 51.59±5.26
RF-GP 20 46.67 42.17±2.39
IGRF-GP 20 70.00 62.35±4.16 ? ∧
ARC
IG-GP 20 78.00 71.22±2.77
RF-GP 20 77.50 71.47±3.21
IGRF-GP 20 82.00 76.38±2.7 ? ∧
DSa
IG-GP 20 100.00 64.00±15.22
RF-GP 20 100.00 61.00±15.83
IGRF-GP 20 100.00 71.33±14.56 ∧
DSb
IG-GP 20 100.00 62.67±12.85
RF-GP 20 100.00 97.33±4.5
IGRF-GP 20 100.00 99.33±2.54 ? ∧
DSc
IG-GP 20 100.00 88.33±12.06
RF-GP 20 100.00 94.67±5.04
IGRF-GP 20 100.00 94.00±9.32 ?
DSd
IG-GP 20 100.00 88.67±11.06
RF-GP 20 100.00 89.00±5.35
IGRF-GP 20 100.00 93.60±8.77 ∧
DSe
IG-GP 20 100.00 95.33±6.29
RF-GP 20 100.00 91.17±3.13
IGRF-GP 20 100.00 95.17±5.49 ∧
DSf
IG-GP 20 100.00 93.89±4.64
RF-GP 20 100.00 96.89±3.27
IGRF-GP 20 100.00 94.11±6.35
DSg
IG-GP 20 100.00 82.33±14.06
RF-GP 20 100.00 85.17±9.8
IGRF-GP 20 100.00 87.67±11.67
DSh
IG-GP 20 100.00 88.83±8.38
RF-GP 20 100.00 89.17±5.88
IGRF-GP 20 100.00 90.33±8.6
DSi
IG-GP 20 96.67 89.11±5.87
RF-GP 20 100.00 86.22±6.53
IGRF-GP 20 100.00 89.11±6.19 ∧
84 CHAPTER 3. ENSEMBLE FEATURE RANKING
Table 3.5: Classification performance of 20 features using NB and J48, ran-
dom forest, and SVMs classifiers.
Dataset Method #Features NB J48 Random Forest SVMs
OVA2
IG 20 89.72 93.67 96.83 97.23
RF 20 96.44 96.83 96.05 96.44
GP 20 94.46 97.23 98.42 97.23
OVA1
IG 20 85.18 86.11 86.57 89.35
RF 20 88.89 86.57 89.35 88.89
GP 20 90.27 88.88 91.67 93.06
PAN
IG 20 65.19 66.85 65.19 62.43
RF 20 60.22 62.98 60.22 60.77
GP 20 65.74 64.08 74.03 71.27
ARC
IG 20 69.00 73.50 80.00 65.50
RF 20 67.50 71.00 73.50 71.00
GP 20 73.5 80.00 80.00 73.00
DSa
IG 20 80.00 90.00 90.00 80.00
RF 20 80.00 90.00 90.00 90.00
GP 20 80.00 90.00 90.00 90.00
DSb
IG 20 60.00 80.00 90.00 100.00
RF 20 100.00 100.00 100.00 100.00
GP 20 100.00 90.00 90.00 100.00
DSc
IG 20 100.00 90.00 100.00 100.00
RF 20 100.00 90.00 100.00 100.00
GA 45 40.00 60.00 40.00 60.00
GP 20 100.00 100.00 100.00 100.00
DSd
IG 20 100.00 100.00 100.00 100.00
RF 20 100.00 100.00 100.00 100.00
GP 20 100.00 91.67 100.00 100.00
DSe
IG 20 100.00 100.00 100.00 100.00
RF 20 100.00 100.00 100.00 100.00
GA 381 54.16 87.50 83.33 66.67
GP 20 100.00 91.67 100.00 100.00
DSf
IG 20 100.00 90.00 100.00 100.00
RF 20 100.00 90.00 100.00 100.00
GP 20 100.00 96.67 100.00 100.00
DSg
IG 20 91.67 100.00 100.00 100.00
RF 20 100.00 91.67 91.67 100.00
GP 20 100.00 100.00 100.00 100.00
DSh
IG 20 100.00 95.45 100.00 100.00
RF 20 100.00 86.36 100.00 100.00
GP 20 95.83 91.67 100.00 91.67
DSi
IG 20 100.00 96.67 100.00 96.67
RF 20 100.00 90.00 93.33 96.67
GP 20 100.00 90.00 100.00 100.00
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datasets, their classification accuracies are the same, which is usually the
perfect performance (100%).
3.6.3 The proposed GP method compared to GA
The top-ranked features from the proposed GP method are also compared
with the features selected by genetic algorithms (GA) wrapped with SVMs
for feature selection. The weka [66] package was used to run the GA fea-
ture selection method and the settings of GA are as follows:
to avoid the premature convergence, the population size is set 300 and
the number of generations is set to 1000.
This makes the same number of evaluations. The crossover and muta-
tion probabilities are to 0.8 and 0.033, respectively. The classification per-
formance is evaluated by NB, J48, random forest, and SVMs, which can be
seen in Table 3.6.
According to Table 3.6, it can be seen that the number of features se-
lected by GA is significantly larger than 20 in the GP method. However,
using only the 20 features from the GP method, NB, J48 and random forest
can achieve better classification performance than using the much larger
feature sets from GA in all the 13 datasets. For example, in the ARC
dataset, GA selected 324 features, which is over 16 times larger than the 20
features from GP. However, the classification performance of NB, J48 and
random forest with the 20 features ranked by GP are better than with the
324 features selected by GA.
SVMs were wrapped in the feature selection process of the GA method
to evaluate the classification performance of the selected features. There-
fore, the features selected by GA are expected to achieve good perfor-
mance with SVMs. However, only in three of the 13 datasets, SVMs with
the features selected by GA achieved better classification performance than
SVMs with the 20 features selected by the proposed GP method. On the
other 10 datasets, the classification performance of the GP method is sig-
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Table 3.6: Comparison between IGRF-GP and GA
Dataset Method #Features NB J48 Random Forest SVMs
OVA2
GA 189 86.56 89.32 92.88 99.20
GP 20 94.46 97.23 98.42 97.23
OVA1
GA 229 85.18 83.33 88.42 94.90
GP 20 90.27 88.88 91.67 93.06
PAN
GA 23 53.59 56.35 49.72 54.69
GP 20 65.74 64.08 74.03 71.27
ARC
GA 324 68.00 69.00 77.50 78.50
GP 20 73.5 80.00 80.00 73.00
DSa
GA 10 70.00 50.00 50.00 90.00
GP 20 80.00 90.00 90.00 90.00
DSb
GA 62 40.00 50.00 70.00 60.00
GP 20 100.00 90.00 90.00 100.00
DSc
GA 45 40.00 60.00 40.00 60.00
GP 20 100.00 100.00 100.00 100.00
DSd
GA 62 33.33 50.00 83.33 66.67
GP 20 100.00 91.67 100.00 100.00
DSe
GA 62 58.33 79.16 83.33 66.67
GP 20 100.00 91.67 100.00 100.00
DSf
GA 62 66.67 96.67 60.00 76.67
GP 20 100.00 96.67 100.00 100.00
DSg
GA 62 66.67 41.67 33.33 58.33
GP 20 100.00 100.00 100.00 100.00
DSh
GA 62 41.67 79.16 62.50 75.00
GP 20 95.83 91.67 100.00 91.67
DSi
GA 62 50.00 86.67 76.67 70.00
GP 20 100.00 90.00 100.00 100.00
nificantly better than that of the GA method. This further shows that the
proposed GP method can outperform the GA method in terms of both the
classification performance and the number of features. It also can be no-
ticed that the performance of GA degrades when the number of examples
is small. Therefore, GA might not be suitable for these datasets where the
available number of examples is very small compared to the number of
features.
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3.6.4 Overlap between top-ranked features
Table 3.7: Percentage of overlap of the top 100 features of IG and RF.
Overlap (%)
OVA2 OVA1 PAN ARC DSa DSb DSc DSd DSe DSf DSg DSh DSi
46 0 41 11 20 6 22 19 48 56 16 43 39
Table 3.8: Percentage of overlap of the top 20 features across the 30 runs.
Feature Overlap (%)
OVA2 OVA1 PAN ARC DSa DSb DSc DSd DSe DSf DSg DSh DSi
1 76.67 60.00 100.00 76.67 100.00 70.00 100.00 56.67 70.00 73.33 66.67 70.00 90.00
2 67.67 56.67 93.33 76.67 100.00 56.67 93.33 46.67 63.33 63.33 53.33 60.00 56.67
3 63.33 53.33 73.33 53.33 100.00 50.00 83.33 46.67 60.00 46.67 46.67 50.00 50.00
4 63.33 53.33 50.00 50.00 100.00 50.00 70.00 46.67 50.00 43.33 46.67 46.67 40.00
5 56.67 50.00 50.00 46.67 100.00 50.00 66.67 43.33 46.67 40.00 46.67 43.33 36.67
6 50.00 46.67 50.00 46.67 100.00 50.00 66.67 43.33 46.67 40.00 46.67 43.33 36.67
7 46.67 43.33 46.67 46.67 100.00 46.67 66.67 40.00 43.33 40.00 46.67 43.33 36.67
8 43.33 40.00 43.33 43.33 100.00 46.67 63.33 40.00 43.33 40.00 43.33 43.33 36.67
9 43.33 40.00 40.00 43.33 100.00 46.67 63.33 40.00 40.00 36.67 40.00 40.00 36.67
10 43.33 36.67 40.00 43.33 100.00 46.67 60.00 40.00 40.00 36.67 40.00 40.00 36.67
11 40.00 36.67 36.67 43.33 100.00 46.67 60.00 40.00 40.00 36.67 40.00 40.00 36.67
12 36.67 33.33 36.67 40.00 100.00 46.67 60.00 40.00 40.00 36.67 40.00 40.00 36.67
13 36.67 33.33 36.67 40.00 100.00 46.67 60.00 40.00 40.00 36.67 40.00 36.67 36.67
14 36.67 33.33 36.67 40.00 100.00 46.67 60.00 40.00 36.67 36.67 40.00 36.67 33.33
15 36.67 33.33 36.67 40.00 100.00 43.33 56.67 36.67 36.67 36.67 40.00 36.67 33.33
16 36.67 33.33 33.33 40.00 100.00 43.33 56.67 36.67 36.67 36.67 40.00 36.67 33.33
17 36.67 33.33 33.33 40.00 100.00 43.33 56.67 36.67 36.67 33.33 36.67 36.67 33.33
18 36.67 33.33 33.33 40.00 100.00 43.33 56.67 36.67 36.67 33.33 36.67 36.67 33.33
19 36.67 33.33 33.33 40.00 100.00 43.33 53.33 36.67 36.67 33.33 36.67 36.67 33.33
20 33.33 33.33 33.33 36.67 100.00 43.33 53.33 0.13 36.67 33.33 36.67 36.67 33.33
To further analyse the top ranked features, the amount of overlap be-
tween the top 100 features from RF and IG is shown in Table 3.7. This
overlap between the features of two metrics benefits in the proposed ap-
proach, where the features are ranked according to the frequency of oc-
currence of each feature in the best evolved programs of GP. The reason
is that a feature selected by both RF and IG indicates that it could be an
important feature. In IGRF-GP, an extra score is given to a feature if it ap-
88 CHAPTER 3. ENSEMBLE FEATURE RANKING
pears in more runs. Therefore, the 20 top ranked features are the features
that appear more in the best evolving programs in more runs.
The overlap percentage between the top 20 features used in the 30 dif-
ferent runs of the GP method is shown in Table 3.8. As shown in Table
3.8, the top 5 features appear in the four MS datasets in at least 50% of the
30 runs, which indicates these features are very important features. For
the LC-MS datasets, the overlap between the features are also high, which
explains why the performance of the top 20 features of those datasets can
achieve the perfect classification performance.
3.7 Chapter Summary
The overall goal of this chapter was to investigate the capability of GP
for processing multiple tasks, which are feature selection, feature ranking,
and classification on the high dimensional MS data. This goal was fulfilled
by developing a two-phase GP approach. In the first phase, GP was used
to select a smaller set of features from the top ranked features obtained by
IG and RF, and improve the feature ranking of these features. In the second
phase, GP was used for classifying the data based on the new top-ranked
features. The proposed GP approach works by embedding two feature
ranking metrics, which are IG and RF, and taking the top ranked features
by these metrics in the terminal set in order to produce a new and smaller
set of features. The results show that the proposed GP approach selected
a smaller number of features than IG and RF. The top 20 features ranked
by GP resulted in a better classification performance than all the original
features and the top 100 or 20 features ranked by IG and RF individually
for most of the thirteen problems using the NB, J48, random forest and
SVMs classifiers. GP as a classifier has the potential to outperform NB,
J48, random forest classifiers on these datasets. The results also suggest
that combining multiple feature selection metrics using GP can improve
the classification performance.
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In the biomarker detection task, GP managed to achieve a detection
rate better than that of IG and RF in all the LC-MS datasets. These datasets
are characterised by a small number of samples and different between-
class and within-class variabilities. This indicates that GP is a promising
approach for this type of challenging task.
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Chapter 4
Multiple Feature Construction
4.1 Introduction
Feature construction is the process of transforming the original input fea-
tures into new features [107]. The new features have the potential to im-
prove the classification performance and also reduce the dimensionality
of the input space.
GP has been widely used for feature construction [62,93,107,122] with
promising results in terms of improving classification accuracy. Most of
the GP based feature construction approaches were based on constructing
a single feature. This single feature is used for classification, or it is used
along with the original set of features. Some other methods construct mul-
tiple features from multiple different independent runs. Using the single
constructed feature alone might not achieve acceptable classification ac-
curacy. The combination of a single constructed feature along with the
original set of features will increase the dimensionality [60, 107] while us-
ing multiple individuals to construct multiple features might also increase
the computational time.
In this chapter, a new GP approach to constructing multiple features [7]
is presented. The proposed approach uses GP to select a good subset of
features and automatically construct new features from a single run. The
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new approach is expected to further decrease the dimensionality of the
selected features and improve the classification performance. This method
is also evaluated according to its performance for biomarker detection on
MS data.
4.1.1 Chapter Goals
The goal of this chapter is to investigate the performance of the features
constructed by GP in terms of the classification accuracy and biomarker
identification. The new GP method works by taking an embedded ap-
proach. The features are constructed by automatically generating high-
level features from the combination of the original low-level features and
the functions from the function set. The sub-trees and root nodes are used
as the constructed features. Fisher criterion and p-values are used to mea-
sure the discriminating information between different classes. Specifically,
we will investigate the following questions:
1. How can multiple features be automatically constructed from a sin-
gle evolved GP tree?
2. How can Fisher criterion and the p-values be used to construct a new
fitness measure?
3. What is the effect of mixing several compounds of peptides or metabo-
lites in terms of classification accuracy?
4. Do the constructed features perform better than the low-level se-
lected features?
5. How well can the new method detect the actual biomarkers?
Chapter Organisation: The rest of the chapter is organised as follows.
Section 4.2 describes the new GP approach. The experiment setup and
the datasets description are presented in Section 4.3. Section 4.4 reports
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the experimental results along with discussions. Section 4.5 contains the
chapter summary.
4.2 GP for Construction of Multiple Features
4.2.1 Algorithm Description
GP can automatically produce multiple outputs from its sub-trees and root
nodes [190]. The use of subtree outputs (internal nodes) has shown to be
effective for classification problems [190], which encourages us to use the
internal nodes outputs for constructing new features. Unlike other ap-
proaches that use only the output of root node of the evolved tree as the
constructed feature, the sub-tree nodes’ output is also used as a high-level
features here. This will help in the construction of more features from
a single evolved tree and not from multiple trees (runs), and, therefore,
reduce the computational cost. The multiple high-level features can also
potentially improve the classification accuracy. The proposed GP method
uses the original low-level features to construct multiple features. The
constructed features are the outputs of the functions that are calculated
using the original features. For example, if two original features from the
terminal set are mixed with a multiplication (×) function, the constructed
feature is the output of the multiplication of those two features. In the ex-
isting GP approaches, the final tree output from the tree node is the only
constructed feature, but in our new approach, different branches of the
tree are also treated as constructed features. The constructed multiple fea-
tures are used to transform the original data. Finally, the projected data is
used for classification. The overview of the GP multiple feature construc-
tion system is shown in Figure 4.1. The steps of the proposed algorithm
are described in Algorithm 2.
The process is as follows:
divide the datasets into a training set and a test set using ten-fold cross-
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Algorithm 2 The GP multiple feature construction algorithm
Require: D, a dataset that contains a vector of instances withm original features.
Ensure: F , of a set of high-level features.
begin
Divide D into ten folds.
While maximum number of generations is not reached; do;
{
For j=1 to 10; do
{
Take the current fold as a test set and the rest folds as a
training set
Randomly Initialise the population (P )
while Maximum generation is not reached do
Evaluate the fitness
Select the individuals using the selection method
Generate new population (CHILD) using the genetic op-
erators
Save the high-level features from the best individual of
each fold in F
end For
}
Compute the average of all the folds
}
end While
Remove the similar features from F
Use the features in F to project test set
return a vector F that contain the constructed features
Calculate the test set classification accuracy of the different solutions
end
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Figure 4.1: Overview of the GP-multiple feature construction system.
validation. Use the training set with GP to construct new features, where
the quality of the features is measured using their discriminating power
between the classes, which is calculated using Fisher criterion and the p-
values. The features are constructed by taking the output of the function
on the original features in the evolved program. The newly constructed
features are used to project both the training and test sets, where different
classification algorithms can be used to evaluate new features. Figure 4.2
shows an example of how the features are constructed from an evolved GP
tree. As shown in Figure 4.2, the two features F1 and F2 construct a new
feature F’1, while the two features F3 and F4 construct the new feature F’2.
Finally, the new feature F’3 which represents the final output of the tree is
constructed from the new features F’1 and F’2. Therefore, this evolved tree
will construct three new features from the four original selected features.
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Figure 4.2: Example of how the features are constructed.
4.2.2 New Fitness Function
The fitness function determines how well a GP tree performs, which is one
of the key components in a GP system. Usually, using a wrapper based fit-
ness measure in GP for feature construction can achieve better classifica-
tion performance than a filter based fitness measure [62], but the computa-
tional cost is higher as it requires training a classifier for each individual of
the population. Meanwhile, the classification performance depends more
on the discrimination power of the classifier. Designing a fitness function
as an embedded method can therefore avoid those disadvantages.
The Fisher criterion [39] works by maximising the between-class scatter
and minimising the within-class scatter.
For a two-class problem, the Fisher criterion is defined as
Fisher criterion =
N∑
n=1
| µi − µj
σ2i − σ2j
| (4.2.2.1)
where µi and µj are the means of the samples which belong to class i and
class j, respectively. σ2i and σ2j are the variances of the samples which
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belong to class i and class j, respectively. N is the number of samples in
the training set.
For c classes where c > 2, the Fisher criterion is calculated for each
adjacent pair of classes based on Equation (4.4.2.1) and the summation of
those pairs is the final value of Fisher criterion.
In addition to the Fisher criterion, minimising the p-value between the
classes helps in the significant maximisation of the distance between the
classes. The p-values are calculated using the one way analysis of variance
(one-way ANOVA) test that also measures the between-class and within-
class separability. The new fitness function Fp is given by:
Fp =
Fisher criterion
Pvalue
(4.2.2.2)
In Equation (4.4.2.2), the Fisher criterion is the measured distribution
of between-class scatter over the within-class scatter of the GP program
outputs. The Pvalue ensures that the degree of separation of the GP pro-
gram outputs of different classes is significantly large. The objective is
to maximise the fitness. Therefore, during the evolution, the p-value is
minimised, and the Fisher criterion is maximised (i.e. the between-class
distance is maximised and the within-class distance is minimised).
4.3 Experiment Setup
This section explains the design of the experiments including the datasets
that were used in the experiments, the terminal set, the function set, and
the GP parameters.
4.3.1 Datasets and Preprocessing
To test the effectiveness of the new GP approach, eight MS datasets were
used. In this section, the datasets characteristics and the preprocessing
will be explained. Table 4.1 summarises the characteristics of the datasets.
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Table 4.1: Datasets characteristics
Dataset # Features # Samples #Classes
PAN 6771 181 2
OVA2 15,154 253 2
OVA1 15,000 216 2
Pros 15,000 322 4
TOX 7105 115 4
ARC 10,000 200 2
Apple-plus 773 40 4
Apple-minus 365 40 4
Preprocessing of the MS data involves several steps that are necessary
for successful analysis of the data. The MS datasets include binary and
multi-class classification problems that are described as follows:
• PAN dataset [20]: This dataset is acquired using a SELDI-TOF sys-
tem.The preprocessing steps include baseline subtraction where piece-
wise linear interpolation is used for the regression of the baseline.
Afterward, filtering and normalisation are performed using Gaus-
sian filter and area under the curve, respectively.
• OVA1 and OVA2 datasets [133]: Both of these datasets were analysed
using SELDI-TOF technology. Although the high-resolution mass
spectra can generate more distinguishable sets of diagnostic features,
the high-resolution data, is more complex than the low-resolution
data. Similar to the preprocessing of the PAN dataset, the prepro-
cessing of these two datasets involves baseline adjustment, filtering,
and normalisation. The final step performed is the alignment to re-
move the fluctuation in the m/z values. The ovarian cancer high-
resolution dataset contains 121 cancer and 95 healthy samples, while
the low-resolution dataset contains 162 cancerous samples and 91
healthy samples.
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• Pros dataset [86]: Samples of three different stages of prostate cancer
and healthy samples were analysed using low resolution SELDI-TOF
mass spectrometer. It is composed of four classes which are: Healthy
(63 samples), Benign (stage1) (190 samples), Prostate Cancer stage2
(26 samples) and Prostate Cancer stage3 (43 samples).
• TOX dataset [134]: Serum samples with toxicity-related biomarkers
were analysed using the SELDI-TOF mass spectrometer. The dataset
consists of four classes which are: definite positive (34 samples), def-
inite negative (28 samples), probable positive (10 samples) and prob-
able negative (43 samples). The Pros and TOX datasets were already
baseline adjusted. Therefore, both of the datasets were only filtered
and normalised.
The above five datasets were downloaded from FDA-NCI Clinical
Proteomics Program1. Those datasets are already binned. Therefore,
the number of features remains the same after preprocessing. Matlab
[114] bioinformatics toolbox was used to perform the preprocessing
of the data.
• ARC dataset [64]: Three different MS datasets were combined to pro-
duce the ARC dataset that contains 100 samples of cancer patients
and 100 healthy samples. The dataset is available after preprocess-
ing, and it is downloaded from the UCI machine learning reposi-
tory [64].
• Apple extracts datasets [169]: These two datasets are metabolomics
datasets where twenty apples were analysed using LC-MS technol-
ogy. Four classes are created from the twenty apples, each class con-
taining ten samples. Three classes contain a mixture of known com-
pounds (biomarkers) during the fourth class is not spiked-in with
those compounds. The negative and positive ion modes form the
1http://home.ccr.cancer.gov/ncifdaproteomics/
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two different datasets. The total number of biomarkers is five and
twelve in the negative and positive ion modes, respectively. The
datasets are available in NetCDF format, and it is preprocessed using
XCMS [152] with the settings described in [169].
4.3.2 GP Settings
The standard tree-based GP is used in the experiments where each node
outputs a single floating point [17,145]. The initial population is generated
using the ramped half-and-half method [92].
The m/z and retention time variables represent the feature identities
of the compounds and the corresponding intensity are the feature value
[176]. Therefore, the terminal set is composed of the intensity variables
(features) which represent the abundance of the compound in the data
and a constant value which is a randomly generated number between [-
1,1]. For each sample in a dataset, a single floating-point value is pro-
Table 4.2: GP settings
Function set +,−,×, %, max, min, IFTE
Variable terminals features
Constant terminals random numbers
Initialization method Ramped Half-and-Half
Tree Depth 2-10
#Generations 50
Mutation rate 20%
Crossover rate 80%
Elitism Yes%
Population Size 2048
Selection type Tournament
Tournament Size 7
duced by the program at the root of its evolved tree [92]. The function
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set is composed of the four mathematical operators +,−,×,% in addition
to the operators, max, min and if-then-else (max,min, IFTE). The % is
a protected division that returns zero for dividing by zero. All the func-
tion set members take two arguments except for IFTE, which takes three
arguments and it returns the second argument if the first argument is neg-
ative and returns the third argument otherwise. The evolution terminates
at a maximum number of generations of 50. The size of the population
is set to 2048. The tree depth has been set between 2 and 10. The basic
crossover and muation operator are used here. The crossover and muta-
tion rates are set to 80% and 20%, respectively. The tournament selection
method is used here and the size is set to 7. An elitist method is taken
to ensure the best individual in the next generation is not worse than the
current generation and, thus, keeping the performance is monotonically
increasing during the evolution [153]. The ECJ [108] package was used in
our experiments for running GP. Table 4.2 shows the various settings for
the new method.
4.3.3 Benchmark Classification Algorithms
To evaluate the classification performance of the constructed features, var-
ious linear and non-linear classifier algorithms are used in the experi-
ments. The WEKA package [67] is used to run the classification algo-
rithms. The classification algorithms used are as follows.
1. Multi-layer perceptron (MLP) classifier: It is the implementation of
the artificial neural network (ANN) which is a non-linear classifier
where the input space is transformed into layers of networks.
2. Naive Bayes Tree (NB-tree): Uses Naive Bayes classifiers at the leaf
nodes of a decision tree.
3. Random Forest (RF): constructs a multitude of decision trees for train-
ing.
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4. K- Nearest Neighbors (K-NN): it is the implementation of the near-
est neighbours algorithm where the output class is the class of the
nearest training example. K is set to 1.
5. Naive Bayes (NB): is a probabilistic method based on Bayes theorem.
6. J-48: The Java implementation of the C4.5 decision tree classifier.
7. Decision table (DT): The possible subset of features is used to con-
struct the decision tables. The test set samples are mapped to cells
in the decision table. The samples in the test set are then classified
according to the label of the majority of training samples of the cell
they are mapped to in the table [88].
4.3.4 Comparison Methods
The performance of the proposed GP method is compared with three meth-
ods. Firstly, the original set of features of each dataset are used with the
seven classifiers for classification. Secondly, the proposed method selects
low-level features (and through its operators form another set of high-
level features). The objective here is to test whether the high-level fea-
tures can perform better than the low-level features selected by the same
method. The features selected by the proposed method are compared with
the features constructed by it. This method is annotated as Method1. Fi-
nally, a GP-based feature selection method (Method2) is also used for com-
parison [3] for MS data. The reason for selecting Method2 is its previous
good performance on MS data. The settings and parameters of Method1
and Method2 are set to be the same as the proposed method on the eight
datasets. Method1 and Method2 select the features that are used in the ter-
minal nodes of the best individual. Both Method1 and Method2 are used
with the same seven classifiers.
The classification performance of the new GP method for feature con-
struction is compared to that of using all the original features, the low-
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level features selected by Method1 and the low-level features selected by
Method2 [3]. For each set of the GP experiments, the GP process is re-
peated for 30 independent runs with 30 random seeds. A significance test
(Z-test) with 90% significance level is performed to compare the classifica-
tion performances of the three methods.
4.4 Results and Discussions
In Table 4.3, the new GP method is annotated as GP-Constructed. The mean
(x), best and the standard deviation (s) of the 30 runs for using the selected
and the constructed features with the seven classifiers are reported in Ta-
ble 4.3. “Avg#” shows the average number of selected or constructed fea-
tures from each method. The evaluation of the seven classifiers is done by
means of ten-fold cross validation. The accuracy of using all the original
features is also reported in the same table and is shown by “All”.
In Table 4.3 the sign ᵀ means that the proposed method is significantly
better than using all the features, while the sign † means that the proposed
method is significantly better than Method1. The sign ? means the new
method is significantly better than Method2. The experiments were run
on a machine with an Intel(R) Core(TM) i7-3770 CPU @ 3.40GHz, running
Ubuntu 4.6 and Java 1.7.0_25 with a total memory of 8GBytes.
4.4.1 Comparison of the Constructed Features with All the
Original Features
As shown in Table 4.3, for all the datasets except for Apple-plus and Apple-
minus, using the original set of features with MLP and NB-tree were both
running out of memory and did not manage to produce any result due to
the huge search space.
The best classification performance of the GP constructed features is
better than using the original set of features on all the datasets except
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Table 4.3: Results of using the constructed, selected and original set of
features with seven classifiers.
Data
set
Classifier
All GP-Constructed Method1 Method2
Best Avg# Best x ±s Avg# Best x ± s Avg# Best x ± s Avg#
PAN
MLP -
6770
95.55 88.48±4.97†?
36.20
94.44 86.17±4.40
65.46
82.60 74.56±6.12
257.66
NB-tree - 96.66 89.57 ±3.77? 96.66 90.92 ±3.38 96.73 92.94 ±2.87
RF 58.56 100.0 95.38 ±2.14ᵀ? 98.88 95.13 ±2.00 97.83 94.11 ±1.51
K-NN 55.80 98.88 95.56 ±1.80ᵀ 98.88 95.70 ±2.16 100.0 95.73 ±1.61
NB 51.38 77.77 62.50 ±5.76ᵀ†? 64.44 57.26 ±3.44 56.52 54.57 ±0.91
J-48 50.82 92.77 87.82 ±2.77ᵀ 94.44 88.48 ±2.41 92.93 88.42 ±2.16
DT 61.32 81.15 72.36 ±5.33ᵀ†? 80.44 71.17 ±4.40 75.61 64.57 ±6.12
OVA1
MLP -
15000
100.0 99.93±0.28†?
27.26
100.0 98.69±0.80
48.23
100.0 97.00±1.63
63.00
NB-tree - 100.0 99.55 ±0.90†? 100.0 98.10 ±1.12 100.0 96.12 ±2.01
RF 87.04 100.0 99.71 ±0.51ᵀ†? 100.0 98.33±0.92 100.0 97.17 ±1.08
K-NN 86.57 100.0 99.85 ±0.43ᵀ†? 100.0 98.97 ±0.83 99.10 96.10 ±1.38
NB 83.79 100.0 94.16 ±4.38ᵀ? 98.13 93.97 ±2.36 93.11 88.22 ±3.34
J-48 86.57 100.0 96.76 ±2.72ᵀ†? 98.59 95.28 ±2.00 97.71 93.93 ±1.77
DT 82.87 97.93 94.74 ±2.16ᵀ†? 97.00 93.69 ±3.20 96.21 92.00 ±3.45
OVA2
MLP -
15154
100.0 99.97±0.14?
27.20
100.0 99.98±0.07
46.10
100.0 99.23±0.66
62.03
NB-tree - 100.0 99.68 ±0.45†? 100.0 99.55 ±0.43 100.0 99.06 ±0.68
RF 93.28 100.0 99.67±0.26ᵀ? 100.0 99.73±0.37 100.0 99.21 ±0.46
K-NN 92.09 100.0 99.95 ±0.20ᵀ†? 100.0 99.76 ±0.47 100.0 99.01 ±0.68
NB 76.28 99.21 96.91 ±1.42ᵀ†? 97.22 94.48 ±2.22 96.87 91.12 ±2.78
J-48 95.65 100.0 98.76 ±1.06ᵀ†? 100.0 98.20 ±1.06 99.22 97.28 ±0.93
DT 92.49 100.0 97.97 ±1.39ᵀ? 100.0 97.98 ±0.49 100.0 97.23 ±2.43
ARC
MLP -
10000
99.00 95.48±2.98†
32.50
100.0 96.15±1.50
58.56
99.00 95.78±1.70
102.1
NB-tree - 98.00 91.57 ±3.10†? 99.00 94.03 ±2.65 99.00 94.73 ±3.01
RF 72.50 100.0 97.28 ±0.51ᵀ? 100.0 97.50±1.27 100.0 96.68 ±1.53
K-NN 84.50 100.0 96.73 ±1.48ᵀ 100.0 96.70 ±1.49 99.00 96.33 ±1.58
NB 70.0 85.50 72.75 ±7.53 88.5 72.00 ±6.56 77.50 69.95 ±3.17
J-48 81.00 95.50 90.43 ±2.76ᵀ? 93.50 90.15 ±2.59 94.50 88.65 ±2.45
DT 71.50 92.00 83.51 ±4.64ᵀ 93.67 84.15 ±3.50 94.00 85.78 ±2.35
Pros
MLP -
15154
100.0 96.47±2.62†
26.03
99.68 97.39±1.54
41.76
99.39 96.69±1.59
40.83
NB-tree - 98.58 95.09 ±2.04? 98.12 94.59 ±1.76 98.78 96.29 ±1.43
RF 98.75 100.0 98.83 ±0.90†? 98.75 97.82±0.76 100.0 98.80 ±0.80
K-NN 97.45 100.0 98.83 ±0.95ᵀ†? 99.37 97.72 ±0.98 100.0 97.74 ±1.04
NB 58.13 84.91 75.37 ±6.13ᵀ†? 82.18 70.34 ±5.25 80.79 69.85 ±6.91
J-48 95.00 94.33 88.55 ±2.86 90.62 87.71 ±2.13 92.07 87.75 ±2.46
DT 72.21 82.25 73.49 ±4.92† 81.25 72.39 ±5.54 83.39 73.65 ±4.59
TOX
MLP -
7105
99.12 94.42±3.03†?
37.1
98.25 93.07±2.95
59.40
96.72 91.45±4.56
177.80
NB-tree - 99.12 89.56 ±4.82 97.36 89.94 ±4.80 96.72 89.84 ±5.75
RF 97.36 100.0 97.92 ±1.39†? 100.0 97.05±1.75 97.54 93.67 ±2.10
K-NN 97.75 100.0 98.65 ±1.10ᵀ†? 100.0 97.75 ±1.14 96.72 92.57 ±1.54
NB 58.12 82.45 61.99 ±8.89†? 60.52 51.23 ±4.93 54.91 49.72 ±2.72
J-48 89.47 89.47 83.59 ±3.48†? 89.47 81.46 ±4.78 88.53 80.19 ±3.68
DT 64.91 76.12 67.42 ±3.03ᵀ†? 78.25 65.07 ±4.45 71.72 62.45 ±2.56
Apple
plus
MLP 100.0
773
100.0 100.0±0.0†?
32.30
100.0 99.25±2.38
46.73
96.72 91.01 ±3.68
33.26
NB-tree 100.0 100.0 100.0 ±0.0†? 100.0 98.83 ±2.38 96.72 87.67 ±5.04
RF 100.0 100.0 99.85 ±0.83†? 100.0 92.65 ±2.33 97.54 91.01 ±3.68
K-NN 100.0 100.0 100.0±0.0? 100.0 100.0 ±0.0 98.36 95.24 ±1.94
NB 100.0 100.0 95.83 ±1.75? 100.0 95.93 ±1.87 71.31 55.57 ±6.62
J-48 100.0 100.0 93.29 ±2.28†? 100.0 92.58 ±3.23 88.52 80.71 ±4.58
DT 100.0 100.0 97.25 ±2.38†? 100.0 96.35 ±3.23 96.72 91.01 ±3.68
Apple
minus
MLP 100.0
365
100.0 99.71±1.66?
28.43
100.0 99.58±1.87
36.33
100.0 98.26±3.63
41.33
NB-tree 100.0 100.0 99.03 ±2.27? 100.0 99.75 ±1.01 100.0 98.96 ±2.67
RF 100.0 100.0 100.0 ±0.0†? 100.0 99.63 ±0.63 100.0 99.86 ±0.53
K-NN 100.0 100.0 100.0±0.0 100.0 100.0 ±0.0 100.0 100.0 ±0.0
NB 100.0 100.0 100.0 ±0.0†? 100.0 99.58 ±1.33 100.0 92.08 ±9.94
J-48 100.0 100.0 100.0 ±0.0? 100.0 100.0 ±0.0 100.0 90.76 ±9.15
DT 100.0 100.0 99.19 ±1.66? 100.0 99.00 ±1.87 100.0 97.26 ±3.63
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for Apple-plus and Apple-minus datasets, where their performances were
both ideal. The average classification performance of the GP constructed
features is significantly better than using all the original features on almost
all the MS datasets excluding the LC-MS datasets (Apple-plus and Apple-
minus). This suggests that GP can benefit in both selecting a good set
of features and, at the same time, in discovering the hidden relationship
between the features by constructing the new features that can perform
better.
For all the seven classifiers, the features constructed by GP managed to
improve the classification accuracy of using all the original features. On
the OVA1, OVA2, Apple-plus and Apple-minus datasets, the constructed
features achieved 100.0% accuracy with most of the classifiers. For other
datasets, the improvement of the accuracy of the seven different classifiers
is 25.97-41.44% on PAN, 14.5-27.5% on ARC, and 2.55-27.79% on Pros and
TOX.
Also, to improve the classification performance, the proposed GP ap-
proach also helps in reduction of dimensionality. For example in Pros
dataset, the mean number of the constructed features is 26.03, which means
that GP reduced around 99.82% of the original dimensionality. The only
exception is the TOX dataset with the J-48 classifier where the original fea-
tures are slightly better than the average performance of the constructed
features, but the best performance of the constructed features achieved the
same performance. This is mainly due to the imbalance problem between
the number of samples in each class and the embedded feature selection
capability of J-48.
4.4.2 Comparison of the New Constructed Features with
the Low-Level Selected Features
The features constructed by the new approach are also compared with
the features selected by GP Method1 (low-level features of the proposed
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method) and GP Method2. The objective is to test whether the new smaller
set of high-level features constructed by GP can perform better than the
selected original low-level features.
Comparing the proposed method with Method1:
In most cases, the classification performance of the features constructed
by the new approach (i.e. notated as GP-Constructed) is significantly bet-
ter than that of the features selected by Method1 (low-level features of
GP-Constructed) for most classifiers. For example, in the TOX dataset, GP-
Constructed is significantly better than Method1 on all the seven classifiers
except for NB-tree, where their results are similar.
On the PAN dataset, the classification performance of the features con-
structed by the new approach (i.e. shown by GP-Constructed) is signifi-
cantly better than that of the features selected by Method1 (i.e. shown by
Method1) when used with MLP, NB and DT classifiers. On the OVA1 and
OVA2 datasets, GP-Constructed is significantly better than Method1 in
four and seven classifiers, respectively. On the Pros dataset, GP-Constructed
is significantly better than Method1 when using RF, KNN, NB and DT in
the Pros dataset. For the two Apple datasets, GP-Constructed is signif-
icantly better than Method1 when using five and two classifiers, respec-
tively.
In terms of the dimensionality reduction, GP-Constructed further de-
creased the number of features over Method1 on all the eight datasets. The
average number is reduced by 7.9-29.26 in different datasets. Meanwhile,
GP-Constructed either significantly improved or maintain the similar per-
formances of the low-level selected features in almost all cases.
Comparing the proposed method with Method2: In almost all datasets,
the classification performance of the new approach is significantly bet-
ter or similar to that of Method2 for most classifiers. For example, GP-
Constructed is significantly better than Method2 on the OVA1, OVA2, and
Apple-plus datasets with almost all the seven classifiers, and on the TOX
and Apple-minus dataset with five of the seven classifiers.
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Figure 4.3: Biomarker detection approach.
The average number of the constructed features is smaller or much
smaller than the average number of the features selected by Method2. The
new method reduces the number of features on average from 1 to 221
features over Method2 on different datasets. With the smaller set of con-
structed features, the new approach still achieves similar or better classifi-
cation performance than Method2 in almost all cases.
4.4.3 Biomarker Identification
We tested the performance of biomarker identification of the proposed
method on the Apple-plus and Apple-minus datasets, because only in
these two datasets was a set of compounds spiked-in and predefined as
the biomarkers.
Figure 4.3 shows an example of the approach used to count the number
of identified biomarkers. As shown in Figure 4.3, the intersection between
the selected features in the terminal nodes of the tree and the predefined
set of biomarkers are used as an evaluation of the biomarker identification
task.
Table 4.4 shows the biomarkers in Apple-plus and Apple-minus datasets
(positive and negative modes of the ions). The table also shows the sta-
tus of identification of the biomarkers by the proposed GP method and
Method2. The percentage of runs in which these biomarkers appear are
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Table 4.4: Identified spike-in biomarkers by the proposed GP method and
Method1 for the Apple datasets. The biomarkers are identified using their
m/z values.
m/z values in Apple-plus dataset New Method Method2
(12 biomakers) Selection
Status
% of
GP
runs
Selection
Status
% of
GP
runs
331.21 7 0 3 100.0
471.09 3 80.00 3 50.00
107.05, 169.05, 238.05, 275.09, 456.11, 459.13 3 100.0 7 0.0
456.62, 475.10 7 0.0 7 0.0
449.11 3 66.67 3 88.0
229.09 3 90.00 7 0.0
m/z values in Apple-minus dataset New Method Method2
(5 biomakers) Selection
Status
% of
GP
runs
Selection
Status
% of
GP
runs
463.0 3 86.67 7 0.0
447.09 3 100.0 3 86.67
273.03 3 100.0 3 93.33
435.13 3 100.0 7 0.0
227.07 3 93.33 7 0.0
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shown in Table 4.4. As shown in Table 4.4, GP identified the complete
set of biomarkers in Apple-minus datasets. Method2 detected only two
biomarkers in 93.33% and 86.67% of the runs, respectively. For Apple-
minus dataset, the new GP method detected three biomarkers in all its 30
runs and the remaining two in 86.67% and 93.33% of the runs. For the
Apple-plus dataset, nine out of the twelve biomarkers (75%) are detected
by the proposed GP method. Seven biomarkers are identified in 100.0%
of runs, and the other three are selected in 66.67%, 80% and 90% of the
GP runs. However, Method2 identified only three of the twelve biomark-
ers. This suggests that the new proposed method can be successfully used
for the task of biomarker identification as it constructs a new set of fea-
tures that can achieve better classification accuracy and biomarker detec-
tion rate.
4.5 Chapter Summary
The goal of this chapter was to test the performance of GP in construct-
ing multiple new high-level features and to examine the effect of these
new features in terms of dimensionality reduction, classification perfor-
mance, and biomarker identification. The goal was successfully achieved
by developing a new GP method, which takes an embedded approach by
maximising the significant discrimination between different classes. The
performances of the high-level constructed features are compared to those
of the whole original set of features and the selected set of low-level fea-
tures from two methods with seven different classifiers. The results show
that the new features performed better than the original set of features
for all the datasets with most of the classifiers. The results also show that
these smaller sets of new features achieved significantly better or similar
performance to the selected low-level features on almost all the datasets.
Moreover, the constructed features helped in reducing the dimensionality
more than the selected features. The biomarker identification results of the
110 CHAPTER 4. MULTIPLE FEATURE CONSTRUCTION
proposed method showed that the new GP method can identify 100.0% of
the biomarkers in the Apple-minus LC-MS dataset and 75% of the prede-
fined biomarkers in the Apple-plus dataset. Due to its better classification
and biomarker identification performance, the new GP can be successfully
applied to this task.
In the next chapter, multi-objective GP methods for feature selection
and construction are proposed. The multi-objective feature construction is
an extension of the method proposed in this chapter that aims to keep the
trade-off between the number of high-level features constructed and the
classification performance.
Chapter 5
Multi-Objective Feature
Manipulation
5.1 Introduction
Many feature selection techniques have been proposed to detect the po-
tential biomarkers in MS data [26, 102–104, 123]. Despite the promise of
the previously proposed methods, none of these methods considered the
number of features as an important independent objective to optimise.
Some studies considered the relative importance of the number of features
to classification accuracy in a single fitness function. The major limitation
of these approaches is the prior specification of the relative importance
of each objective into a single-objective fitness function. Multi-objective
optimisation offers the solution to the optimisation of different conflicting
objectives simultaneously without the need to consider the relative impor-
tance in advance. Section 5.2 of this chapter proposes the first attempt to
use GP as a multi-objective approach to biomarker detection.
Although our previously proposed feature construction approach in
Chapter 4 has shown the effectiveness of the new features on improving
the classification performance, the number of features constructed is still
high. Section 5.3 aims to extend the work in Chapter 4 to consider the
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trade-off between the number of features constructed and the classification
accuracy through the use of multi-objective optimisation.
5.1.1 Chapter Goals
The overall goal of this chapter is to develop GP-based multi-objective
feature selection and construction approaches to classification of MS data.
In feature selection, the proposed GP method uses ideas from NSGAII
[27] and SPEA2 [192] to evolve models that keep the balance between
the conflicting objectives. We notate these methods as NS-GPMOFS and
SP -GPMOFS. The main goal here is to evolve a Pareto front of non-
dominated solutions, which include a small number of selected original
features and achieve a better classification accuracy than using the whole
set of features.
In feature construction, a single evolved tree is used to construct multi-
ple features by replacing the original features with the constructed features
after combining them using the GP functions. Multi-objective optimisa-
tion is used to reduce the number of constructed features while keeping
the high classification accuracy. We notate these methods asNS-GPMOFC
and SP -GPMOFC.
In both approaches, an embedded approach is used to take the advan-
tages of the low computational cost and better classification accuracy.
Precisely, we will investigate the following:
• whether using GP as a multi-objective approach to feature selection
can evolve better non-dominated solutions than using the single ob-
jective GP algorithm,
• whether using multi-objective GP feature selection methods can se-
lect feature subsets that improve the classification performance and
reduce the number of features more effectively than using the tradi-
tional multi-objective algorithms,
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• whether using multi-objective optimisation can reduce the number
of constructed features and at the same time maintain the good clas-
sification accuracy, and
• whether the GP-based method for construction with multiple objec-
tives can further improve the feature subset evolved by the multi-
objective GP feature selection method.
Chapter Organisation: The rest of the chapter is organised as follows.
Section 5.2 describes the GP-based multi-objective feature selection algo-
rithm. Section 5.3 explains the GP-based multi-objective feature construc-
tion method. Section 5.4 gives an overview of the two systems. Section 5.5
describes the experimental design that includes the settings and the MS
datasets used. Section 5.6 presents the experimental results of discussions.
Section 5.7 concludes the chapter.
5.2 The GP Multi-objective Feature Selection Ap-
proach
In this section, we investigate a new approach to feature selection for MS
data with the aim of biomarker detection using multi-objective GP, with
two main objectives to explore the Pareto front of feature subsets. The
objectives here are maximising the classification accuracy and minimis-
ing the number of features used in each individual of the population. As
mentioned earlier, an embedded approach is taken in the proposed algo-
rithm. GP is employed here as a classifier as well, and the number of
correctly classified instances in the training set is stored in a memory list.
The classification accuracy is used to assess the first objective. The second
objective here is to minimise the cardinality of the selected features (num-
ber of features selected automatically in the GP tree). When a new solu-
tion is evolved, it is compared to the other solutions stored in the memory
114 CHAPTER 5. MULTI-OBJECTIVE FEATURE MANIPULATION
list. If the evolved solution is not worse in both objectives and it is better
than a solution in the list in at least one of the objectives, it will dominate
that solution. Pareto optimal contains the set of non-dominated solutions
where a specific solution can not improve any of the objectives without
degrading at least one of the other conflicting objectives [126]. The non-
dominated solution forms the Pareto front in which no solution can be
judged better than the others.
5.2.1 Pareto Fitness Schemes inNS-GPMOFS and SP -GPMOFS
In evolutionary multi-objective optimisation, solutions are usually ranked
according to their performance on the different objectives to measure the
Pareto dominance. The Pareto dominance is measured through the domi-
nance rank or dominance count [192] (or both) of a certain solution. Dom-
inance rank of a solution is the number of solutions that dominates this
solution, while the dominance count is the number of solutions that a
given solution dominates. A solution with a lower number of solutions
that dominate it (lower rank) and a higher count is a better solution. We
propose two mechanisms to measure the Pareto fitness. The first uses the
dominance rank of a solution Si for evaluating the fitness which is similar
to the idea of NSGAII [27], i.e., the number of other solutions in the pop-
ulation that dominate Si, and we annotate this method as NS-GPMOFS.
Similar to SPEA2, the second mechanism uses both dominance rank and
dominance count in the Pareto refined fitness, and this method is anno-
tated as SP -GPMOFS.
5.2.2 Crowding Distance Measure
In addition to the previously mentioned Pareto dominance measures used
in the fitness, a crowding distance measure is used to generate more di-
versity among the population [15]. The crowding distance used is the
Manhattan distance between the solutions. This distance measure is used
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only when two or more solutions have equal Pareto dominance measures,
which means that if solutions have equal rank then the solution with bet-
ter crowding distance is selected. The crowding distance is the average
distance between the two solutions with each of the objectives, where a
lower distance indicates a better result.
5.2.3 NS-GPMOFS and SP -GPMOFS Algorithms
Algorithm 3 shows the pseudocode of GPMOFS algorithms. The input is
D, the dataset, and the output is the Pareto front archive of solutions (PF ).
At each generation, the parent and offspring populations are merged. The
fittest individuals (according to the two objectives) in this merged popu-
lation acts as the new population (CHILD) in the next generation. The
population is reduced to size N (original size of the population) using
dominance rank and crowding distance for NS-GPMOFS. While for SP -
GPMOFS dominance rank, dominance count and the crowding distance
are measured. The size of CHILD is the same as the size of the origi-
nal population and it is produced using the traditional genetic operators
(crossover and mutation operators). In case of SP -GPMOFS, the size of
PF (Pareto front solutions) is kept fixed while in NS-GPMOFS it does
not have a specific size. Another difference between using NS-GPMOFS
and SP -GPMOFS is the use of elitism in SP -GPMOFS, which is not
used inNS-GPMOFS. The non-dominated solutions inCHILD are iden-
tified and copied to PF . These steps are repeated until the maximum num-
ber of generations is reached. At the end of the evolutionary search, the
solutions of PF are used to project the datasets and passed for evalua-
tion. The evaluation is done through both classification accuracy and the
number of features used in each solution in the archive.
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Algorithm 3 Pseudo-Code of NS-GPMOFS and SP -GPMOFS
Require: D, a dataset that contains a vector of instances withm original features.
Ensure: PF , a Pareto front (PF ) of a set of solutions (low-level features).
begin
Divide D into training and test sets.
Initialise the population (P )
while Maximum generation is not reached do
Evaluate the two objectives of each individual { // Acc, |F |}
Select the individuals using the selection method
Generate new population (CHILD) using the genetic operators
if NS-GPMOFS is used then
Non-dominated sorting of the individuals based on ranking and the
crowding distance
else if SP -GPMOFS then
evaluate the individuals based on ranking, count, and the crowding
distance
end if
Copy both CHILD and P to Archive
Identify the individuals who have non-dominated solutions in Archive
and add to Pareto front (PF )
Select a population of size N based upon ranking and crowding distance
Generate new population (CHILD) using the genetic operators
end while
Use the solutions in PF to project the test set
Calculate the test set classification accuracy of the different solutions
Calculate the number of selected features in each solution in PF
return a vector S that contain the number of features and classification accu-
racy of each solution in PF
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5.3 The GP Multi-objective Feature Construction
Approach
The difference between GPMOFS and GPMOFC is that instead of using
the original selected features; GPMOFC constructs new high-level fea-
tures from the original features (resulted features from the tree branches).
In addition to the features constructed from the branches, the final feature
constructed from the root node of the tree is also used.
5.3.1 SP -GPMOFC and NS-GPMOFC Algorithm
Algorithm 4 describes the algorithms of SP -GPMOFC andNS-GPMOFC.
The two algorithms are similar to the feature selection algorithms (SP -
GPMOFS and NS-GPMOFS) except for the final feature set. The differ-
ence here between the two algorithms for feature selection and construc-
tion is that instead of using the original features selected, the high-level
features are constructed to optimise the second objectives.
5.4 Overview of the Two Systems
As shown in Figure 5.1, after preprocessing of the MS spectra datasets, the
system for GPMOFS starts by dividing the dataset into training and test
sets.Each program in the population uses a subset of features in its tree
terminal nodes and generates the fitness value. The fitness value (classi-
fication accuracy) is measured by GP individual classifier’s accuracy that
is passed as a fitness value to measure the dominance. Dominance rank,
dominance count and crowding distance are used to measure the domi-
nance of the solutions. After the fitness calculation, the fitness value of
each solution is compared to the Pareto front archive. If the solution in the
archive is dominated by the new solution, the new solution will replace it
in the archive. Each solution in the Pareto front has a subset of features
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Algorithm 4 Algorithm of NS-GPMOFC and SP -GPMOFC
Require: D, a dataset that contains a vector of instances withm original features.
Ensure: PF , A Pareto front (PF ) (solutions with high-level features).
begin
Divide D into 50% for training and 50% testing.
Randomly Initialise the population (P )
while Maximum generation is not reached do
Save the high-level features resulting from the branches and the root of
the individual tree
Evaluate the number of constructed features and Acc of each individual
Select the individuals using the selection method
Generate new population (CHILD) using the genetic operators
if NS-GPMOFC then
Non-dominated sorting of the individuals based on ranking and the
crowding distance
else if SP -GPMOFC then
Non-dominated sorting of the individuals based on ranking, count and
the crowding distance
end if
Copy both CHILD and P to Archive
Identify the individuals who have non-dominated solutions in Archive
and add to Pareto front (PF )
Select a population of size N based upon ranking and crowding distance
Generate new population (CHILD) using the genetic operators
end while
Use the solutions in PF to project test set
Calculate the test set classification accuracy of the different solutions
Calculate the number of high-level features in each solution in PF
return a vector S that contain the number of high-level features and classifi-
cation accuracy of each solution in PF
end
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that were selected in the terminal nodes. The Pareto front solutions are
used to project the datasets, therefore if the size of the archive is n, there
will be n projected datasets. To test the subsets of features, the test set
is evaluated using GP classifier. As explained earlier, the main difference
between GPMOFS and GPMOFC is the use of low-level and high-level
features.
F
e
a
tu
re
 S
e
le
c
tio
n
D1 D3 Dn
GP Classi!er
Exploration of Pareto front solutions
GPMOFS
GP individual
Objective2
Objective1
Accuracy
# of Features 
in the tree
Measure Dominance
((Dominance rank and count)
Pareto Front
MS Spectra
+-
%
# of high-level features
Objective 1 Objective 2
Pre-processing
Baseline Adjustment
 Normalization
Alignment
Smoothing
Training Set
Test Set
Projected Test Sets
GPMOFC
Accuracy
Measure Dominance
Pareto Front
F
e
a
tu
re
 C
o
n
stru
c
tio
n
Solution_1
Solution_2
Solution_n
:
:
D2
D1 D3 Dn
GP Classi!er
        Projection
Solution_1
Solution_2
Solution_n
:
:
D2
Crowding distance calculation
((Dominance rank and count)
Crowding distance calculation
Figure 5.1: General overview of the multi-objective approaches
5.4.1 Fitness Function
For both algorithms, the fitness values used as objectives are the following:
Firstly, the overall classification accuracy (Acc) and secondly, the number
of features either selected or constructed. Acc is defined as:
Acc =
TP + TN
TP + TN + FP + FN
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Table 5.1: Summary of the Datasets
Dataset No. of spectra No. of features
OVA1 216(121+95) 15000
OVA2 253(162+91) 15154
PAN 181(80+101) 6771
ARC 200 (100+100) 10000
TOX 62(28+34) 45200
HCC 150 (78+72) 36802
DGB 128 (78+25) 16075
Pros 253 (63+190) 15000
Appleminus 40(10+10+10+10) 365
where TP, TN, FP and FN are the true positives, true negatives, false pos-
itives, and false negatives, respectively. For each instance of the training
set, if the output of the program is less than or equal to zero then the in-
stance is classified as class 1, otherwise it is classified as class 2.
Thus, in both GPMOFS and GPMOFC, the first objective is to max-
imise the classification accuracy. The second objective used is to minimise
the cardinality of the feature subset selected or constructed by each GP
tree in the terminal nodes |F |.
5.5 Experiments Design and Settings
This section explains the MS datasets used to testGPMOFS andGPMOFC,
GP operators and parameters, benchmark algorithms used for comparison
reasons, and the evaluation criteria.
5.5.1 MS Datasets
To test the effectiveness of the proposed GP multi-objective approach, nine
different MS datasets are used. Table 5.1 summarises the details of the
datasets used in the experiments.
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• OVA1 and OVA2 [133]: OVA1 is composed of 216 spectral instances
where 121 spectra are cancerous samples and 95 spectra are healthy
ones, while OVA2 consists of 253 spectra with 162 spectrum in the
cancer class and 91 in the unaffected class. The number of features is
15000 and 15154 in OVA1 and OVA 2, respectively.
• PAN [20]: The dataset has 181 spectral examples, where 80 are in
the affected class and 101 are in the healthy class. The number of
features in each spectrum is 6771.
• ARC [22]. ARC is generated from three merged MS datasets (two
prostate and one ovarian cancer dataset) with 100 spectra from can-
cerous class and 100 from normal class. Each spectrum has 10000
features in each spectrum.
• TOX [134]: The dataset consists of 62 spectra (28 in the positive and
34 in the negative class) and each spectrum has 45200 m/z readings.
• HCC [140]: HCC has 150 spectra (78 affected and 72 non-affected)
with 36802 features in each spectrum.
• DGB [22]. This dataset contains three groups of samples (78 healthy
control samples, 25 hepatocellular carcinoma and 25 chronic liver
samples). The total number of features is 16075.
• Pros dataset [86]: This dataset is composed of four classes which are:
Healthy (63 samples), Benign stage1 (190 samples), Prostate Cancer
stage2 (26 samples) and Prostate Cancer stage3 (43 samples). The
number of features in Pros is 15000. For DGB and Pros datasets, we
used only two classes of instances.
• Appleminus: This dataset is composed of 365 features with ten in-
stances of each class. Three classes contain five predefined biomark-
ers, and the last class is not spiked-in. Only one of the spiked-in
classes and the non-spiked class are used in our algorithms.
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Several preprocessing steps were applied to each of the datasets. ARC
datasets are available after preprocessing. The preprocessing of MS data
is important to convert the data to a homogeneous matrix which can be
used for feature selection and classification of the data [22]. The prepro-
cessing steps used in our experiments include baseline adjustment, spec-
trum normalisation, alignment and filtering with different parameters for
each dataset. The baseline removal is used to remove the low-range noise.
The baseline is estimated by passing a window on the spectra and the min-
imum m/z values are calculated. A piecewise linear interpolation method
is used for the regression of the baseline. To make the intensity values
range the same, normalisation is performed. The normalisation of the
spectra is done by calculating the area under the curve [134] and rescaling
the spectra to have a maximum intensity value of 300. This is done by us-
ing the msnorm function in the Matlab toolbox [114]. After normalisation
is performed, alignment of the peaks is performed to match the similar
peaks across all the spectra. Finally, smoothing of the spectra is done to re-
move the low signal fluctuation. Smoothing is done via a Savitzky-Golay
filter. Pros and TOX datasets were already baseline adjusted. Therefore,
both of the datasets were only filtered and normalised. Table 5.2 shows
the running parameters of the preprocessing steps used with each of the
datasets. The parameters are selected based on the original papers of the
datasets [20,22,134,140]. For the spike-in Appleminus dataset, the prepro-
cessing is previously explained in Chapter 4.
5.5.2 Performance Evaluation
GP as a classifier is used to test the selected features in each solution in the
archive on the test sets.
5.5.3 Genetic Operators and Parameters
In the experiments, we adopt the standard tree-based GP which produces
a single floating point number as a result of the fitness evaluation [92]
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Table 5.2: Preprocessing running parameters
OVA1 & OVA2 TOX PAN HCC DGB Pros
Window size for baseline
removal
500 - 200 50 200 -
Smoothing frame size 5 6 3 6 6 3
Maximum intensity after
normalisation
300
for each instance in the dataset. Each of the output values is then used
to determine the relevance of the subset of features used in the program
and the classification accuracy of the genetic program. The initial pop-
ulation is generated using the ramped-half-and-half method [124]. The
function set consists of the four standard elementary mathematical oper-
ators {+,−,%,×} and also a square root √ operator. The % and √ are
"protected" where % returns zero for division by zero and
√
returns zero
for negative numbers. The terminal set has only variable terminals that are
the feature values. The population size is set to 1024. Crossover and muta-
tion probabilities are 0.8, and 0.19, respectively, and tournament selection
is used with the size of 7. The GP, NSGAII and SPEA2 implementations
used in the experiments are based on the Evolutionary Computing Java-
based (ECJ) package [108]. Other parameters for NSGAII and SPEA2 are
set as the default values in the ECJ library. The evolution terminates at a
maximum number of 20 generations.
For each dataset, the experiment is repeated for 30 independent runs
with 30 different random seeds. Each run outputs a set of non-dominated
solutions in the Pareto front. The 30 sets of non-dominated solutions from
the 30 runs are combined to one set by removing the dominated solutions
from the different sets.
Table 5.3 shows the various running parameters of the new GP method.
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Table 5.3: GP running parameters
Function set +,−,×, %,√
Variable terminals features
Initialization method Ramped half-and-half
Tree Depth 8-17
#Generations 20
Mutation rate 0.19
Crossover rate 0.8
Population Size 1024
Selection type Tournament
Tournament Size 7
5.5.4 Benchmark Algorithms
GPMOFS and GPMOFC are compared to the following benchmark al-
gorithms:
1. Standard (Single-Objective) GP method which is the standard GP
classification framework using a fitness of the overall classification
accuracy as a single objective to maximise. The features selected in
the terminal nodes of the tree are treated as the selected features.
2. NSGAII: Multi-objective optimisation using NSGAII and Fisher cri-
terion based class separability for feature selection [157]. The evalu-
ation is done through both the higher Fisher criterion and the smaller
number of features. The first objective which is maximising the Fisher
criterion or the class separability, that is defined as,
Fitness function = Fisher criterion =
N∑
n=1
| µi − µj
σ2i − σ2j
| (5.5.4.1)
where µi and µj are the means, σ2i and σ2j are the variances of the
samples which belong to class i and class j, respectively. N is the
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number of samples in the training set. The second objective is min-
imising the number of features.
3. SPEA2: Multi-objective optimisation using SPEA2 and Fisher crite-
rion to evaluate the selected features.
Similar to GPMOFS and GPMOFC, the population size is set to 1024
and the number of generations is 20. For both NSGAII and SPEA2 , each
individual is encoded as a binary vector. The length of the vector is equal
to the total number of features in the dataset. Hence, if the bit is 0, this
means that the feature is unselected.
5.6 Results and Discussions
This section provides the results and discussions of the proposed algo-
rithms. Figure 5.2 shows the results of GPMOFS compared to using the
single objective GP method, and the SPEA2 and NSGAII, while Figure
5.3 shows the results of GPMOFC compared to GPMOFS. The multi-
objective methods have different numbers of non-dominated solutions.
The results are the non-dominated solutions obtained from the 30 inde-
pendent runs. The x-axis refers to the number of features selected by each
method whereas the y-axis indicates the classification accuracy. Each fig-
ure is divided into a number of sub-figures where each sub-figure repre-
sents the results of each dataset.
5.6.1 Performance of GPMOFS
It can be noticed from Figure 5.2 that using SP -GPMOFS has the poten-
tial to evolve solutions, which have better classification performance and
a smaller number of features than usingNS-GPMOFS in seven out of the
nine datasets. The proposed method also outperformed the single objec-
tive GP approach and the two benchmark multi-objective methods SPEA2
126 CHAPTER 5. MULTI-OBJECTIVE FEATURE MANIPULATION
and NSGAII, on all the nine datasets. This supports our hypothesis that
using multi-objective GP can improve the feature selection performance
from both the classification accuracy and the number of features point of
views.
In some cases, NS-GPMOFS and SP -GPMOFS have common solu-
tions such as in the ARC, TOX, and HCC datasets during the left region
of the front. Only in the TOX dataset, NS-GPMOFS evolves solutions at
the right region of the frontier which have better accuracy, but the number
of features in these solutions are larger. In the Appleminus dataset, NS-
GPMOFS is the best followed by SP -GPMOFS. The single-objective
GP method for the Appleminus dataset has evolved solutions with a large
number of features and lower accuracy compared to the multi-objective
approaches.
The multi-objective approaches SPEA2 and NSGAII for feature selec-
tion are both used with Fisher criterion for comparison to the proposed
method. Comparing NS-GPMOFS and SP -GPMOFS with SPEA2 and
NSGAII, it is clear that GP has improved the performance of both NSGAII
and SPEA2 for feature selection. This can be explained by the GP capabil-
ity to select the subsets of features that are more relevant to classification.
Using multi-objective optimisation along with GP improve both objectives
of reducing the number of features and having a better performance. This
suggests that GP improves the capability of the multi-objective approaches
through its ability to select the better subsets of features.
5.6.2 Comparison of GPMOFS and GPMOFC
Considering the experimental results of GPMOFC that are shown in Fig-
ure 5.3, it can be noticed that the multi-objective feature construction is
better than the multi-objective feature selection in most cases. For OVA1,
SP -GPMOFC is the best with a smaller number of features. For PAN
and HCC, feature construction approaches evolve better solutions than
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Figure 5.2: Experimental Results for GPMOFS
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Figure 5.3: Experimental Results for GPMOFC
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the feature selection algorithms. However, for ARC, using all algorithms
the solutions are similar when the number of features is smaller, but SP -
GPMOFC outperforms the other algorithms in its last two solutions. In
dataset OVA2 (Figure 5.3 (b)), SP -GPMOFC is equivalent to SP -GPMOFS
and it outperforms NS-GPMOFS.
The results suggest that multi-objective feature construction tends to
achieve the balance between reducing the dimensionality and improving
the performance better than multi-objective feature selection. This sup-
ports our first hypothesis that feature construction can further improve
the multi-objective feature manipulation performance through the con-
struction of high-level features that identify the interactions and relations
between the original low-level features.
The exceptions to the conclusion mentioned above that multi-objective
feature construction can achieve better results than the multi-objective fea-
ture selection on these datasets are the TOX and Pros datasets. For Ap-
pleminus dataset, NS-GPMOFS has the best set of solutions and the two
feature construction methods come next. For these two datasets,GPMOFS
is better than GPMOFC. GPMOFC tries to reduce the number of con-
structed features and decreases the dimensionality better than GPMOFS
in these two datasets, but this came on the account of the classification
performance. However, the gap between the selection and construction
is very small. Both selection and construction can achieve 100% accuracy
with a number of features of 10-12 for feature selection and 12-16 for fea-
ture construction, from over 15,000 features in Pros and 45,000 in TOX.
5.6.3 Comparison ofGPMOFC to single objective GP, SPEA2
and NSGAII approaches
Comparing Figure 5.2 and Figure 5.3, GPMOFC is outperforming both
SPEA2 and NSGAII in all the cases. If the results of GPMOFC and the
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single objective GP are compared, it is also clear the multi-objective con-
struction is better with all the tasks.
This indicates the increased effectiveness of using the high-level fea-
tures over the selected original features, and gives more credibility to GP
as a feature construction approach.
5.6.4 GPMOFC vs single objective GP for feature construc-
tion
Considering the method proposed in Chapter 4 in the thesis for feature
construction, the number of high-level features is still an issue that needed
to be considered. GPMOFC managed to keep the good performance of
the algorithm and at the same time significantly reduced the number of
constructed features.
In Table 4.3 (Page 102), the average number of features of OVA1 con-
structed by single objective GP feature construction approach, for instance,
is 27.26. GPMOFC managed to keep the maximum number of features of
14 which means reducing the dimensionality by approximately 50%. For
TOX, the average number of constructed features using the single objec-
tive GP is 37.1 while GPMOFC’s maximum number of features is 12. For
the rest of the datasets, the same scenario happens, which means that our
goal of improving classification through feature construction and reducing
dimensionality has been successfully achieved.
5.6.5 Biomarker Detection
We tested the features selected from the Appleminus dataset to check the
number of detected predefined biomarkers by each method. Table 5.4
shows the selection status of the biomarker by each of the multi-objective
feature selection methods. From the table, it is clear that SP -GPMOFS
has outperformed the other three methods and managed to detect the five
biomarkers. SPEA2 detected four biomarkers while both NS-GPMOFS
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and NSGAII detected three out of the five biomarkers. This suggests that
SP -GPMOFS has better performance in terms of biomarker detection as
well as higher accuracy solutions with a smaller number of features
Table 5.4: Identified spike-in biomarkers by SP -GPMOFS, NS-
GPMOFS, SPEA2 and NSGAII
m/z value SP -GPMOFS NS-GPMOFS SPEA2 NSGAII
(5 Biomarkers)
463.0 3 3 3 7
447.09 3 3 3 3
273.03 3 3 3 3
435.13 3 7 7 7
227.07 3 7 3 3
5.7 Chapter Summary
This chapter proposes the first multi-objective biomarker detection ap-
proach for MS data. Moreover, the chapter also presents the first multi-
objective feature construction algorithm that is applied to MS data. The
goal here was to develop a new GP multi-objective feature manipulation
algorithm.
In Section 5.2 of the chapter, GPMOFS, a GP multi-objective feature
selection method is proposed, which manages the trade-off between the
classification accuracy and the cardinality of features. According to the re-
sults, GPMOFS evolves non-dominated solutions, which has the poten-
tial to solve the problem of high dimensionality and a small number of ex-
amples in MS data. The method outperforms the single-objective feature
selection GP method in terms of both objectives. The method uses the em-
bedded capability of GP to select features with the dominance rank, dom-
inance count and crowding distance to evaluate the solutions. The pro-
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posed method also outperforms both SPEA2 and NSGAII multi-objective
feature selection approaches using Fisher criterion.
The second part of the chapter presents GPMOFC, the first multi-
objective feature construction method on MS data. The method is ex-
tending the GP multiple feature construction method proposed in Chap-
ter 4 of the thesis. For the construction of multiple high-level features,
the features generated from the branches of the evolved GP tree in ad-
dition to the root features are used. This generates a number of new
high-level features, which has the potential to improve the classification
performance. To reduce the dimensionality by generating a smaller num-
ber of features, GPMOFC uses ideas from SPEA2 and NSGAII to keep
the trade-off between the number of features and the classification per-
formance. The results show that GPMOFC outperformed GPMOFS in
almost all the cases, and hence, it was better than SPEA2 and NSGAII ap-
proaches and the single objective GP feature selection method. The results
also show that the number of constructed features are greatly reduced over
the method proposed in Chapter 4, and, therefore, it can be more suitable
for dealing with the high dimensional MS data.
Chapter 6
Biomarker Verification
6.1 Introduction
There have been significant efforts to compare proteome of diseased and
control samples to discover biomarkers or understand the pathogenesis
of diseases. These efforts lead to long lists of biomarkers associated with
a wide range of diseases and these biomarkers require validation. How-
ever, the experimental validation of these biomarkers is extremely chal-
lenging due to the high complexity and heterogeneity of the human sam-
ples [9, 111] and the high cost of the process. Since the evaluation of the
large number of candidate biomarkers is a critical gap in the biomarker
discovery process, an efficient method is needed to select a few candidates
who will be passed to experimental validation. Measuring the detectabil-
ity of peptides can be used to relieve the bottleneck between the biomarker
detection and experimental validation through selecting the high respond-
ing peptides (referred to as the quantifiable surrogates [23], [5], [6]). This
process of measuring the peptide detectability can act as a biomarker ver-
ification step.
Peptide detectability, which is the probability that a certain peptide can
be observed in a mass spectrometer, is used in this chapter for biomarker
verification.
135
136 CHAPTER 6. BIOMARKER VERIFICATION
Peptide detection is a classification problem where the task is to classify
the flyer vs. the non-flyer peptides in the mass spectrometer. Biomarkers
are the flyer peptides that can be detected in the mass spectrometer. The
existing approaches to this task did not make use of the GP’s advantages,
which include flexibility in building models and automatic feature selec-
tion [46, 48, 164]. The fact that the power of GP for peptide detection has
not been fully used motivates us to investigate its capabilities.
6.1.1 Chapter Goals
The goal of this chapter is to develop a new GP peptide detection system
that finds the high responding peptides and selects the important proper-
ties necessary for peptide detection. This peptide detection method is used
for verification of biomarkers. Moreover, the proposed method should
take into account the class imbalance problem of the data. The combina-
tion of GP capabilities of feature selection, evolving classification models
and also handling the class imbalance problem constitutes the peptide de-
tection system. Specifically, we are interested in investigating the follow-
ing:
1. The effectiveness of GP to find the important peptide’s physicochem-
ical properties while considering the relations with other properties
rather than selecting them independently.
2. The requirement to deal with the class imbalance problem while de-
signing the GP peptide detection method.
3. The performance of the proposed method compared to the common
benchmark classification and feature selection methods.
4. The comparison of the proposed method to Enhanced Signature Pep-
tide Predictor (ESP-Predictor) [46], which is considered a popular
method in this area.
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Chapter Organisation:
The rest of the chapter is organised as follows. Section 6.2 describes the
proposed GP peptide detectability method. The design of the experiments
is explained in Section 6.3. The results and discussions are provided in
Section 6.4. Section 6.5 gives the further analysis of the results. The steps
for verification of biomarkers using the proposed method are explained in
Section 6.6. Section 6.7 concludes and summarises the chapter.
6.2 GP for Measuring Peptide Detectability
6.2.1 Method Overview
The proposed method is designed to perform multiple tasks. The first is
feature selection, which is done automatically in GP since it can select the
important features in the evolved classification model. This constitutes an
advantage of using GP, where it is useful for selecting the relevant features
and ignoring the redundant ones. The second task is the prediction of the
detected peptides. This is done through building a classification model
that predicts whether the peptides can be detected in the mass spectrome-
ter. Mostly the peptide datasets are facing an imbalance problem, and the
number of peptides in the observed or the detected class is much smaller
than the peptides in the non-observed class. This problem makes the clas-
sifier more biased to the class with a large number of instances. To tackle
this problem we designed a fitness function, which takes into account the
class imbalance problem.
Figure 6.1 shows the process of generating the data. In Figure 6.1, pro-
tein samples are digested into peptides and passed to LC-MS/MS to pro-
duce the LC-MS/MS spectra. The MS/MS raw data are searched using
SEQUEST software (using the suitable database) to perform the peptide
and protein identification. The identified proteins are filtered to include
only the high confident peptides. The minimum number of the high confi-
138 CHAPTER 6. BIOMARKER VERIFICATION
Proteins
Digestion
Peptides
LC-MS/MS
MS/MS data
SEQUEST
Database 
Search
  Identification  Pre-processing
  High confident 
      peptides
Figure 6.1: Data generation
dent peptides assigned to a protein is one. Figure 6.2 shows an overview of
the proposed GP system, named as PEP-GP. The system takes the peptide
data as an input, and each peptide is labeled as observed if it is found in at
least 50% of the LC-MS/MS experiments in the dataset [38]. Otherwise, it
is labeled as a non-observed peptide. The dataset is passed to the feature
extractor, which generates the physiochemical properties of the peptides.
The features are extracted from the AAindex database, which contain a set
of 544 physiochemical properties for each amino acid. The physiochemical
properties of each amino acid in the peptide are averaged to generate the
feature vector of each peptide instance. Thus, the dataset will construct
a matrix of peptides represented by properties along with the class labels
of observed or non-observed. The dataset is randomly divided into train-
ing and tests where 50% of the data is used for training, while the other
50% is held as unseen data (test set). The imbalance ratio between the two
classes (observed and non-observed) is preserved during the process of di-
viding the data into a training set and a test set. The training set is passed
to the GP peptide detection system to build a prediction model for pep-
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tide detection. Since some of the features (544 physiochemical properties)
might be redundant or not relevant to the classification, feature selection is
needed. The proposed GP method performs both tasks of feature selection
and classification, and hence, the method outputs the important features
which are automatically selected along with the prediction model. The
prediction model is examined on the unseen data. Finally, the important
features selected are evaluated with other classification algorithms and the
prediction probability of the GP is tested.
6.2.2 Feature Vectors
The datasets were obtained in the form of peptides sequences (amino acids)
and the class label. Hence, to use those peptides with the selected machine
learning techniques, they need to be transformed to a numerical feature
vector. The physicochemical properties of the peptides have shown to be
related to their detectability [1]. Therefore, for each peptide, 544 properties
were calculated to transform the peptide data into numerical feature vec-
tors. The 544 properties were extracted from AAindex database [81] and
for each peptide sequence the average of the property values of each indi-
vidual amino acid is calculated over the whole peptide. The physicochem-
ical properties include, for example, mass, alpha-helical (which is the pre-
dicted percentage of the secondary structure), hydrophobicity, gas phase
basicity, and isoelectric point. Therefore, each peptide is an instance used
for training and testing the GP algorithm, where each instance is modeled
by 544 feature values along with either observable or non-observable class
label.
6.2.3 Fitness Measure for Unbalanced Peptide Data
Since the peptide detection problem is facing a high ratio of imbalance
between the observed and non-observed classes, the measure of fitness
should take into account the accuracy of the minority and majority classes
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carefully. Hence, we designed a fitness function that tackle this issue by
maximising the sensitivity and specificity of classification both with equal
weights. The outputs of classification as true or false are the following:
true positive (TP), true negative (TN), false positive (FP) and false negative
(FN).
The accuracy of majority class (sensitivity) is given by:
Sensitivity = MinorityAcc. =
TP
TP + FN
(6.2.3.1)
Additionally, the accuracy of the minority class (Specificity) is given by:
Specificity = MajorityAcc. =
TN
TN + FP
(6.2.3.2)
To avoid the bias of the evolved classifiers toward the classification of the
majority class, the average classification accuracy is used to evaluate the
fitness of the evolved models. The fitness function used is:
Fitness_Fn = 0.5(MajorityAcc.+MinorityAcc.) (6.2.3.3)
6.2.4 Evolving Peptide Detectability Models
The measure of peptide detectability is solved as a classification problem,
where a classification model is first evolved using a training set, and this
model is used to make the prediction. Each genetic program (which is a
mathematical expression) outputs a single floating point number for each
instance in the dataset that will be classified. Our system performs classi-
fication by dividing the output space into two decision intervals. A zero
threshold is used to separate the prediction of each class. Therefore, a
particular instance will be assigned to the observed class if its classifier’s
output is negative. Otherwise, it will be classified as a non-observed pep-
tide. The dataset of peptide detection problem is in the form of D = (v, c),
where v = (v1, v2, ..., vm) is a vector of m instances which has n peptide’s
properties and c is the vector of class labels for each corresponding pep-
tide in v. Suppose (ϕ) is the model GP evolved to separate a class c? from
rest of classes. We define the binary detectability model PDc? as:
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PDc? =
Observed, if ϕc?(v1, v2, ..., vm)<0Non_observed, otherwise
Hence, a peptide is predicted as observed if O= ϕc?(v1, v2, ..., vm) (i.e. O
is the GP program output) falls in the interval of c? which is less than 0,
otherwise, it is predicted to be non-observable.
6.2.5 Selecting Important Properties
Feature selection is performed to find the most relevant features of the
detection task and to remove the non-informative features. The process
of selecting features in our approach is done automatically along with
building the prediction model. Hence, the features will not be selected
independently, but through discovering the relationships between the fea-
tures. One of the advantages of GP is that it evolves a tree for classifi-
cation that has the selected features in its terminal nodes. Therefore, the
two processes of feature selection and classification are not separated. This
will help in both improving the prediction performance and reducing the
computational cost while also considering the interaction between the fea-
tures.
6.2.6 Summary of the Algorithm
Algorithm 5 explains the steps involved in computing the fitness, which
is capable of balancing the accuracy of both the majority and the minority
classes. The algorithm requires a dataset (D), which contains the peptides’
instances and the class label as observed or non-observed. It also requires
the GP program ϕ which acts as a function to transform the data, and fi-
nally the desired class label c? for which the classifier should be built. The
algorithm outputs a fitness value through which one can tell if an individ-
ual is better than another, and hence, the method of selection can perform
its task easily. The algorithm starts with using ϕ for transforming the data
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into a single floating point number for each of the m instances in D. The
algorithm then counts the number of instances correctly and incorrectly
classified and computes the average accuracy of the classification.
Algorithm 6 shows the steps of evolving the GP program that can pre-
dict the detectability of peptides and select the important properties. The
input to the algorithms is D, which is a dataset of peptide instances with
n original features (properties) and a class label for each instance from the
vector of the class label c. The output is the best individual (BestProgram)
and the set of selected features.
F , where the set of selected features is stored, is firstly empty, and at
the end it will contain the selected features in the terminal nodes of the
BestProgram. In each evolved program, the fitness is concerned with
separating a specific class label from the other one. Finally, the best in-
dividual is the one with the highest fitness value. The BestProgram is
updated according to the fitness where the higher, the better. The maxi-
mum fitness fmax is first initialized to zero and updated to the fitness of the
BestProgram. The fitness value (f ) is calculated by calling the Evaluate-
Fitness function. If its value is greater than fmax, then fmax is changed
to the value of f . The main GP loop is terminated either by reaching the
maximum number of generations (MaxGen), or fmax reaches the optimal
value that is 1. Finally, the BestProgram and the set of selected features F
are returned as outputs.
6.3 Design of Experiments
This section explains the experiments’ set-up that includes the peptide
datasets preparation, the GP settings, evaluation process and methods for
comparisons.
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Algorithm 5 Evaluate-Fitness (D,ϕ,c?)
Require: D, a dataset.
Require: ϕ, a GP program which acts as a function.
Require, c?, the class label for which the classifier should be built.
Ensure, fit, a value showing the fitness of the GP program (the higher,
the better and the maximum is 1).
O[i]⇐ ϕ[x1(i),x2(i),..., xm(i)], ∀i ∈ {1,2„..n}
fit⇐ 0;
for i⇐1 to n do
if (O(i)> 0) then
if c[i]= c? then
TP⇐TP+1;
else
FN⇐ FN+1;
end if
end if
if (O(i)≤ 0) then
if c[i]6= c? then
TN⇐TN+1;
else
FP⇐ FP+1;
end if
end if
end for
fit⇐ 0.5*( TP
TP+FN
+ TN
TN+FP
);
return fit;
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Algorithm 6 Predict-Peptide-Detectability (D)
Require: D, a dataset that contains a vector of instances of m original
features of each instance in the dataset and vector of class labels c.
Ensure, BestProgram & F , a pair containing the best performing GP
program which outputs the prediction probability and the vector of se-
lected features of size n.
F ⇐{}
for c? ∈ c do
P⇐ initialize the population
fmax⇐ 0;
while CurrGen < MaxGen ∧ fmax < 1 do
for indvidual ∈ P do
f ⇐ Evaluate-Fitness(D,individual,c?)
if f > fmax then
fmax⇐ f ;
BestProgram⇐ individual;
F ⇐ F ⋃{BestProgram}
end if
end for
end while
end for
return (BestProgram,F );
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6.3.1 Peptide Datasets
Dataset 1 (DS1)
Sample Collection and Preparation
This dataset was obtained in-house (unpublished data) from the Victo-
ria University of Wellington’s proteomic lab. Samples from healthy and
treated HepG2 cells were collected, where the treated cells were fed with
a high concentration of fatty acids and had lipids accumulated in the cell.
Proteins from both cells were extracted, reduced and alkylated according
to Mast et al. [113]. Afterwards, the samples were digested using trypsin.
Dionex UltiMateTM 3000 RSLCnano system (Thermo Scientific, USA)
coupled with Linear Trap Quadrupole (LTQ) and coupled with an Orbi-
trap XL mass spectrometer (Thermo Fisher Scientific, USA) is used. The
peptides were separated on a 300 min LC gradient constructed from 0.1%
formic acid in 80% acetonitrile acid (solvent B). Fourier transform mass
spectrometry (FTMS) in the Orbitrap at a resolution of 30,000 was used to
collect the precursor ions with m/z range of 200-1800. Data-dependent
ms/ms of the top 6 intense ions was dynamically selected for collision-
induced dissociation (CID) fragmentation and detection. Each sample
from the healthy or treated class was run five times, and hence, each class
has one sample with five replicates.
Peptide and protein identification
The spectra were searched against the human proteome database (915565
protein sequences) obtained from UniProt Knowledge-base using the SE-
QUEST algorithm in Proteome Discoverer (v 1.2.0.208, Thermo Fisher Sci-
entific). A mass range of 350-5000 Da was searched with a signal to noise
threshold of 1.5 and allowing 2 missed trypsin cleavages [113].
The spectra were searched with a fragment ion mass tolerance of 0.80
Da and a parent ion tolerance of 10.0 ppm. Trypsin was specified as the
6.3. DESIGN OF EXPERIMENTS 147
digestion enzyme with two maximum missed cleavages. Other protein
modification parameters are: carbamidomethylation of cysteine was set
as a fixed modification (+57.021). Dynamic side chain modifications were:
oxidation +15.995 Da at M; carbamylation +43.066 Da at K; acetylation
+42.011 Da at K; deamidation +0.984 Da atnd N, and Q and R; phospho-
rylation +79.966 Da at R, S, and T and Y. The N-terminal modification
was carbamylation +43.066 Da. The files were searched against a decoy
database, with a strict false discovery rate (FDR) of 1% and relaxed FDR
of 5%. The search resulted in 706 proteins with 4985 peptides, where 3629
are classified as non-observed class and 1356 are labeled as observed. This
dataset is notated as DS1.
Dataset 2 (DS2) and Dataset 3 (DS3)
Two other tryptic peptide datasets originating from yeast are used to test
the performance of the proposed GP method. The datasets were obtained
from [38] and [146], and analysed using LC-ESI-MS (Liquid Chromatography-
Electro Spray Ionization-Mass Spectrometry).
Dataset 2 was produced from 24 yeast experiments originally down-
loaded from PeptideAtlas [30]. The total number of proteins is 2733. The
peptides’ length (number of amino acids) ranges from 6 to 42 residues
with 0-2 missed cleavage. Each peptide was assigned an observed class
label if it was detected in the 24 experiments. Otherwise, it was assigned
a non-observed class label. The total number of peptides in this dataset
is 21515 in which 2121 peptides are in the observed class and 19394 are
in the non-observed class. We annotate this dataset as DS2. More details
about the datasets acquisition and preprocessing can be found in [38]. The
third dataset (Dataset 3) used in our experiments was generated from 15
proteins. The proteins were searched against the NCBInr database [139]
using Mascot server [87] (Matrix science) to confirm identity and elution
time. Extracted ion chromatograms were generated for the peptides that
did not yield tandem MS data. Each peptide contains at least five amino
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acids and generated by either 0 or 1 missed cleavage. The class label as ob-
served or non-observed was set by counting the number of its occurrences
in the dataset, where if the peptide is found in 50% of the experiments it is
assigned as observed. This dataset is annotated as DS3 and contains 809
peptides, where 657 belong to the non-observed class while 152 belong to
the observed class. The three datasets used in this study are summarised
in Table 6.1
Table 6.1: Datasets
Dataset # peptides in the
observable class
# peptides in the non-
observable class
DS1 1356 3629
DS2 2121 19394
DS3 152 657
6.3.2 Program Representation
Th experiments were conducted using the tree-based GP, where each pro-
gram is a hierarchy of nodes. The program forms a mathematical expres-
sion where each of the tree’s nodes produces a single floating point value.
The root node of the tree generates the final output of the evolved pro-
gram, which is used to decide the class label. The program takes variable
terminal nodes and constant terminal nodes as inputs to the program. The
variable terminal nodes take the values from the original features while
the constant terminal nodes take their values randomly from the range
of [-1,1]. The function set consists of the four standard arithmetic opera-
tors and an absolute operator (+, −, ×, %, Abs). The division operator is
protected which returns zero for division by zero. The absolute operator
returns the absolute value of its input. Table 6.2 shows the function set
operators with their inputs and outputs.
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Table 6.2: Function Set
Function Arguments Description
+ Double, Double Performs addi-
tion of the two
arguments
− Double, Double Performs sub-
traction of the
two arguments
× Double, Double Performs multi-
plication of the
two arguments
% Double, Double Performs pro-
tected division
of the two argu-
ments
Abs Double Returns the abso-
lute of the argu-
ment
6.3.3 GP Parameters
The method used to generate the initial population is the ramped-half-
and-half method [136]. The population contains 512 individuals. The
crossover, mutation and reproduction probabilities are 80%, 19% and 1%
, respectively. The tree can grow up to a depth of 10. The selection is
performed using the tournament method with a size of 4. The number of
generations is 100. The evolution stops if the maximum number of gener-
ations is reached, or the best fitness (100%) is achieved.
The evolutionary process is repeated for 30 independent runs where at
each run a different random seed is used. For running GP, the Java-based
Evolutionary Computation research system (ECJ) [108] package was used.
Table 6.3 shows the evolutionary running parameter values used.
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Table 6.3: GP evolutionary parameters
Initialization method Ramped Half-and-Half
Max. Tree Depth 10
Max.# of Generations 100
Mutation probability 19%
Crossover probability 80%
Reproduction probability 1%
Population size 512
Selection method Tournament
Tournament Size 4
6.3.4 Training and Testing Process
The evaluation is performed on the test set, which was not used during
training. As there was no separate test set available in the three datasets.
Each dataset is randomly divided to 50% for training and 50% for testing
while preserving the original ratio of imbalance between the observed and
non-observed classes. The weighted average accuracy, as well as the sen-
sitivity and specificity, are used as evaluation measures to avoid the class
imbalance learning bias. The specificity and sensitivity are used in order
to show the accuracy of each class (majority and minority) independently.
6.3.5 Methods for Comparison
For the methods of comparisons, we used GP with standard classification
accuracy as a fitness function using the original features. This is used as a
baseline for comparison to the proposed method. The baseline GP method
is shown by baseline-GP . The GP settings and parameters of the baseline
method are set to be the same as the proposed method. Moreover, differ-
ent benchmark feature selection and classification algorithms are used for
comparison. The same training and test sets are used with all the other
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methods. Waikato Environment for Knowledge Analysis (WEKA) pack-
age [67] is used for running the benchmark of comparison.
In addition to baseline-GP , the following methods are also used for
comparison:
Classifier learning Methods
A range of various classifier learning algorithms are used for comparison
that are shown as follows:
1. Support Vector Machines (SVMs): SVMs form some hyperplanes
and classify the instances according to the side of the hyperplane
to which the instance belongs [180].
2. Decision Tree (J48): J48 is the Java implementation of the C4.5 deci-
sion tree inducer. J48 classifies instances through sorting them in a
tree which is composed of a hierarchy of nodes. The root node first
tests the value of the feature and then moves to the child nodes until
the label node is reached [68].
3. Voted Perceptron (VP): VP is based on the perceptron algorithm and
uses kernel functions to build hyperplanes as decision boundaries
[43].
4. Conjunctive Rule (CR): CR builds a single conjunctive rule to predict
the class labels. It uses the ”AND" logical operator to determine the
correlation of features and classes [180].
5. OneR: OneR performs classification like a 1-level decision tree [75].
6. CART: CART generates partial decision trees several times to infer
rules [41].
The following feature selection methods are also used for comparison:
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Feature Selection Methods
We choose four common feature selection methods to compare with the
GP’s selected features with that selected by benchmark methods. The
methods are described as the following:
1. Information Gain (IG): determines the amount of information gained
about a class when a certain feature exists or not [147]. It is defined
as follows:
IG(f` , ci) =
∑
c∈{c1,c2}
∑
f`∈{f,f¯}
P (f` , c)
logP (f` , c)
P (f`)P (c)
(6.3.5.1)
where f and f¯ denotes the presence and the absence of a feature and
the healthy and diseased classes are denoted by c1 and c2. The proba-
bility of the occurrence features f` in a specific class is represented by
P (f` , C). P (f`) and P (c) represent the probability of the observation
of a feature and class, respectively.
2. Information Gain Ratio (IGR) feature evaluation: the attributes are
evaluated by measuring the gain ratio with respect to the class [40].
The gain ratio is the ratio between the total entropy of the attribute
and the intrinsic value.
3. Relief-F (REL-F): REL-F ranks the features according to their capa-
bility to distinguish instances of different classes. This is done by
searching the k nearest neighbors of instances between the same and
different classes with respect to the attribute value [161].
4. Chi Square (χ2) feature evaluation: in statistical analysis methods, χ2
test is used to measure the independence of two events. χ2 measures
the association between the features and classes. A score is given to
each feature according to its χ2 statistics with respect to the class [40].
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6.4 Results and Discussions
In this section, the results of the proposed method (PEP-GP) as a classifier
and as a feature selection method are given.
6.4.1 Classification Results
Table 6.4 presents the results of the proposed method (PEP -GP ) on the
unseen data (test set) compared with the other classifiers. In Table 6.4,
the first column indicates the dataset while the second column gives the
method used for peptide detection. The first six classifiers used are de-
terministic methods and hence they only have a single solution, while the
two GP methods run 30 times. Hence, the mean, best, and standard devi-
ation (µ ± σ) are presented. The average of the majority and minority ac-
curacies (Avg.Acc.) are given in the third column. The overall accuracy of
classification, and accuracies of each class (majority and minority classes)
are presented.
The statistical information is provided in the last two columns where
davg.acc. gives the difference in the average accuracies between the pro-
posed method and the methods of comparison while the p-value gives the
p-value of the z-test. The z-test is performed with three different confi-
dence intervals which are 95%, 99%, 99.9%. Each of the ? in the last col-
umn indicates that the PEP -GP is significantly better using the different
confidence intervals.
According to Table 6.4, PEP -GP is highly effective in improving the
average accuracy (Avg.Acc) of all the datasets. In terms of Avg.Acc, it can
be noticed that PEP -GP has outperformed the seven classifiers for all the
three datasets. Testing the significance of the results with three confidence
intervals shows that PEP -GP is significantly better than that of the bench-
mark classifiers.
Although the overall accuracy (Overall Acc.) of the benchmark classi-
fiers are more than PEP -GP , as discussed before the overall accuracy is
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very sensitive to the imbalance of the data. This means that the overall
accuracy is only a good-looking result while the accuracy of majority class
is much larger than the minority class accuracy. It is clear from majority
and minority classes accuracies of DS1 , DS2 and DS3 (where the imbal-
ance ratio is high) that PEP -GP kept the balance between the two classes
and is not biased by the majority class so much. For example, in DS1, the
minority’s class accuracy of the proposed method is better than the other
classifiers by 48.7-61%. For DS2, the performance of the minority class of
PEP -GP is improved over 35.5%-71% than the other six classifiers.
In case of DS3, the mean and the best of 30 runs of Avg.Acc. (µ) are bet-
ter than all other classifiers. It can be noticed that the baseline-GP has the
same attitude with unbalanced data which is being biased to the majority
class. This suggests that the proposed method is more suitable for mea-
suring the peptide detectability than the existing benchmark classification
methods.
6.4.2 Feature Selection Results
Table 6.5 shows the average and overall classification accuracy of using
the features selected by PEP -GP . In Table 6.5, the first column refers to
the dataset, the third column shows the method used for feature selection.
The average and overall accuracies (Avg.Acc and OverallAcc.) are shown
when the features selected by each method are used with each classifier.
The last column shows the number of features used. The average number
of features selected by PEP -GP is used as a reference for selecting the
number of top ranked features used for each method.
According to Table 6.5, the proposed method performs either the same
or better than IG, IGR, χ2 and RLF-F. For DS1, all classifiers with all the
feature selection methods have a similar performance. For DS2, the perfor-
mance of SVMs, VP, and CR are similar when using the different feature
selection methods. Moreover, the best of PEP -GP as a feature selection
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method outperformed the other feature selection methods using J48, OneR
and CART. In DS3, the proposed method is better than the four benchmark
feature selection methods when used with SVMs, J48 and OneR. The fea-
ture selected by PEP -GP improved the performance of the three classi-
fiers in terms of both average accuracy and overall accuracy. The per-
formance of the CR and CART is near similar for all the feature selection
methods. Using VP, the average accuracy of using PEP -GP outperformed
the four methods, however, the overall accuracy of using these methods is
slightly better. It can be noticed that all the feature selection methods are
not successful in improving the average accuracy. The classifiers’ perfor-
mances are biased towards the majority class. The possible reason for this
is that the problem of imbalance of the data depends mainly on the clas-
sifier and not on the feature selection method. Another possible reason
is the separation of the two processes of feature selection and classifica-
tion is not useful for improving the performance. This suggests that the
proposed method is more suitable for solving this problem as it selects
important features and performs classification, while also taking into ac-
count the imbalance problem.
GP-selected features vs. all features
Comparing Table 6.4 with Table 6.5, PEP -GP managed to select a smaller
number of features which either improved or preserved the same perfor-
mance of the classifiers using the original number of features. For exam-
ple, in DS1 using only 7 features, SVMs features achieved similar average
and overall accuracies as the original features. In the same dataset, the
overall accuracy of J48 using the features selected by PEP -GP tends to be
better. The same scenario happened in DS2. For example, VP and CART
using a smaller number features have better average accuracies. In most
cases, the smaller number of features achieved similar performances with
the whole set features when used with the other four classifiers. Finally for
DS3, SVMs performed similarly with a smaller number of features, while
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the best of J48 in terms of the average accuracy is better than all the original
features. However, the mean of overall accuracy of J48 using the PEP -GP
features is far better than the whole set of features. For the other classifiers,
the performance is never worse than using all the original features.
6.5 Further Discussions
In this section, resampling of the datasets is performed to balance the num-
ber of examples between the two classes. The different classifiers are ap-
plied to the datasets after resampling for further comparison of PEP -GP
to the classifiers. A comparison of the proposed method to ESP-predictor
[46] (a state-of-the-art method for peptide detection) is also discussed in
this section. Furthermore, an analysis of the complexity of PEP -GP ’s
evolved models is performed. Finally, this section includes a discussion
of the important properties which are selected by PEP -GP compared to
ESP-predictor.
6.5.1 Comparison after Data Resampling
A resampling of the three datasets is performed on the training set. The
resampled data is used with the different classifiers to further compare
PEP -GP performance (without resampling) to the performance of the
classifiers after resampling of the training data. The filter resampling algo-
rithm Synthetic Minority Oversampling Technique (SMOTE) implemented
in WEKA [67] is used where the percentage of instances for SMOTE to cre-
ate in the minority class is 300% of the original instances.
Table 6.6 shows the results of the test set using PEP -GP and the other
classifiers. As shown in Table 6.6, PEP -GP succeeded in generally out-
performing the six classifiers after resampling of the datasets in terms of
average accuracy. Although the resampling helped in enhancing the per-
formance of some of the classifiers, the average accuracy of PEP -GP with-
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out resampling is better than that of these classifiers. For example, SVMs’s
Avg.Acc. had been improved by 6.75%, 14.42% and 0.40% after resam-
pling, however, PEP -GP is still outperforming SVMs by 1.25%, 6.6% and
10.6% in DS1, DS2 and DS3, respectively. The statistical tests also show
that PEP -GP is significantly better than the other classifiers with resam-
pling in the three datasets. The only exception is CR in DS1, where its
average accuracy is better than PEP -GP . The results suggest that the pro-
posed method has the potential to perform the task of peptide detection
effectively without resampling of the data. The minority class accuracy
using PEP -GP is much higher than using other classifiers which means
that PEP -GP is more suitable to perform peptide biomarker verification
(biomarkers are the flyer peptides).
6.5.2 Comparison to ESP-Predictor
In this section the performance of PEP -GP is compared to a benchmark
method, Enhanced Signature Peptide Predictor (ESP-Predictor) [46], which
is a leading tool for this problem. ESP-Predictor’s input is a list of peptides
and outputs a probability of detection for each peptide. In ESP-Predictor,
the random forest classifier is used to calculate the probability of detec-
tion of each peptide. Similar to our approach, ESP-Predictor generates
the feature set from AAindex. The same unseen data used to test the
proposed method is used with ESP-Predictor. Figure 6.3 shows a com-
parison between the performances of PEP -GP and ESP-Predictor. The
first bar graph shows the Avg.Acc., while the second one shows the Over-
all Acc. of the two methods. It can be noticed from the first bar chart
that the proposed GP method is far better than ESP-Predictor in terms
of Avg. Acc. The performance of ESP-Predictor is biased towards the
non-observed class (majority class). This suggests that PEP -GP is bet-
ter than ESP-Predictor for this task where the observed class (class where
the biomarkers belong) is usually the minority class.
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Figure 6.3: Comparison of PEP -GP with ESP-Predictor
Complexity of the Evolved Models
We also compared the complexity (# of nodes) of PEP -GP to the com-
plexity (the average number of nodes) of baseline-GP and J48. Figure 6.4
shows the average complexity per generation for the 30 runs of both PEP -
GP and the baseline-GP for each of the datasets. The red line indicates
PEP -GP , while the blue line indicates the baseline-GP . The number be-
tween the brackets is the complexity of J48. The average number of nodes
of the 30 runs for each generation is calculated for each of PEP -GP and
baseline-GP . It can be noticed that PEP -GP has reduced the complexity
for DS1. For DS2, in the first 40 generations, the complexity of the proposed
method is less than the baseline-GP . However, in the last 10 generations
baseline-GP drops the complexity. DS2 imbalance ratio is higher than the
other two datasets, and hence, the baseline-GP reduced the complexity
as it tends to create small models completely biased towards the majority
class.
Finally for DS3, the same scenario occurred where the complexity of
PEP -GP is smaller than baseline-GP in the first generations and keeps
smooth till the end, while baseline-GP has more divergent complexity.
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Figure 6.4: Average complexity per generation of PEP -GP vs. Baseline-
GP
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This can be explained by the high ratio of imbalance of this dataset which
makes the complexity of baseline-GP degrades easily as it is generating
models which are more biased to the majority class. Another possible ex-
planation of the stable complexity of PEP -GP for DS3 is that the method
is trapped to a local optima, which means that the method needs more di-
vergence to be introduced between the individuals. Comparing PEP -GP
and J48, it can be noticed that the maximum complexity of PEP -GP is
much smaller than J48 on the three datasets.
6.5.3 Important Properties for Detectability
Another ranking is performed on the features selected by the proposed
method where the more frequently selected by the GP tree, the higher
their rank. Moreover, only features selected in more than 50% (15 runs)
of the runs are considered important. The properties selected by PEP -GP
for the three datasets, which are important for peptide detectability, are
shown in Table 6.7.
In Table 6.7, the first column gives the description of the physicochemi-
cal property selected, the second column indicates the percentage of over-
lap between the 30 GP runs and the third column indicates if the property
has been identified by the domain experts or not. We examined the impor-
tant properties from [46] to test the common properties between our top
properties and the domain experts. In [46], the authors ranked 35 prop-
erties as the most important properties for detection, while our method
identified 14 properties. When comparing the proposed method and the
method in [46] (ESP-Predictor), PEP -GP outperformed ESP-Predictor as
shown in section 6.8.2. This indicates that the 14 properties are more im-
portant than the 35 properties ranked, and the rest of 35 features are re-
dundant. As shown in Table 6.7, 10 properties are common between our
method and the domain experts which suggests that PEP -GP not only
identified the important features which can detect the flyer peptides, but
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Table 6.7: Important properties for peptide detectability
Property Percentage of
overlap be-
tween the GP
runs
Domain Experts
Retention coefficient in
pH2
53.33 3
Fraction of site occupied
by water
50.00 3
Transfer energy organic
solvent water
50.00 3
Hydrophobicity-related
index 3.0 pH
93.33 3
Isoelectric point 56.67 3
Mass 53.33 3
Absolute entropy 53.33 3
Gas phase basicity 56.67 3
Normalised composi-
tion of mt protein
53.33 3
Length 80.00 3
Normalised frequency
of alpha-helix
50.00 7
Normalised frequency
of beta-sheet from LG
56.67 7
Normalised frequency
of C-terminal non beta
region
50.00 7
Slopes tripeptide, FDPB
VFF neutral
50.00 7
is also more efficient in selecting a smaller number of important proper-
ties.
6.6 Biomarker Verification Steps
The input to the proposed GP biomarker verification algorithm is peptide
sequences which then act as examples in the test set. Training is already
performed using the various datasets, and hence, the biomarkers candi-
dates will be the input to the algorithm as the test set’s instances. Using
the verification algorithm, a biomarker is verified if it is classified as a flyer
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or observed peptide. Otherwise, it is classified as a non-verified or non-
trusted biomarker.
The steps involved for the biomarker verification are the following:
1. The biomarker detection approaches output biomarkers in the form
of m/z to the intensity value. Hence, the first step is to perform
identification of the biomarker candidates using the m/z values to
convert them into peptide sequences. These m/z values are used
to perform the identification of the resulting peptides (peptide mass
fingerprinting).
2. Convert the peptide sequence of each biomarker candidate to nu-
merical feature vector that are the physiochemical properties of amino
acids
3. Using the converted biomarker peptides, directly apply them to the
GP peptide detection method for biomarker verification as a test set.
4. Output the list of peptides in the observed class as the verified biomark-
ers.
6.7 Chapter Summary
The overall goal of this chapter was to develop a new GP system for mea-
suring peptide detectability. This goal was successfully achieved by de-
veloping PEP -GP , a GP method which predicts if a specific peptide is
observable or non-observable in the mass spectrometry experiment. The
proposed method performs both feature selection and classification simul-
taneously and also takes into account the class imbalance problem in the
data. According to the results, PEP -GP succeeded in keeping the bal-
ance between both the observed and the non-observed classes and out-
performed the benchmark classification methods used for comparison on
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these datasets. Furthermore, the proposed method achieved better per-
formance than ESP-Predictor on the datasets used. For feature selection
results, neither PEP -GP nor the other feature section algorithms used for
comparison as a separate stage improved the average accuracy of the clas-
sification. This suggests that separating the feature selection from classi-
fication for the class imbalance problems is not useful for these tasks. In
addition, PEP -GP is better than the classifiers used for comparison even
when data resampling is performed. This means that GP is more suitable
for peptide detection as it has the potential to detect the flyer peptides
which lie on the minority class, and can deal with the data without prior
resampling.
Chapter 7
GP for Multiple Alignment of MS
data
7.1 Introduction
The preprocessing of MS data, specifically the alignment step can directly
affect the biomarker detection process. This chapter presents some initial
results of the use of GP for alignment of MS data. A new GP method is
proposed here and tested on a number of benchmark datasets. The results
show that the new GP method has outperformed five different benchmark
alignment methods in most of the datasets that indicate the potential of GP
to solve the various complex tasks involved in the MS data analysis.
7.1.1 Chapter goals
The goal of this chapter is to develop a GP based method for multiple
alignments of LC-MS peak maps that can correct the distortion of RT in
multiple maps simultaneously. The method aims at aligning the MS data
features which will help in improving the biomarker detection process.
The proposed method is composed of two main phases: the first is to
match the peaks across multiple maps and the second is to find the best
167
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dewarping function for the RT of the matched peaks. The method is tested
on one proteomics dataset and two metabolomics datasets and compared
against five benchmark algorithms. Specifically, we will perform the fol-
lowing:
• develop an appropriate peak matching approach across multiple LC-
MS maps with different numbers of peaks;
• design a GP method to perform multiple-output regression;
• model the terminal set of GP, to perform multiple regression simul-
taneously; and
• investigate whether the new GP method outperforms the conven-
tional alignment methods on these datasets.
Chapter Organisation: The rest of the chapter is organised as follows. Sec-
tion 7.2 gives brief background of the MS alignment problem. Section 7.3
describes the proposed approach and the new GP method. The experi-
mental design, the datasets’ description and preprocessing are presented
in Section 7.4. Section 7.5 reports the experimental results along with the
discussions. The conclusions and future work are presented in Section 7.6.
7.2 Background
The LC-MS spectrum is a 3D map, called LC-MS map, which consists of
mass to charge ratio (m/z), retention time (RT) and ion intensity count
(Int). LC-MS can be used for providing quantitative and qualitative infor-
mation about the proteins in a biological sample [171]. Such information
is useful in several applications including system biology, functional ge-
nomics and biomarker detection. For these applications to be successful,
ideally the m/z and RT of the same molecule at different spectra among
the LC-MS replicate runs detected in the same LC-MS platform should be
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the same. However, this is not always the case. In particular, there is a
large shift and sometimes distortion in RT between different runs [171].
Also, the m/z values show smaller distortion that introduces ambiguity
in peak matching in comparative analyses. Moreover, the variations in RT
may show non-linear deviations and can be greater than predicted [98].
Therefore, an effective algorithm is required to address two main tasks.
The first is to match the peaks arising from the same peptides at different
runs within certain m/z and RT windows, and the second is to find the
correct transformation of the RTs to make comparison [99] between the
intensity values effectively.
The methods for alignment of LC-MS spectra can be classified into two
groups. The first group is the raw-based methods, which select the set
of significant peaks from raw data and use these peaks as a reference for
aligning the data. These methods can avoid the errors due to feature de-
tection but they have high computational cost [72]. The second group is
the peak based methods, where the alignment is done by extracting fea-
tures and grouping corresponding features (peaks) from different LC-MS
runs [171]. However, feature extraction and centroidisation can introduce
some errors [72]. Therefore, the quality of the alignment algorithm will
depend on mainly the quality of these preprocessing paradigms.
Examples of raw-based methods include the Hidden Markov Models
(HMMs) approach presented in [104], where the alignment of RT and the
normalisation of the peak intensities were done at the same time. HMMs
were used to represent the correct retention times and the parameters of
the model were estimated using the maximum likelihood estimation. A
star-wise manner alignment of either raw or feature maps was depicted
[98] in the open source platform OpenMS. In the first phase, features were
matched together using pose clustering followed by linear regression to
correct the retention time distortion. In the second phase, the dewarped
maps were combined into a consensus map by using the nearest neigh-
bour search. Li et al. [101] developed a pairwise feature-based alignment
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algorithm in the open source software suite SpecArray. The algorithm com-
putes all the pairwise alignments and combines them to a consensus map.
The RT was corrected using a calibration curve and continuously aligning
the pairs of features with similar m/z values. In [13] a star-wise align-
ment approach to feature maps was proposed, and the algorithm starts
with pairing the most intense features with similar m/z values. After that,
smoothing spline regression was used for dewarping and finally divisive
clustering was used to obtain the consensus map. The RANdom SAmple
Consensus (RANSAC) algorithm was used in the MZmine2 [135] frame-
work to find features that fit a non-linear model within a user-supplied
m/z and RT tolerances. A locally weighted scatter plot smoothing regres-
sion method was used on all the points obtained from RANSAC. Genetic
algorithms were used in [130] to predict the RT dewarping function.
Most of these approaches for alignment of LC-MS data focus on solv-
ing the pairwise alignment problem, which produce somehow suboptimal
results for multiple alignment problems.
GP has been successfully used for alignment and forecasting of time
series data [2] and achieved good results. In particular, GP is well known
for symbolic regression, which provides a potential for aligning LC-MS
data. However, GP has not been used for the alignment of LC-MS datasets
to date.
7.3 The new GP Alignment algorithm
In this section, a new algorithm for alignment of MS data using GP is pro-
posed. This work is the first work using GP for alignment of MS data.
The objective of the alignment of LC-MS maps (we refer to each sample
or run as a map) is to produce a consensus map that contains matching
peaks of the same molecules after transformation of RTs. In other words,
the aim is to produce peak lists that have similar m/z and RT values in
order to perform comparisons of intensity values effectively [4].
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The alignment approach proposed here works with peak data which
has a much smaller amount of data than the raw maps. Therefore, it can
be used to develop faster dewarping techniques. Figure 7.1 shows an
overview of the proposed alignment approach, which starts with taking
the peak lists as inputs. The main aim of alignment is to find the pos-
sible transformations that map the RT points of one map (reference map)
(r1, r2, ..., rn) to the corresponding points of the other maps (m1,m2, ...,mx).
To achieve this objective, the most matched partners must be detected by
the peak matching approach that is used as an intermediate step to allow
GP to search for the optimal transformation. The peak lists that have a
different number of peaks are passed to the peak matching phase to de-
tect the matched peak lists between the reference map and the other maps
((r1,m1), (r2,m2)....(rn,mn)).
For pairwise alignment, GP can be used directly to evolve transforma-
tion functions. However, the multiple alignments of multiple maps re-
quire a different structure of the evolved programs of GP to determine the
transformation of the multiple maps. Therefore, a new GP multi-branch
tree approach is developed for correcting RTs of multiple maps simultane-
ously. Finally, GP outputs the corrected peak lists. The two phases of the
alignment approach are described below. For presentation convenience,
the new approach is called GPMS.
7.3.1 Peak Matching
The first phase of the approach is to identify the significant matching peaks
across all maps. The criteria for peak matching is the distance between the
m/z and RT in the reference map and the other maps. The procedure for
peak matching is as follows:
1. Randomly select a map from the dataset as a reference map R =
(r1, r2, ..., rn).
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Figure 7.1: Overview of the alignment approach.
2. For each peak (m/zi, RTi, Inti) in the reference map, find the list of
peaks in the next map M = (m1,m2, ...,mn) within a predefined m/z
(m/zi±εm/z) and RT (RTi±εRT ) tolerances and with the same charge.
3. Select the nearest neighbour (1-NN) peak from the list of peaks in
the current map with respect to m/z, RT, and Int, and add the two
peaks as significant peaks of the reference and current maps into the
consensus map. The distance between the peaks is measured using
the Euclidean distance between m/z, RT, and Int. A larger weight is
given to m/z because RT and Int are much more tolerable than m/z.
The Euclidean distance is given by:
ED =
√
(W 21 ∗ (Rm/z −Mm/z)2 +W 22 ∗ (RRT −MRT )2 +W 23 ∗ (RInt −MInt)2)
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where ED is the Euclidean distance between the two peaks of the
reference (R) and the current (M ) maps and W1=0.7, W2=0.2 and
W3=0.1.
4. Mark the selected peak on the current map as a processed peak so
that it will not be selected again as the nearest neighbour to another
peak.
5. Repeat steps 2-4 on all the maps until all the peaks in all maps are
processed. If there is no corresponding peak found in half of the
maps, all significant peaks related to this peak are removed from the
significant peak lists.
After identifying the matching peaks across all maps, the list of matching
pairs is passed to GP to correct the RT values.
7.3.2 GP Multi-Branch Regression for Multiple Alignment
Unlike most of the previous RT alignment algorithms, our GP method cor-
rects RTs of all maps simultaneously. The main advantage of this regres-
sion GP technique is that it can work efficiently. Another advantage is not
having the requirement of a specific gold standard reference map for align-
ment of the rest of the maps. In other words, any map can be selected
as a reference to align the rest of the maps. In this approach, we use the
tree-based GP [190] for this task but we modified the tree structure as a
multi-branch tree. In the multi-branch GP approach, each individual is
composed of several branches and each branch is responsible for evolv-
ing a part of the solution [143, 190]. The final solution is integrating all
these partial solutions through a special node which represents the root
node [28, 190]. The number of children of the special node is equal to the
number of maps to be aligned. The children of the root node are the func-
tions. The function node can also take other function nodes as its children.
The terminal nodes of each branch are the RTs of a specific map or random
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Figure 7.2: Tree structure in the Multiple Alignment GP.
constants. The same branch cannot contain RTs from different maps. The
structure of the multiple-output regression tree is shown in Figure 7.2.
In the rest of the section, we will describe the terminal set, the function
set and the fitness function of the new GP method.
7.3.3 Terminal and Function Sets
An LC-MS sample is a 3D map composed of the m/z values, RTs, and the
intensity counts (Ints). The objective here is to correct the RTs of all maps
to the corresponding RTs of the reference map. Therefore, the terminal set
is composed of the RTs of N maps. We consider each input to GP as N RT
dimensions (equal to the number of maps). For example, if we have three
maps, each input to the terminal set is composed of three RT variables.
We also used a random generated constant in the range of [-10,10] in the
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terminal set. Hence, our terminal set is composed of RT values of all maps
and random constant values. The function set used for this problem is
F = {+,−,×,%, cos}, where % is the protected division operator, which
returns zero if the division is by zero. The aim of using the cos operator is
to evolve non-linear function for prediction and regression of the complex
RT deviations. The outputs (Oi) of each map are collected by the special
node that is the root of the tree.
7.3.4 Fitness Function
For function approximation tasks, the performance can be measured as
an error between the predicted and the real target values. As we have
multiple outputs, with each output corresponding to RTs of one map in
the dataset, we calculate the sum of errors between the multiple outputs
(which are the estimated outputs of the genetic programs) and the refer-
ence map output. The root mean square error (RMSE) is used as a fitness
function. Thus, the GP framework is to minimize the fitness so that the
generated programs lead to the minimum error between the RTs to be pre-
dicted. The RMSE fitness function is given by:
RMSE =
√∑N
i=1
∑M
j=1(RTij − RˆT ij)2
N
where N and M are the number of maps and the number of RTs to be
corrected in each map respectively. RTij is the ith real RT value of the jth
map while RˆT ij is the ith estimated RT value of the jth map by the GP
program.
7.4 Experiments Design
7.4.1 Datasets
We tested the proposed approach on one proteomics dataset (P1) and two
metabolomics datasets (M1,M2) obtained from the Open Proteomics Database
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(OPD) [138] and Lange et al. [98]. Dataset P1 contains two LC-MS runs
with six different fractions and it originates from an E.coli sample. For this
dataset, each fraction is composed of pairs of LC-MS runs. The dataset was
analysed using LC/MS/MS with an ESI ion trap mass spectrometer (Ther-
moFinnigan Dexa XP Plus). It was exported into mzXML centroided mode
and preprocessed using TOPP tools [90] to produce the peak lists which
consist of the m/z, RT, intensity values and ignoring the charge states. The
numbers of peaks in each fraction run were between 400 to 5800. A partial
ground truth was produced using the first fraction of the dataset by link-
ing the LC-MS spectra to the MS/MS of the SEQUEST search. More de-
tails about the steps for dataset preparation, analysis, preprocessing, and
parameters optimisation can be found in [98]. For the two metabolomics
datasets, Arabidopsis thaliana leaf tissues were analysed using two dif-
ferent LC-MS setups. An API QSTAR Pulsar i (Applied Biosystems/MDS
Sciex) was used to produce 44 spectra for theM1 dataset and a MicrOTOF-
Q (Bruker Daltonics) to produce 24 spectra for theM2 dataset. Peak extrac-
tion was done using XCMS software [152] resulting in 4000 to 17600 peaks
in each spectrum. The ground truth was generated in the same study by
selecting the high confident peaks. Those were the peaks found in more
than four runs, having the same RT and also showing a high correlation in
their peak shapes. Table 7.1 summarises the datasets used in the approach.
Table 7.1: Datasets used in the approach
Dataset Number of LC-MS runs Number of peaks
P1 2 on 6 fractions 400-5800
M1 44 4000 -17600
M2 24 4000 - 17600
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7.4.2 Genetic Operators and Parameters
The initial populations of GP are generated using the ramped half-and-
half method. Each population consists of 1024 individuals to reduce the
early convergence probability. The tournament selection method is used to
select the individuals that can perform well for reproducing the new gen-
erations. The size of the tournament is set to 5. The standard crossover and
mutation are used here with ratios of 80%, and 19% respectively. Elitism is
also used with a ratio of 1%. The depth of each individual is kept between
2 and 8. Each evolutionary process stops at the maximum generation of
30 unless a perfect error of zero is found. The process is repeated for 30
independent runs. The random seeds for each of the 30 runs in each set
of experiments are different. The peak matching phase parameters are as
follows: the m/z tolerance and RT tolerance are set to 1.5, and 100, re-
spectively for dataset P1 for all the fractions. For datasets M1 and M2 the
m/z tolerance and RT tolerance are set to 0.011, and 20, respectively, for
both datasets. Those parameters were selected via initial search, and they
achieved good results.The GP implementation used in our experiments
is the Evolutionary Computing Java-based (ECJ) package [176]. Table 7.2
describes the parameters used in the experiments.
7.4.3 Benchmark Algorithms
We compared our approach with previously published results of five pub-
licly available benchmark algorithms for alignment of LC-MS maps that
are: msInspect [13], MZmine [80], SpecArray [101], XAlign [189] and XCMS
[152]. msInspect [13] works in a star-wise manner which aligns all maps
with respect to a specific reference map, which is the map with the mini-
mum number of peaks. The process starts with the selection of the most in-
tense peak within a certain RT tolerance and the removal of the rest of the
peaks. After that, pairing the remaining peaks with peaks of similar m/z
is performed. Smoothing spline regression is used for dewarping, and fi-
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Table 7.2: GP parameters
Parameter Value
Initialization method Ramped Half-and-Half
Initial tree Depth 2
Maximum tree depth 8
Generations 30
Mutation probability 19%
Crossover Rate 80%
Elitisim 1%
Population Size 1024
Selection type Tournament
Tournament Size 5
m/z tolerance 1.5, 0.011,0.011 for P1, M1, M2 respectively
RT tolerance before correction 100, 20, 20 for P1, M1, M2 respectively
nally divisive clustering is used to obtain the consensus map. The main
disadvantage of this approach is the removal of less intense peaks, which
might lead to the loss of many important peaks. MZmine [80] works by
scoring the similarity of all features against a master list and if the score is
”good enough”, the feature is assigned to the best matched row. MZmine
does not perform any transformation of RT. The SpecArray [101] schema
works as pairwise alignment and combines the pairwise aligned maps into
a consensus map until all maps are aligned. SpecArray is not applicable
to datasets with a big number of maps. XAlign [189] also works in a star-
wise manner and selects the most intense peaks within a user defined m/z
and RT tolerance, and the map with the minimum difference to the aver-
age RTs is chosen as a reference map. After dewarping the RT, the features
with high correlation coefficients are selected to form the consensus map.
XCMS [152] works as a multiple alignment approach where peak match-
ing is performed in the first phase by using a fixed interval bin and us-
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ing kernel density estimation to determine the distribution of the features.
Boundaries of regions with features that have similar RTs are selected. Fi-
nally, non-linear regression is used to correct RTs.
7.4.4 Performance Evaluation
The performance of the proposed approach is measured through the pre-
cision (PR) and recall (RE) measures. Precision is the probability that a
found item is relevant, which in our case is the percentage of correctly
aligned peaks among all the peaks aligned by the approach.
PR =
Number of correctly aligned peaks
Total number of peaks aligned
Recall is the probability that a relevant item is found (the percentage of the
correctly aligned peaks among the peaks in the ground truth [174]).
RE =
Number of correctly aligned peaks
Total number of peaks in the ground truth
The harmonic mean of the precision and recall is measured through the
F-measure [174].
F-measure =
2*PR*RE
PR+RE
Precision and recall of alignment were calculated using the evaluation
script provided by Lang et al. [98].
7.5 Results and Discussions
7.5.1 Effectiveness Performance
GPMS is initially tested for the pairwise alignment on P1 which is available
in six different fractions. P1 shows a large deviation in RT values which
is a challenge for the alignment tool to correct the RT. Tables 7.3 and 7.4
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show the results of the five conventional approaches compared to our ap-
proach notated as GPMS. As shown in Tables 7.3 and 7.4, GPMS achieved
much better performance than msInspect and SpecArray in all the three
datasets. GPMS outperformed all other methods in three fractions of P1.
For the first fraction (00), the mean of the 30 runs of GPMS is better than
msInspect by 44% in terms of precision, 30% in terms of recall and 38%
in terms of F-measure. For the other approaches, GPMS improves the
precision by 1-25%, the recall and F-measure by 1-21%. For fraction (20),
GPMS achieves similar performance as XCMS and has the third rank after
MZmine and XAlign. GPMS performs better than msInspect, SpecArray
and XCMS for fraction 40. Furthermore, our new method is the third best
after MZmine and XAlign for the same fraction. For fractions (60) and
(100), GPMS outperforms all other methods in terms of precision (which
reaches 1.00 for the fraction (100)) and F-measure. The proposed method
has the best recall in fraction (60) while in the fraction (100) it has the third
best recall after Xalign and XCMS. Finally for the fraction (40), the perfor-
mance of GPMS was slightly better to XCMS, and it is the second best after
MZmine. In general, for P1 the proposed method outperforms the other
methods in three fractions, the second best in two fractions and third best
in one fraction.
For datasets M1 and M2, which contain 44 and 24 maps respectively,
the challenge for the alignment approach on these complex metabolomics
datasets is to assign the most suitable matches and to correct the RT dis-
tortion across multiple maps. SpecArray did not manage to produce any
results for these complex alignment tasks. As shown in Table 7.4, GPMS
appears to be more powerful in aligning a large number of maps as in the
dataset M1 (44 maps). For M1, it has better performance than other meth-
ods by 1-31% in terms of precision and 2-49% with respect to F-measure.
This suggests that the proposed method can be more powerful for mul-
tiple map alignment. The performance of GPMS outperforms msInspect
in terms of precision by 41.87%, XCMS by 1% and it is equal to XCMS for
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Table 7.3: Proteomics dataset P1 alignment results
Fraction Measure msInspect MZmine SpecArray XAlign XCMS GPMS
Min Max Mean ±St.Dev.
00
Precision 0.38 0.81 0.61 0.82 0.58 0.82 0.83 0.83±0.003
Recall 0.52 0.75 0.61 0.82 0.62 0.82 0.83 0.82±0.004
F-measure 0.44 0.78 0.61 0.82 0.60 0.82 0.83 0.82±0.004
20
Precision 0.45 0.88 0.62 0.85 0.80 0.80 0.82 0.81±0.0100
Recall 0.56 0.87 0.62 0.85 0.81 0.80 0.80 0.80±0.0000
F-measure 0.50 0.87 0.62 0.85 0.80 0.80 0.81 0.81±0.0060
40
Precision 0.48 0.90 0.75 0.87 0.80 0.83 0.84 0.84±0.002
Recall 0.63 0.87 0.75 0.87 0.81 0.81 0.81 0.81±0.0
F-measure 0.54 0.88 0.75 0.87 0.80 0.82 0.82 0.82±0.003
60
Precision 0.54 0.84 0.71 0.87 0.75 0.91 0.91 0.91±0.000
Recall 0.73 0.79 0.71 0.87 0.78 0.92 0.92 0.92±0.000
F-measure 0.62 0.81 0.71 0.87 0.76 0.91 0.91 0.91±0.005
80
Precision 0.57 0.94 0.74 0.90 0.88 0.90 0.90 0.90±0.000
Recall 0.70 0.92 0.74 0.90 0.89 0.89 0.89 0.89±0.0000
F-measure 0.63 0.93 0.74 0.90 0.88 0.90 0.90 0.90±0.0040
100
Precision 0.56 0.92 0.77 0.96 0.96 1.00 1.00 1.00±0.000
Recall 0.82 0.94 0.77 0.96 0.96 0.94 0.94 0.94±0.000
F-measure 0.67 0.93 0.77 0.96 0.96 0.97 0.97 0.97±0.000
Table 7.4: Metabolomics datasets M1 and M2 alignment results
Fraction Measure msInspect MZmine SpecArray XAlign XCMS GPMS
Min Max Mean ±St.Dev.
M1
Precision 0.46 0.74 - 0.70 0.70 0.77 0.77 0.77±0.003
Recall 0.27 0.89 - 0.88 0.94 0.89 0.91 0.9±0.004
F-measure 0.34 0.81 - 0.78 0.80 0.83 0.83 0.83±0.001
M2
Precision 0.47 0.84 - 0.79 0.78 0.79 0.79 0.79±0.001
Recall 0.23 0.98 - 0.93 0.98 0.90 0.90 0.90±0.000
F-measure 0.31 0.90 - 0.85 0.87 0.84 0.84 0.84±0.001
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M2. In terms of recall, GPMS performed better than msInspect by 53%
and outperformed SpecArray which did not manage to achieve results in
terms of F-measure. Overall, the performance of GPMS is the second best
with respect to precision, third best with respect to recall and F-measure
in M2. In general, GPMS is among the top two methods or even performs
best (for 00, 60, 100 of P1, M1).
7.5.2 Efficiency Performance
Another comparison is done in terms of the run time of each of the meth-
ods, and the results are shown in Table 7.5. For all the datasets, the average
run time of GPMS is much better than all other approaches. The computa-
tional cost (in terms of time) of GPMS is lower than the rest of the methods,
which represents another advantage of GPMS. For all the datasets, GPMS
improves the efficiency by an order of magnitude over the rest of the meth-
ods except for XCMS. GPMS is also more efficient than XCMS in terms of
computational time for P1 and M2. Moreover, the efficiency of GPMS for
M2 in one of the runs is also better than XCMS.
Table 7.5: Comparison of run time of GPMS with other approaches (in
seconds)
Dataset msInspect MZmine SpecArray XAlign XCMS GPMS
Min Max Mean ±St.Dev.
P1 60 40.2 111 69 54 4.1 9.8 6.1±1.20
M1 720 1200 - 3060 54 36.34 64.92 64.92±4.97
M2 2160 2640 - 2100 348 81.10 94.20 87.37±3.23
7.5.3 Interpretation of the Evolved Regression Models
Table 7.6 shows two examples of the evolved models for fractions (00) and
(100). SPE refers to the special node that is the root node collecting the
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Table 7.6: (a) An evolved model for fraction (00) with some examples of
inputs and outputs of the model. (b) An evolved model for fraction (100).
(SPE T0 (- (- T1 9.05) (cos T1)))
Input Output
T0 T1 T0 T1
1263.95 1271.96 1263.95 1263.89
1307.84 1315.58 1307.84 1307.09
1708.72 1717.28 1708.72 1708.10
(a)
(SPE T0 (+ T1 17.56))
Input Output
T0 T1 T0 T1
182.95 165.425 182.95 182.98
111.45 94.12 111.45 111.68
455.08 438.12 455.08 455.68
(b)
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multiple outputs of the tree. T0 refers to the RTs of the first map while T1
refers to the RTs of the second map. The first map (T0) is selected as the ref-
erence map in which the RTs of both maps should be corrected according
to it. The dewarping functions of both inputs are determined simultane-
ously through the multiple branches. As shown in Table 7.6 (a), GP man-
aged to determine the correct amount of the shift for the RTs of the second
map (T1) through a nonlinear dewarping model in the second branch of
the tree. The RTs of the first map (T0) (the first branch of the tree) is kept
the same as it has been selected as the reference map. Some examples are
shown in the same figure where the inputs to the models and the mapped
outputs after correction show that GP has successfully aligned the maps
with respect to the reference map. The evolved model for fraction (100) is
shown in Table 7.6 (b) where the GP dewarping function has managed to
correct the distortion of RTs through a linear function. Examples of inputs
and outputs of fraction (100) are also shown in Table 7.6 (b), where it is
clear that GP managed to correct the distortion between the inputs and
the outputs.
7.6 Chapter Summary
In this chapter, a new method is proposed for multiple alignments of LC-
MS peak data. The proposed method has two phases. The chapter repre-
sents preliminary results for the first work of GP for multiple alignments
of LC-MS data. In the first phase, the partner peaks across multiple maps
are detected to form the matched peak lists. In the second phase, the
matched peak lists are passed to GP to perform the correction of RTs of
all maps simultaneously. The new GP approach is depicted by dividing
the tree into multiple branches, where each branch produces the output
dewarping function of each map with respect to the reference map. The
proposed GP-based method (GPMS) was tested on one protoemics dataset
of six different fractions. The results show that GPMS achieves better pre-
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cision, recall and F-measure than five other LC-MS benchmark alignment
methods for three fractions of the proteomic dataset and one metabolomic
dataset which has larger number of maps. This suggests that GPMS is
more powerful in the multiple alignments of LC-MS data. The proposed
method also shows very competitive results in the rest of the datasets.
GPMS, in general, is always either the best or among the two top methods
for these datasets. Furthermore, the proposed GP method is much more
efficient in terms of computational time than the benchmark methods.
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Chapter 8
Conclusions
8.1 Introduction
The main goal of this thesis was to improve the biomarker detection pro-
cess for classification of MS data through the use of GP. The thesis focuses
on investigating the capability of GP for different tasks, namely feature
manipulation for biomarker detection and biomarker verification (pep-
tide detection) through classification and feature selection of unbalanced
peptide data. This overall goal was fulfilled through developing new GP
approaches to feature selection, feature construction and classification of
the high dimensional MS data to discover the relevant features for clas-
sification and construct new high-level features for the aim of improving
the classification performance and reducing the number of features. The
goal was extended to the verification of the detected features (biomarkers)
using GP.
The thesis developed a number of new GP algorithms to automatically
select subsets of features and construct a number of high-level features.
The proposed methods were tested on a number of MS datasets, and com-
pared to the existing methods. The results show that GP can effectively
be used for the challenging task of MS data analysis. The proposed meth-
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ods succeeded in improving the MS biomarker detection and verification
performances.
Chapter Organisation: The rest of this chapter is organised as follows.
Section 8.2 explains the achieved objectives of the thesis and the main find-
ings from each chapter. Section 8.3 gives conclusions for each of the thesis
research objectives. Section 8.4 presents some potential research areas for
future work.
8.2 Achieved Objectives
This thesis has achieved the following research objectives:
• Proposes a new ensemble selection method and a new ranking mech-
anism in GP for single objective embedded feature selection in MS
data for biomarker detection. The proposed ensemble method uses
the advantage of GP for automatic feature selection to further select
features from two different feature ranking metrics.
The proposed ranking scheme uses the frequency of occurrences of
features in the evolved tree to generate a new rank for each of the se-
lected features. By combining the new ensemble and ranking mech-
anisms, the proposed GP based algorithm can significantly reduce
the number of features by further selecting from the top features pro-
duced from two different metrics, and improve the classification per-
formance over using all the original features. It also outperforms the
two traditional ranking metrics individually and a standard wrap-
per genetic algorithm method for feature selection. The use of GP
as a classifier also outperforms standard classification algorithms.
The method also detected most of the predefined biomarkers of the
spiked-in datasets.
• Proposes a new GP based approach to embedded single objective
multiple feature construction. Unlike existing GP multiple feature
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construction algorithms which use multiple individuals to construct
multiple new high-level features, the proposed approach uses a sin-
gle GP tree to construct multiple features during the evolutionary
process. The algorithm uses the capability of GP to automatically
combine the original features with the functions from the function
set to find the new high-level features.
The proposed approach can successfully find a set of high-level fea-
tures which significantly improve the classification accuracy. It can
also detect the true biomarkers of the MS datasets. The method
is compared to using the original selected features from the same
method before the combination using the functions. It is also com-
pared to another GP method for feature selection.
After applying the algorithm on a number of benchmark MS datasets,
the results show that the proposed method has a significant potential
to reduce the number of features more than feature selection, and se-
lect a much smaller feature set than the original set of features. At the
same time, it successfully improved the classification performance
more than the methods used for comparison on the used datasets
and managed to detect the predefined biomarkers.
• Proposes the first multi-objective embedded feature selection approach
using GP for the high dimensional MS data. The proposed multi-
objective approach aims to minimise the number of features, and
maximise the classification performance of GP using the smaller sub-
set of features.
The proposed approach has the potential to successfully evolve a
set of non-dominated solutions that are composed of feature sub-
sets. The solutions in the Pareto front have a smaller numbers of
features and better classification performance on GP than the tra-
ditional GP based single objective algorithm. After comparing the
algorithm to the benchmark multi-objective approaches, it is shown
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that it can outperform these methods effectively on the used datasets
in terms of both classiifcation performance and the number of pre-
defined biomarkers detected.
The multi-objective approach for feature selection is modified for
feature construction in order to examine the construction of high-
level features using the multi-objective optimisation. Based on the
method proposed for multiple feature construction, the proposed ap-
proach extends the single objective algorithm feature construction to
a multi-objective one. The proposed approach managed to reduce
the number of evolved constructed features and simultaneously in-
crease the classification accuracy. The methods show further im-
provement of both the number of features and classification perfor-
mance over the aforementioned proposed multi-objective feature se-
lection approach in most of the datasets used, and hence, outperform
the single objective approach and the benchmark multi-objective ap-
proaches for feature selection.
• Proposes a new GP biomarker verification method through peptide
detection. The method acts as a verification stage for the biomarker
candidates, represented as peptides, through the examination and
prediction whether they are going to be observed in the mass spec-
trometer. The proposed approach solves the problem of the unbal-
anced peptide data, where usually the biomarkers peptides are in
the minority class. Using the flexibility of GP to build classification
models that are not biased by the majority class, the proposed ap-
proach succeeds in evolving classifiers which improve the minority
class’s accuracy. Moreover, the proposed approach uses the auto-
matic feature selection capability in GP to discover the important
features represented as the physiochemical properties for detection
of the peptides. After testing on a number of datasets, including an
in-house dataset, and comparing the algorithm to benchmark classi-
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fiers and feature selection algorithms, it is clear that GP for peptide
detection can make better progress. The method is also compared to
ESP-Predictor, which is a benchmark peptide detection method and
shows improved performance.
• Presents some initial work for the use of GP for alignment of MS
data. Alignment of MS data is a main preprocessing step in the data
analysis and can directly affect the biomarker detection process.
8.3 Main Conclusions
This thesis finds that GP can effectively address the biomarker detection
problem through feature selection and construction in single objective or
multi-objective ways. The use of GP has been found to be useful for han-
dling the challenges in MS data, which includes high dimensionality (MS
data that typically has thousands of features), small number of examples,
and a high percentage of noise.
GP showed to be successful for this task and managed to select and
construct features of high capability for improving the classification per-
formance. The thesis also finds that GP can be used effectively for verifi-
cation of biomarkers through classification of unbalanced peptide data.
This section presents and discusses the main conclusions drawn from
the four contributions of the thesis.
8.3.1 Ensemble and Ranking of Features Mechanisms in
GP
Chapter 3 proposes a new single objective GP feature ranking approach
which uses a new ensemble mechanism for selecting and ranking features
using an embedded approach.
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Ensemble feature selection mechanism in the GP embedded approach
The combination of different metrics for feature ranking is found to be
useful for improving the feature selection process. This is because each
metric has its advantages in ranking the top features, and the use of GP
to further select from the top ranking features and generate better feature
combinations.
Biomarker detection was usually performed using a single feature rank-
ing metric which has the risk of ignoring the important relationships be-
tween features. Using more than one metric provides a better combination
of features and has the advantage of reducing the search area for these
metrics. GP can automatically select features and reduce the features to
be used in classification. Using an embedded approach can also evolve
the classification model along with the feature selection process. This is
found to be useful because it combines the advantage of the wrapper ap-
proaches and filter approaches of using a classifier for evaluation of fea-
tures and avoiding the high computational cost. Another advantage of
using the embedded approach is the better understanding of feature inter-
actions through the linking of the feature selection and the classification
processes.
Ranking mechanism in GP
The tree-based GP may select the same feature more frequently than an-
other feature. It is found that the more frequently selected features can be
more relevant to classification and hence, they should be given a higher
rank. In addition, GP as an evolutionary algorithm starts from a random
seed, and therefore, it must be run several times. The appearance of the
feature in several runs gives it more score. The new rank for the auto-
matically selected features has been found to be useful for improving the
performance of classification.
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Generality of embedded approach
Although the performance of GP as a classifier is better with its selected
features, the embedded approach for feature selection has the potential to
be generalised to other classifiers. Testing the features of the embedded
approach feature selection with other classifiers has been found to be ef-
fective in improving their performance.
8.3.2 Single objective Multiple Feature Construction
This thesis proposes the first multiple feature construction approach for
biomarker discovery in MS data (Chapter 4). From Chapter 4, it is found
that the use of the high-level features can significantly influence the per-
formance of the classifier. GP can construct multiple high-level features
automatically from a single GP tree. These features successfully reduce di-
mensionality and improve classification accuracy more than the selected
features. The new fitness function (which is considered as computation-
ally cheap) proposed also managed to construct features that have more
power in distinguishing the classes.
Applying the method on datasets with predefined biomarkers con-
firms its capability of detecting the biomarkers defined.
8.3.3 Multi-objective Feature Manipulation
The first GP multi-objective biomarker detection is proposed in this thesis
(Chapter 5). It is found that the multi-objective optimisation using GP can
successfully be used for feature manipulation in the high dimensional MS
data. Either feature selection or construction involves a large search space
in MS data, which is characterized by high feature-to-sample ratio. This
makes selection or construction of features in MS data a challenging and
complex task.
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Multi-objective Feature Selection
The thesis finds that GP using the ideas from SPEA2 or NSGAII can se-
lect non-dominated solutions from the original set of features. These non-
dominated solutions have a smaller number of features, a better classifica-
tion accuracy and a better biomarker detection rate than the single objec-
tive GP and either SPEA2 or NSGAII individually for feature selection.
Multi-objective Feature Construction
This thesis proposes the first multi-objective feature construction approach
for biomarker detection. Examining the multi-objective approach for fea-
ture construction finds that the achieved Pareto Front contains new high-
level features which significantly improve the classification performance
and reduce the number of generated features from the evolved tree more
effectively than the single objective proposed feature construction approach
discussed in Chapter 4.
The approach further improves the classification performance over the
aforementioned multi-objective feature selection and hence, it outperformed
the single objective and the benchmark multi-objective approaches for fea-
ture selection.
8.3.4 Biomarker Verification
The thesis is the first to link the biomarker detection and their verifica-
tion as an intermediate stage before the experimental validation stage. In
Chapter 6, the thesis proposes the first use of GP for biomarker verifica-
tion. It is also the first verification algorithm which solves the imbalance
problem in the peptide data.
It is found that GP for biomarker verification can significantly improve
the accuracy of the minority class which include the predicted peptides
to be observed in the mass spectrometer. These observed peptides are
classified as the verified peptide biomarkers.
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8.4 Future Directions
This section provides some possible future directions in the use of GP for
biomarker detection and MS data analysis.
8.4.1 Single Objective GP for Feature Construction
The GP-based system proposed in this thesis produces multiple high-level
features from a single evolved program which depends on the tree depth.
To reduce the dimensionality of the evolved features, the arithmetic sim-
plification of the tree might be considered. This can help in evolving a
smaller number of features.
8.4.2 Building a multi-class GP classification system for MS
data
The classification of MS data in case of multiple classification is more dif-
ficult than binary classification. This due to the high dimensionality, small
number of samples in each class and often imbalance of the data. Some-
times, the MS data involves more than two classes (e.g. Stage 1, Stage 2
and Healthy classes). In the thesis, fixed interval thresholds are used for
multiple classes. As future work, one might consider building pairwise
GP classifier models or using multiple output GP for this task.
8.4.3 GP for Quantification of Proteins and Peptides
The thesis discusses a biomarker verification method that predicts the pep-
tide’s detectability. The system can be used for peptide quantification by
using the detection probability as an absolute intensity of the peptide. De-
termining the absolute quantity of peptides, which will help in predicting
the real concentration of the specific peptide, can be more accurate by us-
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ing GP for solving a symbolic regression problem for regressing the actual
intensity of these peptides.
8.4.4 GP for discovering the Pathways of the Diseased Metabo-
lites
Modeling the chemical reactions of the biomarkers in the disease chemical
network is useful for understanding the disease process. Metabolic path-
ways are the chemical reactions that take place within the cell. Modeling
metabolic underlying biochemical processes is difficult and is not system-
atically approached. This analysis of the metabolic pathway is also an
essential tool for metabolic biomarker validation.
Another future direction can be developing a GP method for regres-
sion of the expected pathway of the detected peptides. This method will
help validate the metabolic biomarker detected by the GP feature selection
method and compare these pathways with those in the metabolic path-
ways databases, such as the KEGG database.
8.4.5 GP for Alignment and Peak Extraction in MS data
The thesis presents some initial work on the use of GP for MS data align-
ment and peak extraction. This work can be extended to the use of GP for
clustering the matching peaks. This will relate to another interesting but
challenging research direction, i.e. using GP for peak matching through a
clustering approach that can match the partner peaks better.
8.4.6 GP for Feature Selection in Unbalanced data
In peptide detection problem and generally in MS data, the datasets might
suffer from an imbalance problem. GP has been successfully used in the
thesis to evolve classifiers that can handle the imbalance of the peptide
dataset. However, selecting the features from the unbalanced data is still
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an issue. Hence, in the future, one might take into account the conver-
gence of bagging and boosting with balanced bootstrap sampling in GP to
handle this problem.
8.4.7 Further Selection from Multiple Solutions
The fact that GP produces multiple solutions might be challenged by bi-
ologists (a single solution is required). This disadvantage is related to all
evolutionary algorithms and other stochastic algorithms such as neural
network. Hence, further selection mechanisms to help biologists make a
good choice need to be considered and developed in the future.
8.4.8 Verification and Experimental Validation of the De-
tected Biomarkers
In future work, the candidate biomarkers detected by the proposed GP
biomarker detection approaches will be verified using the GP verification
method presented in Chapter 6. This will help reduce the cost of the exper-
imental validation through passing a smaller number of candidates. The
verified biomarkers will be passed to the final experimental validation.
8.4.9 More MS and LC-MS Datasets
In future work, these GP methods would be evaluated on more biomarker
detection tasks using both MS and LC-MS datasets.
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